WO2021220952A1 - Nitrogen-containing heterocyclic compound and use thereof - Google Patents

Nitrogen-containing heterocyclic compound and use thereof Download PDF

Info

Publication number
WO2021220952A1
WO2021220952A1 PCT/JP2021/016414 JP2021016414W WO2021220952A1 WO 2021220952 A1 WO2021220952 A1 WO 2021220952A1 JP 2021016414 W JP2021016414 W JP 2021016414W WO 2021220952 A1 WO2021220952 A1 WO 2021220952A1
Authority
WO
WIPO (PCT)
Prior art keywords
group
substituent
formula
represented
groups
Prior art date
Application number
PCT/JP2021/016414
Other languages
French (fr)
Japanese (ja)
Inventor
正幸 横山
大地 東山
一剛 萩谷
Original Assignee
東洋紡株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 東洋紡株式会社 filed Critical 東洋紡株式会社
Publication of WO2021220952A1 publication Critical patent/WO2021220952A1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials

Definitions

  • the nitrogen-containing heterocyclic compound and the technology related to its use are disclosed.
  • OLEDs organic light emitting diodes
  • the light emitting material it is required that various characteristics such as light emitting color (for example, light emitting maximum wavelength, full width at half maximum), light emitting efficiency, and durability are preferable.
  • compounds showing Thermally Activated Delayed Fluorescence (TADF) show high luminous efficiency while being pure organic substances, and are expected as next-generation light emitting materials.
  • Patent Document 1 describes the following formula: (In the formula, Y is a cyano group or a trifluoromethyl group.) The compounds represented by are described. Further, in Patent Document 2, the following formula: The compounds represented by are described.
  • a main object of the present invention is to provide a nitrogen-containing heterocyclic compound having excellent luminous efficiency and durability and a technique relating to its use.
  • Cz-L-Ar (1) [During the ceremony, Cz is calculated by the following equation (2): (During the ceremony, Z is absent, single bond, -C (R 29a ) (R 29b )-, -O-, -S-, or -N (R 29c )-. R 22 and R 27 are electron-attracting groups, respectively, and R 23 and R 26 are electron-donating groups, respectively.
  • R 21 , R 24 , R 25 , R 28 , R 29a , R 29b , and R 29c are hydrogen atoms, electron attracting groups, or electron donating groups, respectively.
  • the wavy line indicates the binding site with L) It is a group represented by L is a phenylene group which may have a single bond or a substituent, and is a phenylene group.
  • Ar is a group selected from the group consisting of an aryl group and a heteroaryl group, and the group may have an N, N-diarylamino group or a substituent which may have a substituent.
  • the present invention includes the following aspects.
  • Item 1 Compound represented by the following formula (1): Cz-L-Ar (1) [During the ceremony, Cz is calculated by the following equation (2): (During the ceremony, Z is absent, single bond, -C (R 29a ) (R 29b )-, -O-, -S-, or -N (R 29c )-.
  • R 22 and R 27 are electron-attracting groups, respectively, and R 23 and R 26 are electron-donating groups, respectively.
  • R 21 , R 24 , R 25 , R 28 , R 29a , R 29b , and R 29c are hydrogen atoms, electron attracting groups, or electron donating groups, respectively.
  • L is a phenylene group which may have a single bond or a substituent, and is a phenylene group.
  • Ar is a group selected from the group consisting of an aryl group and a heteroaryl group, and the group may have an N, N-diarylamino group or a substituent which may have a substituent. It may have at least one substituent selected from a cycloalkyl group, an aryl group which may have a substituent, and a heteroaryl group which may have a substituent (where Ar is. , Not a group represented by equation (2))].
  • Ar is a group selected from the group consisting of a phenyl group, a fused bi to hexacyclic aryl group, and a nitrogen-containing heteroaryl group, and the group may have a substituent N, N-diaryl. At least one substituent selected from an amino group, a cycloalkyl group which may have a substituent, an aryl group which may have a substituent, and a heteroaryl group which may have a substituent. (However, Ar is not a group represented by the formula (2)), the compound according to Item 1. Item 3.
  • R 3 is a hydrogen atom, an N, N-diarylamino group which may have a substituent, a cycloalkyl group which may have a substituent, an aryl group which may have a substituent, or It is a heteroaryl group that may have a substituent and
  • the two R 3 which may be present in a positional relationship ortho to each other, may form an aromatic ring bonded to each other, the aromatic ring may have a substituent N, N-diarylamino group Has at least one substituent selected from a cycloalkyl group which may have a substituent, an aryl group which may have a substituent, and a heteroaryl group which may have a substituent.
  • the groups represented by the formula (3) are the following formulas (3-1) to (3-4): (During the ceremony, R 311 and R 312 , R 321 to R 323 , R 331 to R 336 , and R 341 to R 346 , respectively, have a hydrogen atom and an N, N-diarylamino group and a substituent which may have a substituent. A cycloalkyl group which may have a substituent, an aryl group which may have a substituent, or a heteroaryl group which may have a substituent.
  • the wavy line indicates the binding site with L) Item 3.
  • Item 5. Item 3 or 4 in which L is a phenylene group which may have at least one substituent selected from the group consisting of a group represented by the formula (2) and a group represented by the formula (3).
  • the compound described in. Item 6. Item 2. The compound according to any one of Items 1 to 5, wherein Z is a single bond.
  • R 23 and R 26 each have an alkyl group, an alkoxy group, a trialkylsilyl group, an N, N-diarylamino group which may have a substituent, a cycloalkyl group which may have a substituent, and the like.
  • Item 2. The compound according to any one of Items 1 to 7, which is an aryl group which may have a substituent or a heteroaryl group which may have a substituent.
  • R 21 , R 24 , R 25 , and R 28 are hydrogen atoms, or R 21 and R 28 are electron donating groups, respectively, and R 24 and R 25 are electron attracting groups, respectively.
  • the compound according to any one of Items 1 to 8. Item 10.
  • R 51 , R 52 , and R 58 each have a hydrogen atom, an N, N-diarylamino group which may have a substituent, a cycloalkyl group which may have a substituent, and a substituent, respectively. It is an aryl group which may have a substituent or a heteroaryl group which may have a substituent.
  • Each of R 53 to R 57 is a hydrogen atom or a group represented by the formula (2) (however , at least one of R 53 to R 57 is a group represented by the formula (2))].
  • R 61 to R 65 are hydrogen atoms or groups represented by the formula (2), respectively (however , at least one of R 61 to R 65 is a group represented by the formula (2)).
  • R 66 is a hydrogen atom, an N, N-diarylamino group which may have a substituent, a cycloalkyl group which may have a substituent, an aryl group which may have a substituent, or It is a heteroaryl group that may have a substituent];
  • R 81 to R 84 and R 89 each have a hydrogen atom, an N, N-diarylamino group which may have a substituent, a cycloalkyl group which may have a substituent, and a substituent, respectively. It is an aryl group that may be present, or a heteroaryl group that may have a substituent, and is R 85 to R 88 are hydrogen atoms or groups represented by the formula (2) (however , at least one of R 85 to R 88 is a group represented by the formula (2))].
  • Item 2 The compound according to Item 1, which is selected from the group consisting of. Item 11.
  • An organic light emitting device containing the compound according to any one of Items 1 to 10.
  • Item 13. Item 2.
  • Item 14. The following formula (9): (During the ceremony, R 91 and R 94 are perfluoroalkyl groups or cyano groups, respectively.
  • R 92 and R 93 are an alkyl group, an alkoxy group, a trialkylsilyl group, an N, N-diarylamino group which may have a substituent, and a cycloalkyl group which may have a substituent, respectively.
  • Z 9 is absent, single bond, -C (R 95 ) (R 96 )-, -O-, -S-, or -N (R 97 )-, and R 95 to R 97 are a hydrogen atom, an electron attracting group, or an electron donating group, respectively)
  • Compounds represented by (where Z 9 is absent, R 91 and R 94 are trifluoromethyl groups, R 92 and R 93 are methoxy groups, and Z 9 is absent.
  • R 91 and R 94 are cyano groups
  • R 92 and R 93 are phenyl groups).
  • a nitrogen-containing heterocyclic compound having excellent luminous efficiency and durability and a technique related to its use are provided.
  • FIG. 1 is a diagram showing a 1 H NMR spectrum of 3,6-dibromo-2,7-bis (trifluoromethyl) -9H-carbazole.
  • FIG. 2 is a diagram showing a 19 F NMR spectrum of 3,6-dibromo-2,7-bis (trifluoromethyl) -9H-carbazole.
  • FIG. 3 is a diagram showing a 1 H NMR spectrum of intermediate D1.
  • FIG. 4 is a diagram showing a 19 F NMR spectrum of intermediate D1.
  • FIG. 5 is a diagram showing a 1 H NMR spectrum of intermediate D2.
  • FIG. 6 is a diagram showing a 19 F NMR spectrum of intermediate D2.
  • FIG. 7 is a diagram showing a 1 H NMR spectrum of intermediate D3.
  • FIG. 1 is a diagram showing a 1 H NMR spectrum of 3,6-dibromo-2,7-bis (trifluoromethyl) -9H-carbazole.
  • FIG. 3 is a diagram showing
  • FIG. 8 is a diagram showing a 19 F NMR spectrum of intermediate D3.
  • FIG. 9 is a diagram showing a 1 H NMR spectrum of intermediate D5.
  • FIG. 10 is a diagram showing a 19 F NMR spectrum of Intermediate D5.
  • FIG. 11 is a diagram showing a 1 H NMR spectrum of Intermediate A2.
  • FIG. 12 is a diagram showing a 1 H NMR spectrum of Intermediate A3.
  • FIG. 13 is a diagram showing a 19 F NMR spectrum of Intermediate A3.
  • FIG. 14 is a diagram showing a 1 H NMR spectrum of Intermediate A4.
  • FIG. 15 is a diagram showing a 19 F NMR spectrum of Intermediate A4.
  • FIG. 16 is a diagram showing a 1 H NMR spectrum of Intermediate A5.
  • FIG. 17 is a diagram showing a 19 F NMR spectrum of Intermediate A5.
  • FIG. 18 is a diagram showing a 1 H NMR spectrum of Intermediate A6.
  • FIG. 19 is a diagram showing a 19 F NMR spectrum of Intermediate A6.
  • FIG. 20 is a diagram showing a 1 H NMR spectrum of Intermediate A7.
  • FIG. 21 is a diagram showing a 19 F NMR spectrum of Intermediate A7.
  • FIG. 22 is a diagram showing a 1 H NMR spectrum of Intermediate A8.
  • FIG. 23 is a diagram showing a 1 H NMR spectrum of Intermediate A9.
  • FIG. 24 is a diagram showing a 19 F NMR spectrum of Intermediate A9.
  • FIG. 25 is a diagram showing a 1 H NMR spectrum of Example 1.
  • FIG. 26 is a diagram showing a 19 F NMR spectrum of Example 1.
  • FIG. 27 is a diagram showing a 1 H NMR spectrum of Example 2.
  • FIG. 28 is a diagram showing a 19 F NMR spectrum of Example 2.
  • FIG. 29 is a diagram showing a 1 H NMR spectrum of Example 3.
  • FIG. 30 is a diagram showing a 19 F NMR spectrum of Example 3.
  • FIG. 31 is a diagram showing a 1 H NMR spectrum of Example 4.
  • FIG. 32 is a diagram showing a 19 F NMR spectrum of Example 4.
  • FIG. 33 is a diagram showing a 1 H NMR spectrum of Comparative Example 5.
  • FIG. 34 is a diagram showing a 1 H NMR spectrum of Comparative Example 6.
  • FIG. 35 is a diagram showing a 19 F NMR spectrum of Comparative Example 6.
  • FIG. 36 is a diagram showing a 1 H NMR spectrum of Comparative Example 10.
  • FIG. 37 is a diagram showing a 13 C NMR spectrum of Comparative Example 10.
  • FIG. 38 is a diagram showing a 1 H NMR spectrum of Comparative Example 11.
  • FIG. 39 is a diagram showing a 19 F NMR spectrum of Comparative Example 11.
  • FIG. 40 is a diagram showing a 1 H NMR spectrum of Comparative Example 13.
  • FIG. 41 is a diagram showing a 19 F NMR spectrum of Comparative Example 13.
  • halogen atom is used in the sense of including a fluorine atom, a chlorine atom, a bromine atom, an iodine atom and the like.
  • alkyl group means a linear or branched saturated hydrocarbon group, and specifically, for example, a methyl group, an ethyl group, or a propyl group (n).
  • -Propyl group isopropyl group
  • butyl group n-butyl group, isobutyl group, sec-butyl group, tert-butyl group
  • pentyl group hexyl group and other C 1-20 alkyl groups.
  • the "perfluoroalkyl group” means a group in which all hydrogen atoms of the alkyl group are substituted with fluorine atoms, and specifically, for example, a trifluoromethyl group.
  • alkoxy group means a group in which an oxygen atom is bonded to the terminal of the alkyl group, and specifically, for example, a methoxy group, an ethoxy group, or a propoxy group (n).
  • -C 1-12 alkoxy groups such as propoxy group (propoxy group, isopropoxy group), butoxy group (n-butoxy group, isobutoxy group, sec-butoxy group, tert-butoxy group) can be mentioned.
  • alkylsulfanyl group means a group in which a sulfur atom is bonded to the terminal of the alkyl group, and specifically, for example, a methylsulfanyl group, an ethylsulfanyl group, or a propyl.
  • alkylsulfanyl group such as a sulfanyl group (n-propyl sulfanyl group, isopropyl sulfanyl group) and a butyl sulfanyl group.
  • Examples thereof include (C 1-12 alkyl) carbonyl groups such as methylcarbonyl group, ethylcarbonyl group, propylcarbonyl group (n-propylcarbonyl group, isopropylcarbonyl group) and butylcarbonyl group.
  • cycloalkyl group includes a cycloC 5-20 alkyl group such as a cyclopentyl group, a cyclohexyl group, a cycloheptyl group and a cyclooctyl group.
  • the "trialkylsilyl group” means a group in which the three alkyl groups are bonded to a silicon atom, and specifically, for example, a trimethylsilyl group and a triethylsilyl group. Examples thereof include a tri-C 1-4 alkylsilyl group such as a triisopropylsilyl group and a tert-butyldimethylsilyl group.
  • aromatic ring is used in the sense of including an arene ring and a heteroarene ring.
  • the number of carbon atoms in the arene ring is not particularly limited, but is, for example, 6 to 40, preferably 6 to 30, more preferably 6 to 28, and even more preferably 6 to 26.
  • the arene ring is preferably a benzene ring or a fused ring having a structure in which a plurality of benzene rings are condensed.
  • Examples of the arene ring include a benzene ring, a naphthalene ring, a fluorene ring, an anthracene ring, a phenanthrene ring, a fluoranthene ring, a tetracene ring, a tetraphen ring, a chrysene ring, a triphenylene ring, a pyrene ring, a benzopyrene ring, a perylene ring, and a coronene ring.
  • Examples include a coronene ring, a phenalene ring, and a trianglene ring.
  • the number of ring-constituting atoms in the heteroarene ring is not particularly limited, but is, for example, 5 to 40 members.
  • the heteroarene ring may be a monocyclic type or a polycyclic type (for example, a two- to four-ring type).
  • the heteroarene ring is preferably a heteroarene ring containing at least one heteroatom selected from an oxygen atom, a sulfur atom, and a nitrogen atom as a ring-constituting atom.
  • heteroarene ring examples include an oxygen-containing heteroarene ring (eg, furan ring, benzofuran ring, dibenzo [b, d] furan ring) and a sulfur-containing heteroarene ring (eg, thiophene ring, benzothiophene ring, dibenzo [b].
  • oxygen-containing heteroarene ring eg, furan ring, benzofuran ring, dibenzo [b, d] furan ring
  • sulfur-containing heteroarene ring eg, thiophene ring, benzothiophene ring, dibenzo [b].
  • the aryl group is a group obtained by removing one hydrogen atom from the aromatic hydrocarbon ring (arene ring) in the aromatic ring.
  • the aryl group may be a monocyclic aryl group or a fused cyclic aryl group (for example, a fused bi to hexacyclic aryl group).
  • Examples of the monocyclic aryl group include a phenyl group.
  • Examples of the fused cyclic aryl group include a naphthyl group, a fluorenyl group, an anthrasenyl group, a triphenylenyl group, and a pyrenyl group.
  • a C 6-18 aryl group is preferable.
  • the heteroaryl group is a group obtained by removing one hydrogen atom from the aromatic heterocycle (heteroarene ring) in the aromatic ring.
  • the heteroaryl group may be a monocyclic heteroaryl group (eg, a 5- or 6-membered monocyclic heteroaryl group) or a fused cyclic heteroaryl group (eg, a fused 2- to 6-cyclic aryl group). May be.
  • Examples of the monocyclic heteroaryl group include a monocyclic oxygen-containing heteroaryl group such as a frill group; a monocyclic sulfur-containing heteroaryl group such as a thienyl group; a pyrrolyl group, a pyrazolyl group, an imidazolyl group, a triazil group and a pyridyl group.
  • Examples thereof include monocyclic nitrogen-containing heteroaryl groups such as a pyridazyl group, a pyrimidyl group, a pyrazil group and a triazinyl group.
  • fused cyclic heteroaryl group examples include a fused cyclic oxygen-containing heteroaryl group such as a benzofuryl group and a dibenzofuryl group; a fused cyclic sulfur-containing heteroaryl group such as a benzothienyl group and a dibenzothienyl group; an indrill group and a quinolyl group.
  • Fused cyclic nitrogen-containing heteroaryl groups such as groups, isoquinolyl groups, carbazolyl groups, acrizyl groups, 9,10-dihydroacrylidyl groups, phenadyl groups, 5,10-dihydrophenadyl groups; fused cyclic oxygen such as phenoxazyl groups.
  • nitrogen-containing heteroaryl groups; fused cyclic sulfur such as phenothiazil groups and nitrogen-containing heteroaryl groups can be mentioned.
  • the "electron donating group (donor group)" represents a group in which Hammett's ⁇ p is negative. Hansch, C.et.al., Chem.Rev., 91,165-195 (1991) can be referred to for a description of Hammett's ⁇ p and the numerical values of each group.
  • Examples of the electron donating group include an alkyl group such as a methyl group, an isopropyl group and a tertiary butyl group, a cycloalkyl group such as a cyclohexyl group, a phenyl group, a naphthyl group, an anthracenyl group, a triphenylenyl group, a pyrenyl group and a fluorenyl group.
  • an alkyl group such as a methyl group, an isopropyl group and a tertiary butyl group
  • a cycloalkyl group such as a cyclohexyl group, a phenyl group, a naphthyl group, an anthracenyl group, a triphenylenyl group, a pyrenyl group and a fluorenyl group.
  • Aryl group alkoxy group such as methoxy group, alkylsulfanyl group such as methionyl group, trialkylsilyl group such as trimethylsilyl group, pyridyl group, imidazolyl group, pyrazolyl group, oxazolyl group, thiazolyl group, indolyl group, pyrrolyl group, quinolyl.
  • Heteroaryl group, N , N, N-diarylamino group such as N-diphenylamino group.
  • the "electron-attracting group (acceptor group)” means a group other than an electron-donating group, for example, an alkylcarbonyl group (acyl group), an alkylsulfonyl group, and the like. Examples thereof include a perfluoroalkyl group, a cyano group and a nitro group.
  • the compound of the present invention is preferably a compound represented by the following formula (1): Cz-L-Ar (1) [During the ceremony, Cz is calculated by the following equation (2): (During the ceremony, Z is absent, single bond, -C (R 29a ) (R 29b )-, -O-, -S-, or -N (R 29c )-.
  • R 22 and R 27 are electron-attracting groups, respectively, and R 23 and R 26 are electron-donating groups, respectively.
  • R 21 , R 24 , R 25 , R 28 , R 29a , R 29b , and R 29c are hydrogen atoms, electron attracting groups, or electron donating groups, respectively.
  • L is a phenylene group which may have a single bond or a substituent, and is a phenylene group.
  • Ar is a group selected from the group consisting of an aryl group and a heteroaryl group, and the group may have an N, N-diarylamino group or a substituent which may have a substituent. It may have at least one substituent selected from a cycloalkyl group, an aryl group which may have a substituent, and a heteroaryl group which may have a substituent (where Ar is. , Not a group represented by equation (2))].
  • Cz (Equation (2)) Z is preferably a single bond, -C (R 29a ) (R 29b )-, -O-, -S-, or -N (R 29c )-, and more preferably a single bond.
  • the present inventors consider that when R 22 and R 27 are electron attracting groups and R 23 and R 26 are electron donating groups, R 22 and R 27 are electron seeking groups. Emission compared to the case where R 23 and R 26 are hydrogen atoms and where R 22 and R 27 are hydrogen atoms and R 23 and R 26 are electron donating groups. We have found that the half-price range of the peak can be further narrowed.
  • R 22 , R 27 , and R 21 , R 24 , R 25 , R 28 , and R 29a to R 29c are electron-attracting groups
  • the electron-attracting groups are, respectively. It is preferably a perfluoroalkyl group or a cyano group. More preferably, it is a perfluoroC 1-4 alkyl group or a cyano group. More preferably, it is a perfluoroC 1-3 alkyl group or a cyano group. Even more preferably, it is a perfluoroC 1-2 alkyl group or a cyano group. Particularly preferably, it is a trifluoromethyl group or a cyano group.
  • R 23 , R 26 , and R 21 , R 24 , R 25 , R 28 , and R 29a to R 29c are electron-donating groups
  • the electron-donating groups are, respectively. It preferably has an alkyl group, an alkoxy group, a trialkylsilyl group, an N, N-diarylamino group which may have a substituent, a cycloalkyl group which may have a substituent, or a substituent. It may have an aryl group or a heteroaryl group which may have a substituent, and more preferably a C 1-6 alkyl group, a C 1-6 alkoxy group, a tri C 1-6 alkylsilyl group and a substituent.
  • N, N-di C 6-18 arylamino group may have substituent C 5-12 cycloalkyl group, may have substituent C 6-18 aryl
  • a 5- or 6-membered monocyclic heteroaryl group which may have a group, a substituent, or a fused 2- to tetracyclic heteroaryl group which may have a substituent.
  • the N, N-diarylamino group is preferably an electron attracting group and an electron donating group.
  • the cycloalkyl group, the aryl group, and the substituent optionally contained in the heteroaryl group are preferably an aryl group or a heteroaryl group, more preferably an aryl group, and further preferably a C 6-12 aryl group. It is particularly preferably a C 6-10 aryl group. It is also preferable that the substituent arbitrarily contained in the heteroaryl group is an electron-attracting group and an electron-donating group. The number of the substituents is, for example, 0, 1, 2, 3, or 4.
  • the electron donating group is also preferably a group represented by the formula (2).
  • R 21 , R 24 , R 25 , and R 28 are combinations of hydrogen atoms; or R 21 and R 28 are electron donating groups, respectively, and R 24 and R 25 are electron attracting groups, respectively.
  • the base combination is preferred.
  • the group represented by the formula (2) is preferably a group selected from the following group: (In the formula, Me is a methyl group, i-Pr is an isopropyl group, t-Bu is a tertiary butyl group, Ph is a phenyl group, and a wavy line indicates a binding site with L).
  • Ar Ar is It is preferably a group selected from an aryl group and a heteroaryl group (however, it is not a group represented by the formula (2)). More preferably, it is a group selected from a C 6-18 aryl group, a 5-membered or 6-membered monocyclic heteroaryl group, and a fused 2- to tetracyclic heteroaryl group (however, it is represented by the formula (2)). Not the basis), More preferably, it is a group selected from a C 6-16 aryl group, a 5-membered or 6-membered monocyclic nitrogen-containing heteroaryl group, and a condensed 2- to tetracyclic nitrogen-containing heteroaryl group (however, the formula (2)).
  • These groups may have an N, N-diarylamino group (for example, a group represented by the formula (2) in which Z is absent), which may have a substituent, and a cyclo which may have a substituent.
  • An alkyl group preferably a C 5-12 cycloalkyl group
  • an aryl group optionally having a substituent preferably a C 6-12 aryl group
  • a heteroaryl group optionally having a substituent preferably a C 5-12 cycloalkyl group.
  • At least one selected from a 5- or 6-membered monocyclic heteroaryl group or a fused 2- to tetracyclic heteroaryl group (eg, a group represented by formula (2) in which Z is other than absent). It may have a substituent of.
  • the substituent arbitrarily contained in the cycloalkyl group, the aryl group, and the heteroaryl group is not particularly limited, but is, for example, an aryl group (for example, C 6-12 aryl group) or a heteroaryl group (for example, 5 members).
  • it may be a 6-membered monocyclic heteroaryl group, a fused bi to tetracyclic heteroaryl group), or a group represented by the formula (2).
  • R 3 is a hydrogen atom, an N, N-diarylamino group which may have a substituent, a cycloalkyl group which may have a substituent, an aryl group which may have a substituent, or It is a heteroaryl group that may have a substituent and
  • the two R 3 which may be present in a positional relationship ortho to each other, may form an aromatic ring bonded to each other, the aromatic ring may have a substituent N, N-diarylamino group Has at least one substituent selected from a cycloalkyl group which may have a substituent, an aryl group which may have a substituent, and a heteroaryl group which may have a substituent.
  • You may be The wavy line indicates the binding site with L).
  • R 3 is preferably a hydrogen atom, an N, N-di C 6-12 arylamino group which may have a substituent (for example, a group represented by the formula (2) in which Z is absent), a substituent.
  • a C 5-12 cycloalkyl group which may have a group, a C 6-12 aryl group which may have a substituent, and a 5-membered or 6-membered monocyclic hetero which may have a substituent. It is a fused bi to tetracyclic heteroaryl group which may have an aryl group or a substituent (for example, a group represented by the formula (2) in which Z is other than absent).
  • substituents examples include an aryl group (for example, C 6-12 aryl group) or a heteroaryl group (for example, a 5-membered or 6-membered monocyclic heteroaryl group, a condensed 2- to 4-cyclic heteroaryl group). It may be a group represented by the formula (2).
  • the combination of) is more preferable.
  • the combination of X 31 , X 32 , and X 35 to X 39 is as a combination.
  • the combination of) is more preferable.
  • the group represented by the formula (3) is preferably a group represented by any of the following formulas (3-1) to (3-4): (In the formula, R 311 , R 312 , R 321 to R 323 , R 331 to R 336 , and R 341 to R 346 , respectively, may have a hydrogen atom and a substituent N, N-diarylamino. A group, a cycloalkyl group which may have a substituent, an aryl group which may have a substituent, or a heteroaryl group which may have a substituent. The wavy line indicates the binding site with L).
  • R 311, R 312, R 321 ⁇ R 323, R 331 ⁇ R 336, and R 341 ⁇ R 346 are each preferably a hydrogen atom, which may have a substituent N, N-di C 6-
  • a 12arylamino group for example, a group represented by the formula (2) in which Z is absent
  • a C 5-12 cycloalkyl group which may have a substituent and a C which may have a substituent.
  • substituent include an aryl group (for example, C 6-12 aryl group) or a heteroaryl group (for example, a 5-membered or 6-membered monocyclic heteroaryl group, a condensed 2- to 4-cyclic heteroaryl group). It may be a group represented by the formula (2).
  • the phenylene group may be any of 1,2-phenylene group, 1,3-phenylene group, and 1,4-phenylene group.
  • the substituent is Preferably, it is an N, N-diarylamino group which may have a substituent, an aryl group which may have a substituent, or a heteroaryl group which may have a substituent. More preferably, it may have an N, N-di C 6-18 arylamino group which may have a substituent, a C 6-18 aryl group which may have a substituent, and a substituent.
  • a fused 2- to tetracyclic heteroaryl group which may have a 5- or 6-membered monocyclic heteroaryl group or a substituent, and is a fused two- to tetracyclic heteroaryl group. More preferably, it is a group represented by the formula (2) or a group represented by the formula (3).
  • the number of the substituents is, for example, 0, 1, 2, 3, or 4.
  • R 41 to R 44 are represented by the formula (2) in which Z is absent, for example , N, N-di C 6-12 arylamino groups which may have a hydrogen atom and a substituent, respectively. Group), C 5-12 cycloalkyl group which may have a substituent, C 6-12 aryl group which may have a substituent, 5 members or 6 which may have a substituent. It is a member monocyclic heteroaryl group or a fused bi to tetracyclic heteroaryl group which may have a substituent (for example, a group represented by the formula (2) in which Z is other than absent).
  • substituents examples include an aryl group (for example, C 6-12 aryl group) or a heteroaryl group (for example, a 5-membered or 6-membered monocyclic heteroaryl group, a condensed 2- to 4-cyclic heteroaryl group). It may be a group represented by the formula (2).
  • the compound represented by the formula (4) is preferably a compound represented by the following formula (4-1) or (4-2): (In the formula, each Cz is the same or different from each other and is a group represented by the formula (2), and X 41 to X 43 and R 41 are the same as described above).
  • the compound represented by the formula (1) is preferably a compound in which L is a phenylene group which may have a substituent, and has one or more Ars on the benzene ring and one or more formulas (1 or more).
  • a compound in which the group represented by 2) is substituted (the total number of Ars and the number of substitutions of the groups represented by the formula (2) is 2 or more and 6 or less) is more preferable, and one Ar and one Ar in the benzene ring and A compound in which one or more and five or less groups represented by the formula (2) are substituted is more preferable, and a compound represented by the following formula (5) is particularly preferable:
  • R 51 , R 52 , and R 58 each have a hydrogen atom, an N, N-diarylamino group which may have a substituent, a cycloalkyl group which may have a substituent, and a substituent, respectively. It is an aryl group which may have a substituent or a heteroaryl group which may have a substituent.
  • Each of R 53 to R 57 is a hydrogen atom or a group represented by the formula (2) (however , at least one of R 53 to R 57 is a group represented by the formula (2))]. ..
  • R 51 , R 52 , and R 58 each preferably have an N, N-di C 6-12 arylamino group (eg, Z is absent), which may have a hydrogen atom and a substituent, respectively (eg, formula (2) in which Z is absent. ), C 5-12 cycloalkyl group which may have a substituent, C 6-12 aryl group which may have a substituent, and may have a substituent.
  • a five- or six-membered monocyclic heteroaryl group or a fused two- to tetracyclic heteroaryl group which may have a substituent for example, a group represented by the formula (2) in which Z is other than absent). Is.
  • substituents examples include an aryl group (for example, C 6-12 aryl group) or a heteroaryl group (for example, a 5-membered or 6-membered monocyclic heteroaryl group, a condensed 2- to 4-cyclic heteroaryl group). It may be a group represented by the formula (2).
  • the compound represented by the formula (5) is preferably a compound represented by any of the following formulas (5-1) to (5-14): (In the formula, Cz is a group represented by the formula (2), and when a plurality of Cz exists, the plurality of Cz may be the same or different from each other, and X 51 to X 53 , R 51. , And R 52 are the same as above).
  • the compound represented by the formula (1) is preferably a compound represented by the following formula (6):
  • R 61 to R 65 are hydrogen atoms or groups represented by the formula (2), respectively (however , at least one of R 61 to R 65 is a group represented by the formula (2)).
  • R 66 is a hydrogen atom, an N, N-diarylamino group which may have a substituent, a cycloalkyl group which may have a substituent, an aryl group which may have a substituent, or It is a heteroaryl group that may have a substituent].
  • R 66 is preferably a hydrogen atom, an N, N-di C 6-12 arylamino group which may have a substituent (for example, a group represented by the formula (2) in which Z is absent), a substituent.
  • a C 5-12 cycloalkyl group which may have a group, a C 6-12 aryl group which may have a substituent, and a 5-membered or 6-membered monocyclic hetero which may have a substituent.
  • a fused bi- to tetracyclic heteroaryl group which may have an aryl group or a substituent (for example, a group represented by the formula (2) in which Z is other than absent).
  • substituents examples include an aryl group (for example, C 6-12 aryl group) or a heteroaryl group (for example, a 5-membered or 6-membered monocyclic heteroaryl group, a condensed 2- to 4-cyclic heteroaryl group). It may be a group represented by the formula (2).
  • the compound represented by the formula (6) is preferably a compound represented by the following formula (6-1): (In the formula, Cz is a group represented by the formula (2), and the two Cz may be the same or different from each other, and X 61 to X 67 are the same as described above).
  • the compound represented by the formula (1) is preferably a compound in which L is a phenylene group which may have a substituent, and has two Ars on the benzene ring and one or more and four or less.
  • a compound in which the group represented by the formula (2) is substituted is more preferable, and a compound represented by the following formula (7) is further preferable:
  • R 71 to R 74 and R 79 each have a hydrogen atom, an N, N-diarylamino group which may have a substituent, a cycloalkyl group which may have a substituent, and a substituent, respectively.
  • R 75 to R 78 are hydrogen atoms or groups represented by the formula (2) (however , at least one of R 75 to R 78 is a group represented by the formula (2))].
  • R 71 to R 74 and R 79 each preferably have a hydrogen atom and a substituent, respectively, N, N-di C 6-12 arylamino groups (for example, formula (2) in which Z is absent).
  • Group represented by) C 5-12 cycloalkyl group which may have a substituent, C 6-12 aryl group which may have a substituent, and may have a substituent 5
  • a fused two- to tetracyclic heteroaryl group which may have a member or 6-membered monocyclic heteroaryl group or a substituent (for example, a group represented by the formula (2) in which Z is other than absent).
  • substituents examples include an aryl group (for example, C 6-12 aryl group) or a heteroaryl group (for example, a 5-membered or 6-membered monocyclic heteroaryl group, a condensed 2- to 4-cyclic heteroaryl group). It may be a group represented by the formula (2).
  • the compound represented by the formula (7) is preferably a compound represented by any of the following formulas (7-1) to (7-3): (In the formula, Cz is a group represented by the formula (2), and when a plurality of Cz exists, the plurality of Cz may be the same or different from each other, and X 71 to X 76 and R 71. ⁇ R 74 is the same as above).
  • the compound represented by the formula (1) is preferably a compound represented by the following formula (8):
  • R 81 to R 84 and R 89 each have a hydrogen atom, an N, N-diarylamino group which may have a substituent, a cycloalkyl group which may have a substituent, and a substituent, respectively.
  • R 85 to R 88 are hydrogen atoms or groups represented by the formula (2) (provided that at least one of R 85 to R 88 is a group represented by the formula (2))].
  • R 81 to R 84 and R 89 preferably have an N, N-diC 6-12 arylamino group which may have a hydrogen atom and a substituent, respectively (for example, formula (2) in which Z is absent).
  • a fused two- to tetracyclic heteroaryl group which may have a member or 6-membered monocyclic heteroaryl group or a substituent (for example, a group represented by the formula (2) in which Z is other than absent).
  • substituents examples include an aryl group (for example, C 6-12 aryl group) or a heteroaryl group (for example, a 5-membered or 6-membered monocyclic heteroaryl group, a condensed 2- to 4-cyclic heteroaryl group). It may be a group represented by the formula (2).
  • the compound represented by the formula (8) is preferably a compound represented by any of the following formulas (8-1) to (8-6): (In the formula, Cz is a group represented by the formula (2), and when a plurality of Cz exists, the plurality of Cz may be the same or different from each other, and X 81 to X 86 and R 81. ⁇ R 84 is the same as above).
  • the half width of the emission peak of the compound of the present invention may be preferably 90 nm or less, more preferably 85 nm or less, further preferably 80 nm or less, or 10 nm or more.
  • the full width at half maximum can be determined by measuring the emission spectrum when a solution (concentration: 1 ⁇ 10-5 M) in which the compound of the present invention is dissolved is irradiated with excitation light at 340 nm at room temperature.
  • the spectrum width of half the peak top intensity is defined as the half width (FWHM, Full Width Half Maximum).
  • the luminous efficiency (PLQY) of the compound of the present invention is preferably 50% or more, more preferably 55% or more, still more preferably 60% or more.
  • Luminous efficiency (PLQY) is a value when a solution (concentration: 1 ⁇ 10-5 M) in which the compound of the present invention is dissolved is irradiated with excitation light at 340 nm at room temperature, and is an absolute PL quantum yield measuring device (for example). , Hamamatsu Photonics Quantaurus-QY C11347-01) can be used for measurement.
  • the HOMO level of the compound of the present invention may preferably be -5.0 eV or less or -5.5 eV or less, and is -7.0 eV or more, -6.5 eV or more, or -6.4 eV or more. May be good. Due to such a HOMO level, compatibility with peripheral materials such as host materials is excellent.
  • the HOMO level can be measured using an atmospheric photoelectron spectrometer (for example, AC-3 manufactured by RIKEN Keiki Co., Ltd.).
  • the orientation parameter S of the compound of the present invention may be preferably 0.002 or more, 0.003 or more, 0.004 or more, or 0.005 or more, and is 0.05 or less. There may be.
  • the orientation parameter S is in the range of 45 to 75 degrees (in 5 degree increments) using a spectroscopic ellipsometer (JA Woollam Japan product) by forming a single film (film thickness of about 30 nm) of the light emitting material on a bare silicon substrate. It can be calculated by performing spectrum measurement and fitting analysis of the obtained spectrum.
  • the redox characteristic ⁇ E of the compound of the present invention may be preferably 0.1 eV or less, 0.08 eV or less, 0.06 eV or less, or 0.05 eV or less, and is 0.01 eV or more.
  • ⁇ E can be calculated by performing cyclic voltammetry measurement under the following measurement conditions. ⁇ Measurement conditions> Working electrode: Glassy carbon Counter electrode: Platinum wire Reference electrode: Ag / AgNO 3 Acetonitrile solution Solvent: THF Electrolyte: Bu 4 NPF 6 Running speed: 50 meV / s Luminescent material concentration: 1 mM Electrolyte concentration: 100 mM
  • the compound represented by the formula (1) is not particularly limited, but for example, the following formula (11): (In the formula, Z and R 21 to R 28 are the same as above)
  • Q 1 is a halogen atom Ar and L are the same as above
  • n is an integer greater than or equal to 1 selected according to the valence of Ar.
  • L is a phenylene group which may have a substituent
  • n is an integer of 1 or more selected according to the valence of L). It can be produced by a method including a step of reacting with a compound represented by.
  • the compound represented by the formula (11) can be produced by a combination of known reactions.
  • the compound represented by the formula (11) is represented by the following formula (13): (In the formula, Q 2 and Q 3 are halogen atoms, respectively, and R 21 , R 22 , R 24 , R 25 , R 27 , and R 28 are the same as above).
  • Q 2 and Q 3 may be the same or different from each other, and are preferably fluorine atoms, chlorine atoms, or bromine atoms, respectively.
  • ⁇ B (OH) 2 is expressed by the following formula: It may be a group represented by.
  • the total amount of the compounds represented by the formulas (14) and (15) used is 2 mol or more, 2.5 mol or more, or 3 mol or more with respect to 1 mol of the compound represented by the formula (13). It is preferably 6 mol or less, 5 mol or less, or 4 mol or less.
  • the reaction is preferably carried out in the presence of a catalyst.
  • a catalyst include a transition metal catalyst, and specific examples thereof include a palladium catalyst, a copper catalyst, a nickel catalyst, and a cobalt catalyst. These catalysts can be used alone or in combination of two or more. When these catalysts are used, International Publication No. 2011/08902, International Publication No. 2015/137472, and the like can be referred to.
  • the reaction is preferably carried out in the presence of a base.
  • a base examples include n-butyllithium, NaH, t-butoxysodium, KOH, K 2 CO 3 , K 3 PO 4 , t-butoxy potassium, potassium acetate, Cs 2 CO 3. and the like. These bases can be used alone or in combination of two or more. When these bases are used, International Publication No. 2008/1178226, Chemistry of Materials, 2010, 22 (7), 2403-2410, Korean Patent Application Publication No. 2018-063708, etc. can be referred to.
  • the reaction is preferably carried out in the presence of a solvent.
  • the solvent is not particularly limited as long as the reaction component can be dissolved, and is, for example, ether (eg, diethyl ether, dipropyl ether, dibutyl ether, 1,4-dioxane, tetrahydrofuran), aromatic hydrocarbon (eg, tetrahydrofuran). Examples include toluene, xylene), amines (eg, chain amines such as triethylamine, cyclic amines such as N-methylpyrrolidone), amides (eg, dimethylformamide), sulfoxides (eg, dimethylsulfoxide) and the like.
  • the solvent one type can be used alone or two or more types can be mixed and used.
  • the reaction temperature and reaction time of the reaction are not particularly limited as long as the reaction proceeds.
  • the reaction temperature may be, for example, 0 ° C. or higher, 15 ° C. or higher, or 25 ° C. or higher, or 200 ° C. or lower, 150 ° C. or lower, or 100 ° C. or lower.
  • the reaction time may be, for example, 1 hour or more, 2 hours or more, or 5 hours or more, and may be 50 hours or less, 30 hours or less, or 10 hours or less.
  • Compound Q 1 represented by the fluorine atom is preferably a chlorine atom, or bromine atom.
  • the compound represented by the formula (12) can be produced by a combination of known reactions.
  • the compound in which L is a single bond can be a commercially available product as it is, and the compound in which L is a phenylene group which may have a substituent may be used.
  • ⁇ B (OH) 2 is expressed by the following formula: It may be a group represented by.
  • reaction of the compound represented by the formula (11) and the compound represented by the formula (12) The reaction may adopt the same reaction conditions as the reaction of the compounds represented by the formulas (13) to (15). can.
  • the compounds represented by the formulas (13) to (15) are reacted, and then the compound represented by the formula (11) is continuously purified.
  • It may be a reaction (one-pot reaction) in which the compound represented by the formula (12) is reacted (without), and after the compounds represented by the formulas (16) and (17) are reacted, the reaction (without the formula (12)) is continued.
  • reaction (one-pot reaction) in which the compound represented by the formulas (13) to (15) is reacted without purifying the compound represented by 12).
  • the delayed fluorescent material of the present invention preferably comprises the compound of the present invention.
  • the delayed fluorescent material can be suitably used, for example, as a light emitting material for an organic light emitting device described later.
  • the organic light emitting device of the present invention preferably contains the compound of the present invention.
  • organic light emitting element examples include an organic photoluminescence element (organic PL element) and an organic electroluminescence element (organic EL element).
  • organic light emitting element is preferably an organic EL element.
  • the organic EL element preferably has an anode, a cathode, and an organic layer formed between the anode and the cathode.
  • the organic layer preferably contains at least a light emitting layer, and may be composed of only a light emitting layer, or may include one or more other organic layers in addition to the light emitting layer.
  • Other organic layers include, for example, injection layers (eg, hole injection layer, electron injection layer), blocking layers (eg, electron blocking layer, hole blocking layer, exciton blocking layer), transport layers (eg, positive). Hole transport layer, electron transport layer) and the like.
  • the hole transport layer may be a hole injection transport layer having a hole injection function
  • the electron transport layer may be an electron injection transport layer having an electron injection function.
  • the organic EL element may be a bottom emission type that extracts the light generated in the light emitting layer from the substrate side, or may be a top emission type that extracts the light generated in the light emitting layer from the opposite side of the substrate.
  • the electrode formed on the substrate side may be an anode or a cathode.
  • the electrode on the side that extracts light is preferably transparent, and the electrode on the opposite side may or may not be transparent.
  • the organic EL element is preferably supported by a substrate.
  • the substrate is not particularly limited as long as it is conventionally used for organic EL elements, and for example, a substrate made of glass, transparent plastic, quartz, silicon, or the like can be used.
  • anode in the organic EL element a metal having a large work function (for example, 4 eV or more), an alloy, an electrically conductive compound, and a mixture thereof as an electrode material are preferably used.
  • electrode materials include metals such as Au and transparent conductive materials such as CuI, indium tin oxide (ITO), SnO 2, and ZnO.
  • a material capable of producing an amorphous transparent conductive film such as IDIXO (In 2 O 3-ZnO) may be used.
  • a thin film may be formed by a method such as vapor deposition or sputtering of the electrode material to form a pattern having a desired shape by a photolithography method. May be formed.
  • a wet film forming method such as a printing method or a coating method can also be used.
  • the sheet resistance as the anode is preferably several hundred ⁇ / ⁇ or less.
  • the film thickness of the anode depends on the material, but is usually selected in the range of 10 to 1000 nm, preferably 10 to 200 nm.
  • a metal having a small work function for example, 4 eV or less
  • electron-injectable metal an alloy, an electrically conductive compound, or a mixture thereof as an electrode material
  • Specific examples of such electrode materials include sodium, sodium-potassium alloy, magnesium, lithium, magnesium / copper mixture, magnesium / silver mixture, magnesium / aluminum mixture, magnesium / indium mixture, aluminum / aluminum oxide (Al 2 O). 3 ) A mixture, a lithium / aluminum mixture, aluminum and the like are suitable.
  • the cathode can be produced by forming a thin film of an electrode material by a method such as thin film deposition or sputtering.
  • the sheet resistance as a cathode is preferably several hundred ⁇ / ⁇ or less.
  • the film thickness of the cathode is usually selected in the range of 10 nm to 5 ⁇ m, preferably 50 to 200 nm. It is preferable that either the anode or the cathode of the organic EL element is transparent or translucent because the emission brightness is improved. Further, by using the transparent conductive material mentioned in the description of the anode for the cathode, a transparent or translucent cathode can be produced, and an element in which both the anode and the cathode have transparency can be produced.
  • the light emitting layer is a layer that emits light (eg, fluorescent light emission, delayed fluorescent light emission, or both) after excitons are generated by recombination of holes and electrons injected from each of the anode and cathode. Is preferable.
  • the light emitting layer may be a layer containing a light emitting material alone, but is preferably a layer containing a light emitting material and a host material.
  • the compound of the present invention one type or two or more types
  • the host material is not particularly limited, but it is preferable to use an organic compound in which at least one of the excitation singlet energy and the excitation triplet energy has a value higher than that of the compound of the present invention. Further, the host material is preferably an organic compound having a hole transporting ability and an electron transporting ability, preventing a long wavelength of light emission, and having a high glass transition temperature.
  • a compound exhibiting TADF property when included in the light emitting layer as a third component (assist dopant compound) in the light emitting layer containing the host material and the light emitting material, it is effective in developing high luminous efficiency (H. Nakan Albany, et al. , Nature Compound, 2014, 5, 4016-4022).
  • H. Nakan Albany, et al. Nature Compound, 2014, 5, 4016-4022.
  • the triplet excitons generate singlet excitons with inverse intersystem crossing (RISC). can do.
  • the energy of the singlet excitons is transferred to the light emitting material, and the light emitting material can emit light. Therefore, theoretically 100% of the exciton energy can be used to make the light emitting material emit light, and high luminous efficiency is exhibited.
  • the content of the compound of the present invention in the light emitting layer is preferably 0.1% by mass or more, more preferably 1% by mass or more, and preferably 50% by mass or less, preferably 20% by mass. It is more preferably 10% by mass or less, and further preferably 10% by mass or less.
  • the injection layer is preferably a layer provided between the electrode and the organic layer in order to reduce the driving voltage or improve the emission brightness.
  • the injection layer includes a hole injection layer and an electron injection layer.
  • the injection layer may be provided between the anode and the light emitting layer or the hole transport layer, and between the cathode and the light emitting layer or the electron transport layer.
  • the blocking layer is preferably a layer capable of blocking the diffusion of charges (electrons or holes) and / or excitons existing in the light emitting layer to the outside of the light emitting layer.
  • the electron blocking layer can be arranged between the light emitting layer and the hole transporting layer, and can prevent electrons from passing through the light emitting layer toward the hole transporting layer.
  • the hole blocking layer can be placed between the light emitting layer and the electron transporting layer to prevent holes from passing through the light emitting layer towards the electron transporting layer.
  • the electron blocking layer and the hole blocking layer can also function as exciton blocking layers, respectively.
  • the electron blocking layer or exciton blocking layer referred to in the present specification is used in the sense that one layer includes a layer having the functions of an electron blocking layer and an exciton blocking layer.
  • the hole blocking layer has the function of an electron transport layer in a broad sense.
  • the hole blocking layer has a role of blocking the holes from reaching the electron transporting layer while transporting electrons, which can improve the recombination probability of electrons and holes in the light emitting layer.
  • As the material of the hole blocking layer a material of the electron transport layer described later can be used as needed.
  • the electron blocking layer has a function of transporting holes in a broad sense.
  • the electron blocking layer has a role of blocking electrons from reaching the hole transporting layer while transporting holes, which can improve the probability of recombination of electrons and holes in the light emitting layer. ..
  • the exciton blocking layer is preferably a layer for blocking excitons generated by recombination of holes and electrons in the light emitting layer from diffusing into the charge transport layer.
  • the exciton blocking layer can be inserted into either the anode side or the cathode side adjacent to the light emitting layer, and both can be inserted at the same time.
  • the layer when the exciton blocking layer is provided on the anode side, the layer can be inserted between the hole transport layer and the light emitting layer adjacent to the light emitting layer, and when inserted on the cathode side, the light emitting layer and the light emitting layer can be inserted.
  • the layer can be inserted adjacent to the light emitting layer between the cathode and the light emitting layer.
  • a hole injection layer, an electron blocking layer and the like can be provided between the anode and the exciton blocking layer adjacent to the anode side of the light emitting layer.
  • An electron injection layer, an electron transport layer, a hole blocking layer, and the like can be provided between the cathode and the exciton blocking layer adjacent to the cathode side of the light emitting layer.
  • the blocking layer it is preferable that at least one of the excitation singlet energy and the excitation triplet energy of the material used as the blocking layer is higher than the excitation singlet energy and the excitation triplet energy of the light emitting material.
  • the hole transport layer is preferably made of a hole transport material having a function of transporting holes, and the hole transport layer can be provided as a single layer or a plurality of layers.
  • a hole transporting material a material having any of hole injection or transport and electron barrier property is preferable, and either an organic substance or an inorganic substance may be used.
  • the hole transporting material that can be used include triazole derivative, oxadiazole derivative, imidazole derivative, carbazole derivative, indolocarbazole derivative, polyarylalkane derivative, pyrazoline derivative and pyrazolone derivative, phenylenediamine derivative, arylamine derivative, and amino.
  • Examples thereof include substituted chalcone derivatives, oxazole derivatives, styrylanthracene derivatives, fluorenone derivatives, hydrazone derivatives, stilben derivatives, silazane derivatives, aniline-based copolymers, and conductive polymer oligomers, particularly thiophene oligomers.
  • As the hole transport material it is preferable to use a porphyrin compound, an aromatic tertiary amine compound, and a styrylamine compound, and it is more preferable to use an aromatic tertiary amine compound.
  • Inorganic semiconductors such as molybdenum oxide can also be used as the hole transport material.
  • the electron transport layer is preferably made of a material having a function of transporting electrons, and the electron transport layer can be provided with a single layer or a plurality of layers.
  • the electron transporting material (which may also serve as a hole blocking material) preferably has a function of transferring electrons injected from the cathode to the light emitting layer.
  • Examples of the electron transporting layer that can be used include nitro-substituted fluorene derivatives, diphenylquinone derivatives, thiopyrandioxide derivatives, carbodiimides, freolenidenemethane derivatives, anthracinodimethane and anthron derivatives, and oxadiazole derivatives.
  • a thiadiazole derivative in which the oxygen atom of the oxadiazole ring is replaced with a sulfur atom, and a quinoxalin derivative having a quinoxalin ring known as an electron attractant can also be used as an electron transport material.
  • a polymer material in which these materials are introduced into a polymer chain or these materials are used as a polymer main chain can also be used.
  • an inorganic semiconductor such as zinc oxide can also be used as an electron transport material.
  • the compound of the present invention may be used not only for the light emitting layer but also for a layer other than the light emitting layer.
  • the compound of the present invention used for the light emitting layer and the compound of the present invention used for the layer other than the light emitting layer may be the same or different.
  • the compound of the present invention may be used for the above-mentioned injection layer, blocking layer (eg, hole blocking layer, electron blocking layer, exciton blocking layer), hole transport layer, electron transport layer and the like.
  • the film forming method for these layers is not particularly limited, and may be formed by either a dry process or a wet process.
  • R, R', and R 1 to R 10 in the structural formulas of the following exemplified compounds each independently represent a hydrogen atom or a substituent.
  • X represents a carbon atom or a complex atom forming a ring skeleton
  • n represents an integer of 3 to 5
  • Y represents a substituent
  • m represents an integer of 0 or more.
  • the HOMO / LUMO level of the host material can be adjusted by appropriately introducing a substituent into the basic skeleton of the following exemplified compound. For example, by introducing a cyano group or a perfluoroalkyl group into the basic skeleton of the following exemplified compound, a compound having a deepened HOMO / LUMO level can be obtained, which can be used as a host material or a peripheral compound.
  • the host material it is also a bipolar character (flow good both holes and electrons) may be a unipolar resistance, but high excited triplet energy level E T1 than the light emitting material Is preferable. More preferred host material has a bipolar property, those high excited triplet energy level E T1 than the light emitting material.
  • preferable compounds as materials that can be further added are given.
  • it can be added as a stabilizing material.
  • the organic EL element of the present invention can be applied to any of a single element, an element having a structure arranged in an array, and a structure in which an anode and a cathode are arranged in an XY matrix.
  • the organic light emitting device such as the organic EL device of the present invention can be further applied to various applications.
  • Organic EL device of the present invention can also be applied to organic electroluminescence lighting and backlight, which are in great demand.
  • the organic light emitting device of the present invention can be applied to an organic light emitting diode.
  • 2-Bromo-4,6-diphenylpyrimidine (611 mg), 2,4,6-trifluorophenylboronic acid (482 mg), potassium carbonate (1.33 g), tris (dibenzylidene) in a 20 mL eggplant flask under a nitrogen atmosphere.
  • Acelatin dipalladium (0) chloroform adduct (124 mg) and tri-tert-butylphosphonium tetrafluoroborate (156 mg) were added, and DMF (10 mL) was added to dissolve the mixture. After degassing the reaction solvent, the mixture was stirred with heating under reflux for 20 hours. The reaction mixture was allowed to cool, and toluene and water were added to separate the solutions.
  • 6-iodoquinoline (509 mg), 3,5-difluorophenylboronic acid (471 mg), potassium carbonate (1.08 g), and tetrakistriphenylphosphine palladium (132 mg) were placed in a 20 mL eggplant flask, and toluene (toluene) was added. 8 mL) and water (3 mL) were added and dissolved. After degassing the reaction solvent, the mixture was stirred with heating under reflux for 21 hours. The reaction mixture was allowed to cool, ethyl acetate and water were added, and the layers were separated. The aqueous layer was extracted with ethyl acetate, and the organic layers were combined and concentrated under reduced pressure.
  • 6-iodoquinoline (613 mg), 3-bromo-5-fluorophenylboronic acid (796 mg), potassium carbonate (1.28 g), and tetrakistriphenylphosphine palladium (150 mg) were placed in a 30 mL eggplant flask.
  • Toluene (10 mL) and water (4 mL) were added and dissolved.
  • After degassing the reaction solvent the mixture was stirred with heating under reflux for 17 hours.
  • the reaction mixture was allowed to cool, ethyl acetate and water were added, and the layers were separated. The aqueous layer was extracted with ethyl acetate, and the organic layers were combined and concentrated under reduced pressure.
  • reaction mixture was allowed to cool, subjected to a silica gel filtration column (ethyl acetate), and the filtrate was concentrated under reduced pressure. Hexane was added to the obtained crude product, and the precipitate was collected by filtration to obtain 2,2'-(2-fluoro-1,4-phenylene) bis (4,4,5,5-tetramethyl-1). , 3,2-Dioxaborolane) (1.79 g, yield 72%) was obtained.
  • Comparative Examples 2 to 4 have the following formulas, respectively: It is a compound represented by, and was synthesized by the method described in International Publication No. 2018047948.
  • intermediate A1 500 mg
  • 2,7-bistrifluoromethylcarbazole (444 mg) and cesium carbonate (961 mg) were placed in a 30 mL eggplant flask under a nitrogen atmosphere and dissolved in DMSO (20 mL). rice field. After stirring at 85 ° C. for 3 hours, the mixture was allowed to cool to room temperature. Water (12 mL) and chloroform (10 mL) were added to the reaction solution, and the mixture was allowed to stand for 10 minutes. The precipitated gray crystals were collected by filtration and washed with water (2 mL) and chloroform (3 mL) to form 9- (4- (4,6-diphenyl-1,3,5-triazine-2-yl)-.
  • Comparative Example 5 (515 mg, yield 71%).
  • the 1 H NMR spectrum of Comparative Example 5 is shown in FIG. 33.
  • Comparative Example 6 (85 mg, yield 68%).
  • the 1 H NMR spectrum and the 19 F NMR spectrum of Comparative Example 6 are shown in FIGS. 34 and 35, respectively.
  • Comparative Examples 7 to 9 have the following formulas, respectively: It is a compound represented by, and was synthesized by the method described in Nature 2012, 492 (13), 234-238.
  • Comparative Example 10 has the following formula: It is a compound represented by, and was synthesized by the method described in Chinese Patent Application Publication No. 107384364.
  • the 1 H NMR spectrum and the 13 C NMR spectrum of Comparative Example 10 are shown in FIGS. 36 and 37, respectively.
  • Comparative Example 11 has the following formula: It is a compound represented by, and was synthesized by the method described in International Publication No. 2019087936.
  • the 1 H NMR spectrum and the 19 F NMR spectrum of Comparative Example 11 are shown in FIGS. 38 and 39, respectively.
  • Comparative Example 12 has the following formula: In the synthesis of Comparative Example 11, the compound represented by was synthesized using 2,7-bis (trifluoromethyl) carbazole instead of the raw material 3,6-bis (trifluoromethyl) carbazole. The m / z of the target object was confirmed by mass spectrometry (ASAP, positive).
  • ⁇ max Maximum emission wavelength ( ⁇ max), full width at half maximum) ⁇ max, full width at half maximum, and CIE of Comparative Examples and Examples show the emission spectrum when a toluene solution of luminescent material (luminescent material concentration: 1 ⁇ 10-5 M) is irradiated with excitation light at 340 nm at room temperature. It was measured using Fluoromax 4 manufactured by Fluoromax 4 manufactured by Fluoromax 4 and measured as follows based on the emission spectrum. ⁇ max was measured by the wavelength of the peak top. The full width at half maximum was measured by the spectral width of half the value of the peak top intensity.
  • the PLQY of Comparative Examples and Examples is a value when a toluene solution of a light emitting material (light emitting material concentration: 1 ⁇ 10-5 M) is irradiated with excitation light of 340 nm at room temperature, and is an absolute PL quantum yield measuring device (absolute PL quantum yield measuring device). It was measured using Quantaurus-QY C11347-01) manufactured by Hamamatsu Photonics.
  • HOMO level The HOMO levels of Comparative Examples and Examples were measured using an atmospheric photoelectron spectrometer (AC-3 manufactured by RIKEN Keiki Co., Ltd.). As the measurement sample, a light emitting material vacuum-deposited on an ITO substrate so as to have a film thickness of 50 nm was used. The measurement was carried out with an ultraviolet light intensity of 10 nW and a measurement range of -4.00 eV to -7.00 eV (in increments of 0.05 eV), and the energy threshold value of photoelectron emission during ultraviolet irradiation was set as the HOMO level.
  • AC-3 atmospheric photoelectron spectrometer
  • the orientation parameter S of Comparative Examples and Examples is 45 to 75 degrees (5) using a spectroscopic ellipsometer (JA Woollam Japan product) after forming a single film (thickness of about 30 nm) of the light emitting material on a bare silicon substrate. The spectrum was measured in the range of (in increments), and the spectrum was calculated by fitting analysis of the obtained spectrum.

Abstract

Provided are a nitrogen-containing heterocyclic compound and technology relating to use of the same. The nitrogen-containing heterocyclic compound is a compound represented by the formula: Cz-L-Ar (1) [in the formula, Cz is a group represented by formula (2): (in the formula, Z is a single bond, etc., R22 and R27} are each electron-withdrawing groups, R23 and R26 are each electron-donating groups, R21, R24, R25, and R28 are each a hydrogen atom, an electron-withdrawing group, or an electron-donating group, and the wavy line indicates the bonding site with L), L is a single bond or an optionally substituted phenylene group, Ar is a group selected from the group consisting of aryl groups and heteroaryl groups, and said group may have at least one substituent selected from optionally substituted N,N-diarylamino groups, optionally substituted cycloalkyl groups, optionally substituted aryl groups, and optionally substituted heteroaryl groups (however, Ar is not a group represented by formula (2)].

Description

含窒素複素環化合物及びその利用Nitrogen-containing heterocyclic compounds and their use
 含窒素複素環化合物及びその利用に関する技術が開示される。 The nitrogen-containing heterocyclic compound and the technology related to its use are disclosed.
 有機発光ダイオード(Organic Light Emitting Diode, OLED)などの有機発光素子用の発光材料の探索が行われている。発光材料としては、発光色(例えば、発光極大波長、半値幅)、発光効率、耐久性など種々の特性が好ましいことが求められる。OLED用の発光材料の中でも、熱活性化遅延蛍光(Thermally Activated Delayed Fluorescence, TADF)を示す化合物は、純有機物でありながら高い発光効率を示し、次世代の発光材料として期待されている。 A search for light emitting materials for organic light emitting elements such as organic light emitting diodes (OLEDs) is being conducted. As the light emitting material, it is required that various characteristics such as light emitting color (for example, light emitting maximum wavelength, full width at half maximum), light emitting efficiency, and durability are preferable. Among the light emitting materials for OLED, compounds showing Thermally Activated Delayed Fluorescence (TADF) show high luminous efficiency while being pure organic substances, and are expected as next-generation light emitting materials.
 TADF材料として、例えば、特許文献1には、下記式:
Figure JPOXMLDOC01-appb-C000010
(式中、Yは、シアノ基又はトリフルオロメチル基である。)
で表される化合物が記載されている。また、特許文献2には、下記式:
Figure JPOXMLDOC01-appb-C000011
で表される化合物が記載されている。
As a TADF material, for example, Patent Document 1 describes the following formula:
Figure JPOXMLDOC01-appb-C000010
(In the formula, Y is a cyano group or a trifluoromethyl group.)
The compounds represented by are described. Further, in Patent Document 2, the following formula:
Figure JPOXMLDOC01-appb-C000011
The compounds represented by are described.
国際公開第2018/047948号International Publication No. 2018/0479848 特開2017-103440号公報JP-A-2017-103440
 特許文献1及び2に記載された化合物は、TADF材料として有用であるが、発光効率及び耐久性の点で改善の余地がある。本発明は、発光効率及び耐久性に優れた含窒素複素環化合物及びその利用に関する技術を提供することを主な課題とする。 The compounds described in Patent Documents 1 and 2 are useful as TADF materials, but there is room for improvement in terms of luminous efficiency and durability. A main object of the present invention is to provide a nitrogen-containing heterocyclic compound having excellent luminous efficiency and durability and a technique relating to its use.
 本発明者らは、前記課題を解決すべく鋭意検討を重ねた結果、化合物の構造として下記式(1)で表される構造を採用することにより、発光効率及び耐久性を改善できることを見出した:
Cz-L-Ar (1)
[式中、
Czは、下記式(2):
Figure JPOXMLDOC01-appb-C000012
(式中、
Zは、不存在、単結合、-C(R29a)(R29b)-、-O-、-S-、又は-N(R29c)-であり、
22及びR27は、それぞれ、電子求引性基であり、
23及びR26は、それぞれ、電子供与性基であり、
21、R24、R25、R28、R29a、R29b、及びR29cは、それぞれ、水素原子、電子求引性基、又は電子供与性基であり、
波線は、Lとの結合部位を示す)
で表される基であり、
Lは、単結合、又は置換基を有していてもよいフェニレン基であり、
Arは、アリール基及びヘテロアリール基からなる群より選択される基であり、当該基は、置換基を有していてもよいN,N-ジアリールアミノ基、置換基を有していてもよいシクロアルキル基、置換基を有していてもよいアリール基、及び置換基を有していてもよいヘテロアリール基から選択される少なくとも一種の置換基を有していてもよい(但し、Arは、式(2)で表される基ではない)]
 本発明は、この知見に基づいてさらに検討を重ねて完成したものである。
As a result of diligent studies to solve the above problems, the present inventors have found that the luminous efficiency and durability can be improved by adopting the structure represented by the following formula (1) as the structure of the compound. :
Cz-L-Ar (1)
[During the ceremony,
Cz is calculated by the following equation (2):
Figure JPOXMLDOC01-appb-C000012
(During the ceremony,
Z is absent, single bond, -C (R 29a ) (R 29b )-, -O-, -S-, or -N (R 29c )-.
R 22 and R 27 are electron-attracting groups, respectively, and
R 23 and R 26 are electron-donating groups, respectively.
R 21 , R 24 , R 25 , R 28 , R 29a , R 29b , and R 29c are hydrogen atoms, electron attracting groups, or electron donating groups, respectively.
The wavy line indicates the binding site with L)
It is a group represented by
L is a phenylene group which may have a single bond or a substituent, and is a phenylene group.
Ar is a group selected from the group consisting of an aryl group and a heteroaryl group, and the group may have an N, N-diarylamino group or a substituent which may have a substituent. It may have at least one substituent selected from a cycloalkyl group, an aryl group which may have a substituent, and a heteroaryl group which may have a substituent (where Ar is. , Not a group represented by equation (2))]
The present invention has been further studied and completed based on this finding.
 本発明は、以下の態様を包含する。
項1.
 下記式(1)で表される化合物:
Cz-L-Ar (1)
[式中、
Czは、下記式(2):
Figure JPOXMLDOC01-appb-C000013
(式中、
Zは、不存在、単結合、-C(R29a)(R29b)-、-O-、-S-、又は-N(R29c)-であり、
22及びR27は、それぞれ、電子求引性基であり、
23及びR26は、それぞれ、電子供与性基であり、
21、R24、R25、R28、R29a、R29b、及びR29cは、それぞれ、水素原子、電子求引性基、又は電子供与性基であり、
波線は、Lとの結合部位を示す)
で表される基であり、
Lは、単結合、又は置換基を有していてもよいフェニレン基であり、
Arは、アリール基及びヘテロアリール基からなる群より選択される基であり、当該基は、置換基を有していてもよいN,N-ジアリールアミノ基、置換基を有していてもよいシクロアルキル基、置換基を有していてもよいアリール基、及び置換基を有していてもよいヘテロアリール基から選択される少なくとも一種の置換基を有していてもよい(但し、Arは、式(2)で表される基ではない)]。
項2.
 Arが、フェニル基、縮合二乃至六環式アリール基、及び窒素含有ヘテロアリール基からなる群より選択される基であり、当該基は、置換基を有していてもよいN,N-ジアリールアミノ基、置換基を有していてもよいシクロアルキル基、置換基を有していてもよいアリール基、及び置換基を有していてもよいヘテロアリール基から選択される少なくとも一種の置換基を有していてもよい(但し、Arは、式(2)で表される基ではない)、項1に記載の化合物。
項3.
 Arが、下記式(3):
Figure JPOXMLDOC01-appb-C000014
(式中、
31~X35は、それぞれ、-N=又は-C(R)=であり、
は、水素原子、置換基を有していてもよいN,N-ジアリールアミノ基、置換基を有していてもよいシクロアルキル基、置換基を有していてもよいアリール基、又は置換基を有していてもよいヘテロアリール基であり、
互いにオルトの位置関係で存在し得る2つのRは、互いに結合して芳香環を形成していてもよく、当該芳香環は、置換基を有していてもよいN,N-ジアリールアミノ基、置換基を有していてもよいシクロアルキル基、置換基を有していてもよいアリール基、及び置換基を有していてもよいヘテロアリール基から選択される少なくとも一種の置換基を有していてもよく、
波線は、Lとの結合部位を示す)
で表される基である、項1又は2に記載の化合物。
項4.
 式(3)で表される基が、下記式(3-1)~(3-4):
Figure JPOXMLDOC01-appb-C000015
(式中、
311、R312、R321~R323、R331~R336、及びR341~R346は、それぞれ、水素原子、置換基を有していてもよいN,N-ジアリールアミノ基、置換基を有していてもよいシクロアルキル基、置換基を有していてもよいアリール基、又は置換基を有していてもよいヘテロアリール基であり、
波線は、Lとの結合部位を示す)
のいずれかで表される基である、項3に記載の化合物。
項5.
 Lが、式(2)で表される基及び式(3)で表される基からなる群より選択される少なくとも一種の置換基を有していてもよいフェニレン基である、項3又は4に記載の化合物。
項6.
 Zが単結合である、項1~5のいずれかに記載の化合物。
項7.
 R22及びR27が、それぞれ、パーフルオロアルキル基又はシアノ基である、項1~6のいずれかに記載の化合物。
項8.
 R23及びR26が、それぞれ、アルキル基、アルコキシ基、トリアルキルシリル基、置換基を有していてもよいN,N-ジアリールアミノ基、置換基を有していてもよいシクロアルキル基、置換基を有していてもよいアリール基、又は置換基を有していてもよいヘテロアリール基である、項1~7のいずれかに記載の化合物。
項9.
 R21、R24、R25、及びR28が、水素原子である、又は
 R21及びR28が、それぞれ、電子供与性基であり、R24及びR25が、それぞれ、電子求引性基である、
項1~8のいずれかに記載の化合物。
項10.
 下記式(4)で表される化合物:
Figure JPOXMLDOC01-appb-C000016
[式中、
41~X43は、それぞれ、-N=又は-C(R44)=であり、
41~R44は、それぞれ、水素原子、置換基を有していてもよいN,N-ジアリールアミノ基、置換基を有していてもよいシクロアルキル基、置換基を有していてもよいアリール基、又は置換基を有していてもよいヘテロアリール基(但し、R41~R43のうち、少なくとも1つは、式(2)で表される基)である];
 下記式(5)で表される化合物:
Figure JPOXMLDOC01-appb-C000017
[式中、
51~X53は、それぞれ、-N=又は-C(R58)=であり、
51、R52、及びR58は、それぞれ、水素原子、置換基を有していてもよいN,N-ジアリールアミノ基、置換基を有していてもよいシクロアルキル基、置換基を有していてもよいアリール基、又は置換基を有していてもよいヘテロアリール基であり、
53~R57は、それぞれ、水素原子又は式(2)で表される基(但し、R53~R57のうち、少なくとも1つは、式(2)で表される基)である];
 下記式(6)で表される化合物:
Figure JPOXMLDOC01-appb-C000018
[式中、
61~X67は、それぞれ、-N=又は-C(R66)=であり、
61~R65は、それぞれ、水素原子又は式(2)で表される基(但し、R61~R65のうち、少なくとも1つは、式(2)で表される基)であり、
66は、水素原子、置換基を有していてもよいN,N-ジアリールアミノ基、置換基を有していてもよいシクロアルキル基、置換基を有していてもよいアリール基、又は置換基を有していてもよいヘテロアリール基である];
 下記式(7)で表される化合物:
Figure JPOXMLDOC01-appb-C000019
[式中、
71~X76は、それぞれ、-N=又は-C(R79)=であり、
71~R74及びR79は、それぞれ、水素原子、置換基を有していてもよいN,N-ジアリールアミノ基、置換基を有していてもよいシクロアルキル基、置換基を有していてもよいアリール基、又は置換基を有していてもよいヘテロアリール基であり、
75~R78は、水素原子又は式(2)で表される基(但し、R75~R78のうち、少なくとも1つは、式(2)で表される基)である];及び
 下記式(8)で表される化合物:
Figure JPOXMLDOC01-appb-C000020
[式中、
81~X86は、それぞれ、-N=又は-C(R89)=であり、
81~R84及びR89は、それぞれ、水素原子、置換基を有していてもよいN,N-ジアリールアミノ基、置換基を有していてもよいシクロアルキル基、置換基を有していてもよいアリール基、又は置換基を有していてもよいヘテロアリール基であり、
85~R88は、水素原子又は式(2)で表される基(但し、R85~R88のうち、少なくとも1つは、式(2)で表される基)である]
からなる群より選択される、項1に記載の化合物。
項11.
 項1~10のいずれかに記載の化合物を含む遅延蛍光材料。
項12.
 項1~10のいずれかに記載の化合物を含む有機発光素子。
項13.
 有機EL素子である、項12に記載の有機発光素子。
項14.
 下記式(9):
Figure JPOXMLDOC01-appb-C000021
(式中、
91及びR94は、それぞれ、パーフルオロアルキル基又はシアノ基であり、
92及びR93は、それぞれ、アルキル基、アルコキシ基、トリアルキルシリル基、置換基を有していてもよいN,N-ジアリールアミノ基、置換基を有していてもよいシクロアルキル基、置換基を有していてもよいアリール基、又は置換基を有していてもよいヘテロアリール基であり、
は、不存在、単結合、-C(R95)(R96)-、-O-、-S-、又は-N(R97)-であり、
95~R97は、それぞれ、水素原子、電子求引性基、又は電子供与性基である)
で表される化合物(但し、Zが不存在であり、R91及びR94がトリフルオロメチル基であり、R92及びR93がメトキシ基である化合物、並びに、Zが不存在であり、R91及びR94がシアノ基であり、R92及びR93がフェニル基である化合物を除く)。
The present invention includes the following aspects.
Item 1.
Compound represented by the following formula (1):
Cz-L-Ar (1)
[During the ceremony,
Cz is calculated by the following equation (2):
Figure JPOXMLDOC01-appb-C000013
(During the ceremony,
Z is absent, single bond, -C (R 29a ) (R 29b )-, -O-, -S-, or -N (R 29c )-.
R 22 and R 27 are electron-attracting groups, respectively, and
R 23 and R 26 are electron-donating groups, respectively.
R 21 , R 24 , R 25 , R 28 , R 29a , R 29b , and R 29c are hydrogen atoms, electron attracting groups, or electron donating groups, respectively.
The wavy line indicates the binding site with L)
It is a group represented by
L is a phenylene group which may have a single bond or a substituent, and is a phenylene group.
Ar is a group selected from the group consisting of an aryl group and a heteroaryl group, and the group may have an N, N-diarylamino group or a substituent which may have a substituent. It may have at least one substituent selected from a cycloalkyl group, an aryl group which may have a substituent, and a heteroaryl group which may have a substituent (where Ar is. , Not a group represented by equation (2))].
Item 2.
Ar is a group selected from the group consisting of a phenyl group, a fused bi to hexacyclic aryl group, and a nitrogen-containing heteroaryl group, and the group may have a substituent N, N-diaryl. At least one substituent selected from an amino group, a cycloalkyl group which may have a substituent, an aryl group which may have a substituent, and a heteroaryl group which may have a substituent. (However, Ar is not a group represented by the formula (2)), the compound according to Item 1.
Item 3.
Ar is the following formula (3):
Figure JPOXMLDOC01-appb-C000014
(During the ceremony,
X 31 to X 35 are -N = or -C (R 3 ) =, respectively.
R 3 is a hydrogen atom, an N, N-diarylamino group which may have a substituent, a cycloalkyl group which may have a substituent, an aryl group which may have a substituent, or It is a heteroaryl group that may have a substituent and
The two R 3 which may be present in a positional relationship ortho to each other, may form an aromatic ring bonded to each other, the aromatic ring may have a substituent N, N-diarylamino group Has at least one substituent selected from a cycloalkyl group which may have a substituent, an aryl group which may have a substituent, and a heteroaryl group which may have a substituent. You may be
The wavy line indicates the binding site with L)
Item 2. The compound according to Item 1 or 2, which is a group represented by.
Item 4.
The groups represented by the formula (3) are the following formulas (3-1) to (3-4):
Figure JPOXMLDOC01-appb-C000015
(During the ceremony,
R 311 and R 312 , R 321 to R 323 , R 331 to R 336 , and R 341 to R 346 , respectively, have a hydrogen atom and an N, N-diarylamino group and a substituent which may have a substituent. A cycloalkyl group which may have a substituent, an aryl group which may have a substituent, or a heteroaryl group which may have a substituent.
The wavy line indicates the binding site with L)
Item 3. The compound according to Item 3, which is a group represented by any of the above.
Item 5.
Item 3 or 4 in which L is a phenylene group which may have at least one substituent selected from the group consisting of a group represented by the formula (2) and a group represented by the formula (3). The compound described in.
Item 6.
Item 2. The compound according to any one of Items 1 to 5, wherein Z is a single bond.
Item 7.
Item 6. The compound according to any one of Items 1 to 6, wherein R 22 and R 27 are perfluoroalkyl groups or cyano groups, respectively.
Item 8.
R 23 and R 26 each have an alkyl group, an alkoxy group, a trialkylsilyl group, an N, N-diarylamino group which may have a substituent, a cycloalkyl group which may have a substituent, and the like. Item 2. The compound according to any one of Items 1 to 7, which is an aryl group which may have a substituent or a heteroaryl group which may have a substituent.
Item 9.
R 21 , R 24 , R 25 , and R 28 are hydrogen atoms, or R 21 and R 28 are electron donating groups, respectively, and R 24 and R 25 are electron attracting groups, respectively. Is,
Item 2. The compound according to any one of Items 1 to 8.
Item 10.
Compound represented by the following formula (4):
Figure JPOXMLDOC01-appb-C000016
[During the ceremony,
X 41 to X 43 are -N = or -C (R 44 ) =, respectively.
R 41 to R 44 may have a hydrogen atom, an N, N-diarylamino group which may have a substituent, a cycloalkyl group which may have a substituent, and a substituent, respectively. A good aryl group or a heteroaryl group which may have a substituent (provided that at least one of R 41 to R 43 is a group represented by the formula (2))];
Compound represented by the following formula (5):
Figure JPOXMLDOC01-appb-C000017
[During the ceremony,
X 51 to X 53 are -N = or -C (R 58 ) =, respectively.
R 51 , R 52 , and R 58 each have a hydrogen atom, an N, N-diarylamino group which may have a substituent, a cycloalkyl group which may have a substituent, and a substituent, respectively. It is an aryl group which may have a substituent or a heteroaryl group which may have a substituent.
Each of R 53 to R 57 is a hydrogen atom or a group represented by the formula (2) (however , at least one of R 53 to R 57 is a group represented by the formula (2))]. ;
Compound represented by the following formula (6):
Figure JPOXMLDOC01-appb-C000018
[During the ceremony,
X 61 to X 67 are -N = or -C (R 66 ) =, respectively.
R 61 to R 65 are hydrogen atoms or groups represented by the formula (2), respectively (however , at least one of R 61 to R 65 is a group represented by the formula (2)).
R 66 is a hydrogen atom, an N, N-diarylamino group which may have a substituent, a cycloalkyl group which may have a substituent, an aryl group which may have a substituent, or It is a heteroaryl group that may have a substituent];
Compound represented by the following formula (7):
Figure JPOXMLDOC01-appb-C000019
[During the ceremony,
X 71 to X 76 are -N = or -C (R 79 ) =, respectively.
R 71 to R 74 and R 79 each have a hydrogen atom, an N, N-diarylamino group which may have a substituent, a cycloalkyl group which may have a substituent, and a substituent, respectively. It is an aryl group that may be present, or a heteroaryl group that may have a substituent, and is
R 75 to R 78 are hydrogen atoms or groups represented by the formula (2) (provided that at least one of R 75 to R 78 is a group represented by the formula (2))]; Compound represented by the following formula (8):
Figure JPOXMLDOC01-appb-C000020
[During the ceremony,
X 81 to X 86 are −N = or −C (R 89 ) =, respectively.
R 81 to R 84 and R 89 each have a hydrogen atom, an N, N-diarylamino group which may have a substituent, a cycloalkyl group which may have a substituent, and a substituent, respectively. It is an aryl group that may be present, or a heteroaryl group that may have a substituent, and is
R 85 to R 88 are hydrogen atoms or groups represented by the formula (2) (however , at least one of R 85 to R 88 is a group represented by the formula (2))].
Item 2. The compound according to Item 1, which is selected from the group consisting of.
Item 11.
A delayed fluorescent material containing the compound according to any one of Items 1 to 10.
Item 12.
An organic light emitting device containing the compound according to any one of Items 1 to 10.
Item 13.
Item 2. The organic light emitting element according to Item 12, which is an organic EL element.
Item 14.
The following formula (9):
Figure JPOXMLDOC01-appb-C000021
(During the ceremony,
R 91 and R 94 are perfluoroalkyl groups or cyano groups, respectively.
R 92 and R 93 are an alkyl group, an alkoxy group, a trialkylsilyl group, an N, N-diarylamino group which may have a substituent, and a cycloalkyl group which may have a substituent, respectively. An aryl group which may have a substituent or a heteroaryl group which may have a substituent.
Z 9 is absent, single bond, -C (R 95 ) (R 96 )-, -O-, -S-, or -N (R 97 )-, and
R 95 to R 97 are a hydrogen atom, an electron attracting group, or an electron donating group, respectively)
Compounds represented by (where Z 9 is absent, R 91 and R 94 are trifluoromethyl groups, R 92 and R 93 are methoxy groups, and Z 9 is absent. , R 91 and R 94 are cyano groups, and R 92 and R 93 are phenyl groups).
 本発明によれば、発光効率及び耐久性に優れた含窒素複素環化合物及びその利用に関する技術が提供される。 According to the present invention, a nitrogen-containing heterocyclic compound having excellent luminous efficiency and durability and a technique related to its use are provided.
図1は、3,6-ジブロモ-2,7-ビス(トリフルオロメチル)-9H-カルバゾールのH NMRスペクトルを示す図である。 FIG. 1 is a diagram showing a 1 H NMR spectrum of 3,6-dibromo-2,7-bis (trifluoromethyl) -9H-carbazole. 図2は、3,6-ジブロモ-2,7-ビス(トリフルオロメチル)-9H-カルバゾールの19F NMRスペクトルを示す図である。 FIG. 2 is a diagram showing a 19 F NMR spectrum of 3,6-dibromo-2,7-bis (trifluoromethyl) -9H-carbazole. 図3は、中間体D1のH NMRスペクトルを示す図である。FIG. 3 is a diagram showing a 1 H NMR spectrum of intermediate D1. 図4は、中間体D1の19F NMRスペクトルを示す図である。FIG. 4 is a diagram showing a 19 F NMR spectrum of intermediate D1. 図5は、中間体D2のH NMRスペクトルを示す図である。FIG. 5 is a diagram showing a 1 H NMR spectrum of intermediate D2. 図6は、中間体D2の19F NMRスペクトルを示す図である。FIG. 6 is a diagram showing a 19 F NMR spectrum of intermediate D2. 図7は、中間体D3のH NMRスペクトルを示す図である。FIG. 7 is a diagram showing a 1 H NMR spectrum of intermediate D3. 図8は、中間体D3の19F NMRスペクトルを示す図である。FIG. 8 is a diagram showing a 19 F NMR spectrum of intermediate D3. 図9は、中間体D5のH NMRスペクトルを示す図である。FIG. 9 is a diagram showing a 1 H NMR spectrum of intermediate D5. 図10は、中間体D5の19F NMRスペクトルを示す図である。FIG. 10 is a diagram showing a 19 F NMR spectrum of Intermediate D5. 図11は、中間体A2のH NMRスペクトルを示す図である。FIG. 11 is a diagram showing a 1 H NMR spectrum of Intermediate A2. 図12は、中間体A3のH NMRスペクトルを示す図である。FIG. 12 is a diagram showing a 1 H NMR spectrum of Intermediate A3. 図13は、中間体A3の19F NMRスペクトルを示す図である。FIG. 13 is a diagram showing a 19 F NMR spectrum of Intermediate A3. 図14は、中間体A4のH NMRスペクトルを示す図である。FIG. 14 is a diagram showing a 1 H NMR spectrum of Intermediate A4. 図15は、中間体A4の19F NMRスペクトルを示す図である。FIG. 15 is a diagram showing a 19 F NMR spectrum of Intermediate A4. 図16は、中間体A5のH NMRスペクトルを示す図である。FIG. 16 is a diagram showing a 1 H NMR spectrum of Intermediate A5. 図17は、中間体A5の19F NMRスペクトルを示す図である。FIG. 17 is a diagram showing a 19 F NMR spectrum of Intermediate A5. 図18は、中間体A6のH NMRスペクトルを示す図である。FIG. 18 is a diagram showing a 1 H NMR spectrum of Intermediate A6. 図19は、中間体A6の19F NMRスペクトルを示す図である。FIG. 19 is a diagram showing a 19 F NMR spectrum of Intermediate A6. 図20は、中間体A7のH NMRスペクトルを示す図である。FIG. 20 is a diagram showing a 1 H NMR spectrum of Intermediate A7. 図21は、中間体A7の19F NMRスペクトルを示す図である。FIG. 21 is a diagram showing a 19 F NMR spectrum of Intermediate A7. 図22は、中間体A8のH NMRスペクトルを示す図である。FIG. 22 is a diagram showing a 1 H NMR spectrum of Intermediate A8. 図23は、中間体A9のH NMRスペクトルを示す図である。FIG. 23 is a diagram showing a 1 H NMR spectrum of Intermediate A9. 図24は、中間体A9の19F NMRスペクトルを示す図である。FIG. 24 is a diagram showing a 19 F NMR spectrum of Intermediate A9. 図25は、実施例1のH NMRスペクトルを示す図である。FIG. 25 is a diagram showing a 1 H NMR spectrum of Example 1. 図26は、実施例1の19F NMRスペクトルを示す図である。FIG. 26 is a diagram showing a 19 F NMR spectrum of Example 1. 図27は、実施例2のH NMRスペクトルを示す図である。FIG. 27 is a diagram showing a 1 H NMR spectrum of Example 2. 図28は、実施例2の19F NMRスペクトルを示す図である。FIG. 28 is a diagram showing a 19 F NMR spectrum of Example 2. 図29は、実施例3のH NMRスペクトルを示す図である。FIG. 29 is a diagram showing a 1 H NMR spectrum of Example 3. 図30は、実施例3の19F NMRスペクトルを示す図である。FIG. 30 is a diagram showing a 19 F NMR spectrum of Example 3. 図31は、実施例4のH NMRスペクトルを示す図である。FIG. 31 is a diagram showing a 1 H NMR spectrum of Example 4. 図32は、実施例4の19F NMRスペクトルを示す図である。FIG. 32 is a diagram showing a 19 F NMR spectrum of Example 4. 図33は、比較例5のH NMRスペクトルを示す図である。FIG. 33 is a diagram showing a 1 H NMR spectrum of Comparative Example 5. 図34は、比較例6のH NMRスペクトルを示す図である。FIG. 34 is a diagram showing a 1 H NMR spectrum of Comparative Example 6. 図35は、比較例6の19F NMRスペクトルを示す図である。FIG. 35 is a diagram showing a 19 F NMR spectrum of Comparative Example 6. 図36は、比較例10のH NMRスペクトルを示す図である。FIG. 36 is a diagram showing a 1 H NMR spectrum of Comparative Example 10. 図37は、比較例10の13C NMRスペクトルを示す図である。FIG. 37 is a diagram showing a 13 C NMR spectrum of Comparative Example 10. 図38は、比較例11のH NMRスペクトルを示す図である。FIG. 38 is a diagram showing a 1 H NMR spectrum of Comparative Example 11. 図39は、比較例11の19F NMRスペクトルを示す図である。FIG. 39 is a diagram showing a 19 F NMR spectrum of Comparative Example 11. 図40は、比較例13のH NMRスペクトルを示す図である。FIG. 40 is a diagram showing a 1 H NMR spectrum of Comparative Example 13. 図41は、比較例13の19F NMRスペクトルを示す図である。FIG. 41 is a diagram showing a 19 F NMR spectrum of Comparative Example 13.
<定義>
 本明細書において、特に断りのない限り、「ハロゲン原子」は、フッ素原子、塩素原子、臭素原子、及びヨウ素原子などを含む意味で用いる。
<Definition>
In the present specification, unless otherwise specified, "halogen atom" is used in the sense of including a fluorine atom, a chlorine atom, a bromine atom, an iodine atom and the like.
 本明細書において、特に断りのない限り、「アルキル基」は、直鎖状又は分岐鎖状の飽和炭化水素基を意味し、具体的には、例えば、メチル基、エチル基、プロピル基(n-プロピル基、イソプロピル基)、ブチル基(n-ブチル基、イソブチル基、sec-ブチル基、tert-ブチル基)、ペンチル基、ヘキシル基などのC1-20アルキル基が挙げられる。 In the present specification, unless otherwise specified, the "alkyl group" means a linear or branched saturated hydrocarbon group, and specifically, for example, a methyl group, an ethyl group, or a propyl group (n). -Propyl group, isopropyl group), butyl group (n-butyl group, isobutyl group, sec-butyl group, tert-butyl group), pentyl group, hexyl group and other C 1-20 alkyl groups.
 本明細書において、特に断りのない限り、「パーフルオロアルキル基」は、前記アルキル基の全ての水素原子がフッ素原子に置換された基を意味し、具体的には、例えば、トリフルオロメチル基、ペンタフルオロエチル基、ヘプタフルオロプロピル基(ヘプタフルオロn-プロピル基又はヘプタフルオロi-プロピル基)などのパーフルオロC1-12アルキル基が挙げられる。 In the present specification, unless otherwise specified, the "perfluoroalkyl group" means a group in which all hydrogen atoms of the alkyl group are substituted with fluorine atoms, and specifically, for example, a trifluoromethyl group. , Pentafluoroethyl group, heptafluoropropyl group (heptafluoro n-propyl group or heptafluoro i-propyl group) and other perfluoroC 1-12 alkyl groups.
 本明細書において、特に断りのない限り、「アルコキシ基」は、前記アルキル基の末端に酸素原子が結合した基を意味し、具体的には、例えば、メトキシ基、エトキシ基、プロポキシ基(n-プロポキシ基、イソプロポキシ基)、ブトキシ基(n-ブトキシ基、イソブトキシ基、sec-ブトキシ基、tert-ブトキシ基)などのC1-12アルコキシ基が挙げられる。 In the present specification, unless otherwise specified, the "alkoxy group" means a group in which an oxygen atom is bonded to the terminal of the alkyl group, and specifically, for example, a methoxy group, an ethoxy group, or a propoxy group (n). -C 1-12 alkoxy groups such as propoxy group (propoxy group, isopropoxy group), butoxy group (n-butoxy group, isobutoxy group, sec-butoxy group, tert-butoxy group) can be mentioned.
 本明細書において、特に断りのない限り、「アルキルスルファニル基」は、前記アルキル基の末端に硫黄原子が結合した基を意味し、具体的には、例えば、メチルスルファニル基、エチルスルファニル基、プロピルスルファニル基(n-プロピルスルファニル基、イソプロピルスルファニル基)、ブチルスルファニル基などのC1-12アルキルスルファニル基が挙げられる。 In the present specification, unless otherwise specified, the "alkylsulfanyl group" means a group in which a sulfur atom is bonded to the terminal of the alkyl group, and specifically, for example, a methylsulfanyl group, an ethylsulfanyl group, or a propyl. Examples thereof include a C 1-12 alkyl sulfanyl group such as a sulfanyl group (n-propyl sulfanyl group, isopropyl sulfanyl group) and a butyl sulfanyl group.
 本明細書において、特に断りのない限り、「アルキルカルボニル基」は、前記アルキル基の末端にカルボニル基(-C(=O)-)が結合した基を意味し、具体的には、例えば、メチルカルボニル基、エチルカルボニル基、プロピルカルボニル基(n-プロピルカルボニル基、イソプロピルカルボニル基)、ブチルカルボニル基などの(C1-12アルキル)カルボニル基が挙げられる。 In the present specification, unless otherwise specified, the "alkylcarbonyl group" means a group in which a carbonyl group (-C (= O)-) is bonded to the end of the alkyl group, and specifically, for example, for example. Examples thereof include (C 1-12 alkyl) carbonyl groups such as methylcarbonyl group, ethylcarbonyl group, propylcarbonyl group (n-propylcarbonyl group, isopropylcarbonyl group) and butylcarbonyl group.
 本明細書において、特に断りのない限り、「アルキルスルホニル基」は、前記アルキル基の末端にスルホニル基(-S(=O)-)が結合した基を意味し、具体的には、例えば、メチルスルホニル基、エチルスルホニル基、プロピルスルホニル基(n-プロピルスルホニル基、イソプロピルスルホニル基)、ブチルスルホニル基などのC1-12アルキルスルホニル基が挙げられる。 In the present specification, unless otherwise specified, the "alkylsulfonyl group" means a group in which a sulfonyl group (-S (= O) 2- ) is bonded to the end of the alkyl group, and specifically, for example. , Methylsulfonyl group, ethylsulfonyl group, propylsulfonyl group (n-propylsulfonyl group, isopropylsulfonyl group), butylsulfonyl group and other C 1-12 alkylsulfonyl groups.
 本明細書において、特に断りのない限り、「シクロアルキル基」は、シクロペンチル基、シクロヘキシル基、シクロヘプチル基、シクロオクチル基などのシクロC5-20アルキル基が挙げられる。 In the present specification, unless otherwise specified, the "cycloalkyl group" includes a cycloC 5-20 alkyl group such as a cyclopentyl group, a cyclohexyl group, a cycloheptyl group and a cyclooctyl group.
 本明細書において、特に断りのない限り、「トリアルキルシリル基」は、3個の前記アルキル基が珪素原子に結合した基を意味し、具体的には、例えば、トリメチルシリル基、トリエチルシリル基、トリイソプロピルシリル基、tert-ブチルジメチルシリル基などのトリC1-4アルキルシリル基が挙げられる。 In the present specification, unless otherwise specified, the "trialkylsilyl group" means a group in which the three alkyl groups are bonded to a silicon atom, and specifically, for example, a trimethylsilyl group and a triethylsilyl group. Examples thereof include a tri-C 1-4 alkylsilyl group such as a triisopropylsilyl group and a tert-butyldimethylsilyl group.
 本明細書において、特に断りのない限り、「芳香環」は、アレーン環及びヘテロアレーン環を含む意味で用いる。 In the present specification, unless otherwise specified, "aromatic ring" is used in the sense of including an arene ring and a heteroarene ring.
 アレーン環の炭素数は、特に制限されないが、例えば6~40、好ましくは6~30、より好ましくは6~28、さらに好ましくは6~26である。アレーン環は、ベンゼン環又は複数のベンゼン環が縮合した構造を有する縮合環であることが好ましい。アレーン環としては、例えば、ベンゼン環、ナフタレン環、フルオレン環、アントラセン環、フェナントレン環、フルオランテン環、テトラセン環、テトラフェン環、クリセン環、トリフェニレン環、ピレン環、ベンゾピレン環、ペリレン環、コロネン環、コラヌレン環、フェナレン環、トリアングレン環などが挙げられる。 The number of carbon atoms in the arene ring is not particularly limited, but is, for example, 6 to 40, preferably 6 to 30, more preferably 6 to 28, and even more preferably 6 to 26. The arene ring is preferably a benzene ring or a fused ring having a structure in which a plurality of benzene rings are condensed. Examples of the arene ring include a benzene ring, a naphthalene ring, a fluorene ring, an anthracene ring, a phenanthrene ring, a fluoranthene ring, a tetracene ring, a tetraphen ring, a chrysene ring, a triphenylene ring, a pyrene ring, a benzopyrene ring, a perylene ring, and a coronene ring. Examples include a coronene ring, a phenalene ring, and a trianglene ring.
 ヘテロアレーン環は、環構成原子の数に特に制限はないが、例えば5員~40員である。ヘテロアレーン環は、単環式であってもよく、多環式(例えば二乃至四環式)であってもよい。ヘテロアレーン環は、環構成原子として、酸素原子、硫黄原子、及び窒素原子から選ばれる少なくとも1個のヘテロ原子を含有するヘテロアレーン環であることが好ましい。ヘテロアレーン環としては、例えば、酸素含有ヘテロアレーン環(例:フラン環、ベンゾフラン環、ジベンゾ[b,d]フラン環)、硫黄含有ヘテロアレーン環(例:チオフェン環、ベンゾチオフェン環、ジベンゾ[b,d]チオフェン環)、窒素含有ヘテロアレーン環(例:ピロール環、ピラゾール環、イミダゾール環、1,2,3-トリアゾール環、1,2,4-トリアゾール環、ピリジン環、ピリダジン環、ピリミジン環、ピラジン環、1,3,5-トリアジン環、インドール環、インダゾール環、ベンゾイミダゾール環、キノリン環、イソキノリン環、シノリン環、キノキサリン環、フタラジン環、ナフチリジン環、プリン環、アクリジン環、9,10-ジヒドロアクリジン環、フェナジン環、5,10-ジヒドロフェナジン環、フェナントリジン環、フェナントロリン環、アセナフト[1,2-b]ピラジン環)、酸素及び窒素含有ヘテロアレーン環(例:オキサゾール環、イソオキサゾール環、ベンゾオキサゾール環、フェノキサジン環)、硫黄及び窒素含有ヘテロアレーン環(例:チアゾール環、イソチアゾール環、ベンゾチアゾール環、フェノチアジン環)が挙げられる。 The number of ring-constituting atoms in the heteroarene ring is not particularly limited, but is, for example, 5 to 40 members. The heteroarene ring may be a monocyclic type or a polycyclic type (for example, a two- to four-ring type). The heteroarene ring is preferably a heteroarene ring containing at least one heteroatom selected from an oxygen atom, a sulfur atom, and a nitrogen atom as a ring-constituting atom. Examples of the heteroarene ring include an oxygen-containing heteroarene ring (eg, furan ring, benzofuran ring, dibenzo [b, d] furan ring) and a sulfur-containing heteroarene ring (eg, thiophene ring, benzothiophene ring, dibenzo [b]. , D] Thiophen ring), nitrogen-containing heteroarene ring (eg, pyrrole ring, pyrazole ring, imidazole ring, 1,2,3-triazole ring, 1,2,4-triazole ring, pyridine ring, pyridazine ring, pyrimidine ring) , Pyrazine ring, 1,3,5-triazole ring, indole ring, indazole ring, benzimidazole ring, quinoline ring, isoquinoline ring, sinoline ring, quinoxaline ring, phthalazine ring, naphthylidine ring, purine ring, acrydin ring, 9,10 -Dihydroaclydin ring, phenazine ring, 5,10-dihydrophenazine ring, phenanthridin ring, phenanthroline ring, acenaft [1,2-b] pyrazine ring), oxygen and nitrogen-containing heteroarene ring (eg, oxazole ring, iso) Oxazole ring, benzoxazole ring, phenoxazine ring), sulfur and nitrogen-containing heteroarene ring (eg, thiazole ring, isothiazole ring, benzothiazole ring, phenothiazine ring).
 アリール基は、前記芳香環のうち芳香族炭化水素環(アレーン環)から1個の水素原子を除いた基である。アリール基は、単環式アリール基であってもよく、縮合環式アリール基(例えば、縮合二乃至六環式アリール基)であってもよい。単環式アリール基としては、例えば、フェニル基が挙げられる。縮合環式アリール基としては、例えば、ナフチル基、フルオレニル基、アントラセニル基、トリフェニレニル基、ピレニル基が挙げられる。アリール基としては、C6-18アリール基が好ましい。 The aryl group is a group obtained by removing one hydrogen atom from the aromatic hydrocarbon ring (arene ring) in the aromatic ring. The aryl group may be a monocyclic aryl group or a fused cyclic aryl group (for example, a fused bi to hexacyclic aryl group). Examples of the monocyclic aryl group include a phenyl group. Examples of the fused cyclic aryl group include a naphthyl group, a fluorenyl group, an anthrasenyl group, a triphenylenyl group, and a pyrenyl group. As the aryl group, a C 6-18 aryl group is preferable.
 ヘテロアリール基は、前記芳香環のうち芳香族複素環(ヘテロアレーン環)から1個の水素原子を除いた基である。ヘテロアリール基は、単環式ヘテロアリール基(例えば、5員又は6員単環式ヘテロアリール基)であってもよく、縮合環式ヘテロアリール基(例えば、縮合二乃至六環式アリール基)であってもよい。単環式ヘテロアリール基としては、フリル基などの単環式酸素含有ヘテロアリール基;チエニル基などの単環式硫黄含有ヘテロアリール基;ピロリル基、ピラゾリル基、イミダゾリル基、トリアジル基、ピリジル基、ピリダジル基、ピリミジル基、ピラジル基、トリアジニル基などの単環式窒素含有ヘテロアリール基が挙げられる。縮合環式ヘテロアリール基としては、例えば、ベンゾフリル基、ジベンゾフリル基などの縮合環式酸素含有ヘテロアリール基;ベンゾチエニル基、ジベンゾチエニル基などの縮合環式硫黄含有ヘテロアリール基;インドリル基、キノリル基、イソキノリル基、カルバゾリル基、アクリジル基、9,10-ジヒドロアクリジル基、フェナジル基、5,10-ジヒドロフェナジル基などの縮合環式窒素含有ヘテロアリール基;フェノキサジル基などの縮合環式酸素及び窒素含有ヘテロアリール基;フェノチアジル基などの縮合環式硫黄及び窒素含有ヘテロアリール基が挙げられる。 The heteroaryl group is a group obtained by removing one hydrogen atom from the aromatic heterocycle (heteroarene ring) in the aromatic ring. The heteroaryl group may be a monocyclic heteroaryl group (eg, a 5- or 6-membered monocyclic heteroaryl group) or a fused cyclic heteroaryl group (eg, a fused 2- to 6-cyclic aryl group). May be. Examples of the monocyclic heteroaryl group include a monocyclic oxygen-containing heteroaryl group such as a frill group; a monocyclic sulfur-containing heteroaryl group such as a thienyl group; a pyrrolyl group, a pyrazolyl group, an imidazolyl group, a triazil group and a pyridyl group. Examples thereof include monocyclic nitrogen-containing heteroaryl groups such as a pyridazyl group, a pyrimidyl group, a pyrazil group and a triazinyl group. Examples of the fused cyclic heteroaryl group include a fused cyclic oxygen-containing heteroaryl group such as a benzofuryl group and a dibenzofuryl group; a fused cyclic sulfur-containing heteroaryl group such as a benzothienyl group and a dibenzothienyl group; an indrill group and a quinolyl group. Fused cyclic nitrogen-containing heteroaryl groups such as groups, isoquinolyl groups, carbazolyl groups, acrizyl groups, 9,10-dihydroacrylidyl groups, phenadyl groups, 5,10-dihydrophenadyl groups; fused cyclic oxygen such as phenoxazyl groups. And nitrogen-containing heteroaryl groups; fused cyclic sulfur such as phenothiazil groups and nitrogen-containing heteroaryl groups can be mentioned.
 本明細書において、特に断りのない限り、「電子供与性基(ドナー性基)」は、ハメットのσpが負の基を表す。ハメットのσpに関する説明と各基の数値については、Hansch,C.et.al.,Chem.Rev.,91,165-195(1991)を参照することができる。電子供与性基としては、例えば、メチル基、イソプロピル基、ターシャリーブチル基などのアルキル基、シクロヘキシル基などのシクロアルキル基、フェニル基、ナフチル基、アントラセニル基、トリフェニレニル基、ピレニル基、フルオレニル基などのアリール基、メトキシ基などのアルコキシ基、メチオニル基などのアルキルスルファニル基、トリメチルシリル基などのトリアルキルシリル基、ピリジル基、イミダゾリル基、ピラゾリル基、オキサゾリル基、チアゾリル基、インドリル基、ピロリル基、キノリル基、ベンゾフリル基、ジベンゾフリル基、ベンゾチエニル基、ジベンゾチエニル基、カルバゾリル基、9,10-ジヒドロアクリジル基、5,10-ジヒドロフェナジル基、フェノキサジル基、フェノチアジル基などのヘテロアリール基、N,N-ジフェニルアミノ基などのN,N-ジアリールアミノ基が挙げられる。 In the present specification, unless otherwise specified, the "electron donating group (donor group)" represents a group in which Hammett's σp is negative. Hansch, C.et.al., Chem.Rev., 91,165-195 (1991) can be referred to for a description of Hammett's σp and the numerical values of each group. Examples of the electron donating group include an alkyl group such as a methyl group, an isopropyl group and a tertiary butyl group, a cycloalkyl group such as a cyclohexyl group, a phenyl group, a naphthyl group, an anthracenyl group, a triphenylenyl group, a pyrenyl group and a fluorenyl group. Aryl group, alkoxy group such as methoxy group, alkylsulfanyl group such as methionyl group, trialkylsilyl group such as trimethylsilyl group, pyridyl group, imidazolyl group, pyrazolyl group, oxazolyl group, thiazolyl group, indolyl group, pyrrolyl group, quinolyl. Heteroaryl group, N , N, N-diarylamino group such as N-diphenylamino group.
 本明細書において、特に断りのない限り、「電子求引性基(アクセプター性基)」は、電子供与性基以外の基を意味し、例えば、アルキルカルボニル基(アシル基)、アルキルスルホニル基、パーフルオロアルキル基、シアノ基、ニトロ基が挙げられる。 In the present specification, unless otherwise specified, the "electron-attracting group (acceptor group)" means a group other than an electron-donating group, for example, an alkylcarbonyl group (acyl group), an alkylsulfonyl group, and the like. Examples thereof include a perfluoroalkyl group, a cyano group and a nitro group.
<化合物>
 一実施態様において、本発明の化合物は、下記式(1)で表される化合物であることが好ましい:
Cz-L-Ar (1)
[式中、
Czは、下記式(2):
Figure JPOXMLDOC01-appb-C000022
(式中、
Zは、不存在、単結合、-C(R29a)(R29b)-、-O-、-S-、又は-N(R29c)-であり、
22及びR27は、それぞれ、電子求引性基であり、
23及びR26は、それぞれ、電子供与性基であり、
21、R24、R25、R28、R29a、R29b、及びR29cは、それぞれ、水素原子、電子求引性基、又は電子供与性基であり、
波線は、Lとの結合部位を示す)
で表される基であり、
Lは、単結合、又は置換基を有していてもよいフェニレン基であり、
Arは、アリール基及びヘテロアリール基からなる群より選択される基であり、当該基は、置換基を有していてもよいN,N-ジアリールアミノ基、置換基を有していてもよいシクロアルキル基、置換基を有していてもよいアリール基、及び置換基を有していてもよいヘテロアリール基から選択される少なくとも一種の置換基を有していてもよい(但し、Arは、式(2)で表される基ではない)]。
<Compound>
In one embodiment, the compound of the present invention is preferably a compound represented by the following formula (1):
Cz-L-Ar (1)
[During the ceremony,
Cz is calculated by the following equation (2):
Figure JPOXMLDOC01-appb-C000022
(During the ceremony,
Z is absent, single bond, -C (R 29a ) (R 29b )-, -O-, -S-, or -N (R 29c )-.
R 22 and R 27 are electron-attracting groups, respectively, and
R 23 and R 26 are electron-donating groups, respectively.
R 21 , R 24 , R 25 , R 28 , R 29a , R 29b , and R 29c are hydrogen atoms, electron attracting groups, or electron donating groups, respectively.
The wavy line indicates the binding site with L)
It is a group represented by
L is a phenylene group which may have a single bond or a substituent, and is a phenylene group.
Ar is a group selected from the group consisting of an aryl group and a heteroaryl group, and the group may have an N, N-diarylamino group or a substituent which may have a substituent. It may have at least one substituent selected from a cycloalkyl group, an aryl group which may have a substituent, and a heteroaryl group which may have a substituent (where Ar is. , Not a group represented by equation (2))].
Cz(式(2))
 Zは、単結合、-C(R29a)(R29b)-、-O-、-S-、又は-N(R29c)-であることが好ましく、単結合であることがさらに好ましい。
Cz (Equation (2))
Z is preferably a single bond, -C (R 29a ) (R 29b )-, -O-, -S-, or -N (R 29c )-, and more preferably a single bond.
 本発明者らは、式(2)において、R22及びR27が電子求引性基であり、R23及びR26が電子供与性基である場合には、R22及びR27が電子求引性基であり、R23及びR26が水素原子である場合、並びに、R22及びR27が水素原子であり、R23及びR26が電子供与性基である場合と比較して、発光ピークの半値幅をより一層狭くすることができることを見出した。 In the formula (2), the present inventors consider that when R 22 and R 27 are electron attracting groups and R 23 and R 26 are electron donating groups, R 22 and R 27 are electron seeking groups. Emission compared to the case where R 23 and R 26 are hydrogen atoms and where R 22 and R 27 are hydrogen atoms and R 23 and R 26 are electron donating groups. We have found that the half-price range of the peak can be further narrowed.
 R22、R27、並びに、R21、R24、R25、R28、及びR29a~R29cが電子求引性基である場合、当該電子求引性基は、それぞれ、
好ましくはパーフルオロアルキル基又はシアノ基であり、
より好ましくはパーフルオロC1-4アルキル基又はシアノ基であり、
さらに好ましくはパーフルオロC1-3アルキル基又はシアノ基であり、
さらにより好ましくはパーフルオロC1-2アルキル基又はシアノ基であり、
特に好ましくはトリフルオロメチル基又はシアノ基である。
If R 22 , R 27 , and R 21 , R 24 , R 25 , R 28 , and R 29a to R 29c are electron-attracting groups, the electron-attracting groups are, respectively.
It is preferably a perfluoroalkyl group or a cyano group.
More preferably, it is a perfluoroC 1-4 alkyl group or a cyano group.
More preferably, it is a perfluoroC 1-3 alkyl group or a cyano group.
Even more preferably, it is a perfluoroC 1-2 alkyl group or a cyano group.
Particularly preferably, it is a trifluoromethyl group or a cyano group.
 R23、R26、並びに、R21、R24、R25、R28、及びR29a~R29cが電子供与性基である場合、当該電子供与性基は、それぞれ、
好ましくはアルキル基、アルコキシ基、トリアルキルシリル基、置換基を有していてもよいN,N-ジアリールアミノ基、置換基を有していてもよいシクロアルキル基、又は置換基を有していてもよいアリール基、置換基を有していてもよいヘテロアリール基であり、より好ましくはC1-6アルキル基、C1-6アルコキシ基、トリC1-6アルキルシリル基、置換基を有していてもよいN,N-ジC6-18アリールアミノ基、置換基を有していてもよいC5-12シクロアルキル基、置換基を有していてもよいC6-18アリール基、置換基を有していてもよい5員又は6員単環式ヘテロアリール基、又は置換基を有していてもよい縮合二乃至四環式ヘテロアリール基であり、
さらに好ましくはC1-4アルキル基、C1-4アルコキシ基、トリC1-4アルキルシリル基、置換基を有していてもよいN,N-ジC6-14アリールアミノ基、C5-7シクロアルキル基、C6-14アリール基、置換基を有していてもよい5員又は6員単環式窒素含有ヘテロアリール基、又は置換基を有していてもよい縮合二乃至四環式窒素含有ヘテロアリール基である。
 前記N,N-ジアリールアミノ基が任意に有する置換基は、好ましくは電子求引性基及び電子供与性基である。前記シクロアルキル基、前記アリール基、及び前記ヘテロアリール基が任意に有する置換基は、好ましくはアリール基又はヘテロアリール基であり、より好ましくはアリール基であり、さらに好ましくはC6-12アリール基であり、特に好ましくはC6-10アリール基である。前記ヘテロアリール基が任意に有する置換基は、電子求引性基及び電子供与性基であることも好ましい。前記置換基の数は、例えば、0、1、2、3、又は4個である。
 当該電子供与性基は、式(2)で表される基であることも好ましい。
If R 23 , R 26 , and R 21 , R 24 , R 25 , R 28 , and R 29a to R 29c are electron-donating groups, the electron-donating groups are, respectively.
It preferably has an alkyl group, an alkoxy group, a trialkylsilyl group, an N, N-diarylamino group which may have a substituent, a cycloalkyl group which may have a substituent, or a substituent. It may have an aryl group or a heteroaryl group which may have a substituent, and more preferably a C 1-6 alkyl group, a C 1-6 alkoxy group, a tri C 1-6 alkylsilyl group and a substituent. May have N, N-di C 6-18 arylamino group, may have substituent C 5-12 cycloalkyl group, may have substituent C 6-18 aryl A 5- or 6-membered monocyclic heteroaryl group which may have a group, a substituent, or a fused 2- to tetracyclic heteroaryl group which may have a substituent.
More preferably, it may have a C 1-4 alkyl group, a C 1-4 alkoxy group, a tri C 1-4 alkylsilyl group, a substituent N, N-di C 6-14 arylamino group, C 5 A -7 cycloalkyl group, a C 6-14 aryl group, a 5- or 6-membered monocyclic nitrogen-containing heteroaryl group which may have a substituent, or a condensed 2-4 which may have a substituent. It is a cyclic nitrogen-containing heteroaryl group.
The substituent arbitrarily contained in the N, N-diarylamino group is preferably an electron attracting group and an electron donating group. The cycloalkyl group, the aryl group, and the substituent optionally contained in the heteroaryl group are preferably an aryl group or a heteroaryl group, more preferably an aryl group, and further preferably a C 6-12 aryl group. It is particularly preferably a C 6-10 aryl group. It is also preferable that the substituent arbitrarily contained in the heteroaryl group is an electron-attracting group and an electron-donating group. The number of the substituents is, for example, 0, 1, 2, 3, or 4.
The electron donating group is also preferably a group represented by the formula (2).
 R21、R24、R25、及びR28の組合せとしては、
 R21、R24、R25、及びR28は、水素原子である組合せ;又は
 R21及びR28が、それぞれ、電子供与性基であり、R24及びR25が、それぞれ、電子求引性基である組合せ
が好ましい。
As a combination of R 21 , R 24 , R 25 , and R 28,
R 21 , R 24 , R 25 , and R 28 are combinations of hydrogen atoms; or R 21 and R 28 are electron donating groups, respectively, and R 24 and R 25 are electron attracting groups, respectively. The base combination is preferred.
 式(2)で表される基は、下記群から選択される基であることが好ましい:
Figure JPOXMLDOC01-appb-C000023
(式中、Meはメチル基、i-Prはイソプロピル基、t-Buはターシャリーブチル基、Phはフェニル基、波線はLとの結合部位を示す)。
The group represented by the formula (2) is preferably a group selected from the following group:
Figure JPOXMLDOC01-appb-C000023
(In the formula, Me is a methyl group, i-Pr is an isopropyl group, t-Bu is a tertiary butyl group, Ph is a phenyl group, and a wavy line indicates a binding site with L).
Ar
 Arは、
好ましくはアリール基及びヘテロアリール基から選択される基であり(但し、式(2)で表される基ではない)、
より好ましくはC6-18アリール基、5員又は6員単環式ヘテロアリール基、及び縮合二乃至四環式ヘテロアリール基から選択される基であり(但し、式(2)で表される基ではない)、
さらに好ましくはC6-16アリール基、5員又は6員単環式窒素含有ヘテロアリール基、及び縮合二乃至四環式窒素含有ヘテロアリール基から選択される基である(但し、式(2)で表される基ではない)。
 これらの基は、置換基を有していてもよいN,N-ジアリールアミノ基(例えばZが不存在である式(2)で表される基)、置換基を有していてもよいシクロアルキル基(好ましくはC5-12シクロアルキル基)、置換基を有していてもよいアリール基(好ましくはC6-12アリール基)、及び置換基を有していてもよいヘテロアリール基(好ましくは5員又は6員単環式ヘテロアリール基、又は縮合二乃至四環式ヘテロアリール基)(例えばZが不存在以外である式(2)で表される基)から選択される少なくとも一種の置換基を有していてもよい。
 前記シクロアルキル基、アリール基、及びヘテロアリール基が任意に有する置換基は、特に限定されるものではないが、例えば、アリール基(例えばC6-12アリール基)又はヘテロアリール基(例えば5員又は6員単環式ヘテロアリール基、縮合二乃至四環式ヘテロアリール基)であってもよく、式(2)で表される基であってもよい。
Ar
Ar is
It is preferably a group selected from an aryl group and a heteroaryl group (however, it is not a group represented by the formula (2)).
More preferably, it is a group selected from a C 6-18 aryl group, a 5-membered or 6-membered monocyclic heteroaryl group, and a fused 2- to tetracyclic heteroaryl group (however, it is represented by the formula (2)). Not the basis),
More preferably, it is a group selected from a C 6-16 aryl group, a 5-membered or 6-membered monocyclic nitrogen-containing heteroaryl group, and a condensed 2- to tetracyclic nitrogen-containing heteroaryl group (however, the formula (2)). It is not a group represented by).
These groups may have an N, N-diarylamino group (for example, a group represented by the formula (2) in which Z is absent), which may have a substituent, and a cyclo which may have a substituent. An alkyl group (preferably a C 5-12 cycloalkyl group), an aryl group optionally having a substituent (preferably a C 6-12 aryl group), and a heteroaryl group optionally having a substituent (preferably a C 5-12 cycloalkyl group). Preferably at least one selected from a 5- or 6-membered monocyclic heteroaryl group or a fused 2- to tetracyclic heteroaryl group (eg, a group represented by formula (2) in which Z is other than absent). It may have a substituent of.
The substituent arbitrarily contained in the cycloalkyl group, the aryl group, and the heteroaryl group is not particularly limited, but is, for example, an aryl group (for example, C 6-12 aryl group) or a heteroaryl group (for example, 5 members). Alternatively, it may be a 6-membered monocyclic heteroaryl group, a fused bi to tetracyclic heteroaryl group), or a group represented by the formula (2).
 Arは、下記式(3)で表される基であることが好ましい:
Figure JPOXMLDOC01-appb-C000024
(式中、
31~X35は、それぞれ、-N=又は-C(R)=であり、
は、水素原子、置換基を有していてもよいN,N-ジアリールアミノ基、置換基を有していてもよいシクロアルキル基、置換基を有していてもよいアリール基、又は置換基を有していてもよいヘテロアリール基であり、
互いにオルトの位置関係で存在し得る2つのRは、互いに結合して芳香環を形成していてもよく、当該芳香環は、置換基を有していてもよいN,N-ジアリールアミノ基、置換基を有していてもよいシクロアルキル基、置換基を有していてもよいアリール基、及び置換基を有していてもよいヘテロアリール基から選択される少なくとも一種の置換基を有していてもよく、
波線は、Lとの結合部位を示す)。
Ar is preferably a group represented by the following formula (3):
Figure JPOXMLDOC01-appb-C000024
(During the ceremony,
X 31 to X 35 are -N = or -C (R 3 ) =, respectively.
R 3 is a hydrogen atom, an N, N-diarylamino group which may have a substituent, a cycloalkyl group which may have a substituent, an aryl group which may have a substituent, or It is a heteroaryl group that may have a substituent and
The two R 3 which may be present in a positional relationship ortho to each other, may form an aromatic ring bonded to each other, the aromatic ring may have a substituent N, N-diarylamino group Has at least one substituent selected from a cycloalkyl group which may have a substituent, an aryl group which may have a substituent, and a heteroaryl group which may have a substituent. You may be
The wavy line indicates the binding site with L).
 式(3)において、X31~X35の組合せとしては、
 X31、X33、及びX35が-N=であり、X32及びX34が-C(R)=である組合せ;
 X31及びX35が-N=であり、X32~X34が-C(R)=である組合せ;又は X31~X35が-C(R)=である組合せ
が好ましい。
In the formula (3), as a combination of X 31 to X 35,
A combination in which X 31 , X 33 , and X 35 are -N = and X 32 and X 34 are -C (R 3 ) =;
A combination in which X 31 and X 35 are -N = and X 32 to X 34 are -C (R 3 ) =; or a combination in which X 31 to X 35 are -C (R 3 ) = is preferable.
 Rは、好ましくは水素原子、置換基を有していてもよいN,N-ジC6-12アリールアミノ基(例えばZが不存在である式(2)で表される基)、置換基を有していてもよいC5-12シクロアルキル基、置換基を有していてもよいC6-12アリール基、置換基を有していてもよい5員又は6員単環式ヘテロアリール基、置換基を有していてもよい縮合二乃至四環式ヘテロアリール基(例えばZが不存在以外である式(2)で表される基)である。前記置換基としては、例えば、アリール基(例えばC6-12アリール基)又はヘテロアリール基(例えば5員又は6員単環式ヘテロアリール基、縮合二乃至四環式ヘテロアリール基)であってもよく、式(2)で表される基であってもよい。 R 3 is preferably a hydrogen atom, an N, N-di C 6-12 arylamino group which may have a substituent (for example, a group represented by the formula (2) in which Z is absent), a substituent. A C 5-12 cycloalkyl group which may have a group, a C 6-12 aryl group which may have a substituent, and a 5-membered or 6-membered monocyclic hetero which may have a substituent. It is a fused bi to tetracyclic heteroaryl group which may have an aryl group or a substituent (for example, a group represented by the formula (2) in which Z is other than absent). Examples of the substituent include an aryl group (for example, C 6-12 aryl group) or a heteroaryl group (for example, a 5-membered or 6-membered monocyclic heteroaryl group, a condensed 2- to 4-cyclic heteroaryl group). It may be a group represented by the formula (2).
 式(3)で表される基は、互いにオルトの位置関係で存在し得る2つのRが互いに結合して芳香環を形成する場合、例えば、下記式(3a)又は(3b)で表される基であってもよい:
Figure JPOXMLDOC01-appb-C000025
(式中、X36~X39は、それぞれ、-N=又は-C(R)=であり、X31~X33、X35、及びRは前記と同じである)。
The group represented by the formula (3), when forming the aromatic ring, e.g., represented by the following formula (3a) or (3b) bonded to each other two R 3 which may be present in a positional relationship ortho to one another May be a base:
Figure JPOXMLDOC01-appb-C000025
(In the equation, X 36 to X 39 are -N = or -C (R 3 ) = , respectively, and X 31 to X 33 , X 35 , and R 3 are the same as described above).
 式(3a)において、X31~X33及びX36~X39の組合せとしては、
 X31~X33が-C(R)=であり、X36~X39が-N=又は-C(R)=である組合せが好ましく、
 X31~X33及びX36~X38が-C(R)=であり、X39が-N=である組合せ;又は
 X31~X33及びX36~X39が-C(R)=である組合せがより好ましい。
In the formula (3a), the combination of X 31 to X 33 and X 36 to X 39 is
A combination in which X 31 to X 33 are -C (R 3 ) = and X 36 to X 39 are -N = or -C (R 3 ) = is preferable.
A combination in which X 31 to X 33 and X 36 to X 38 are -C (R 3 ) = and X 39 is -N =; or X 31 to X 33 and X 36 to X 39 are -C (R 3). The combination of) = is more preferable.
 式(3b)において、X31、X32、及びX35~X39の組合せとしては、
 X31、X32、及びX35が-C(R)=であり、X36~X39が-N=又は-C(R)=である組合せが好ましく、
 X31、X32及びX35~X38が-C(R)=であり、X39は-N=である組合せ;又は
 X31、X32及びX35~X39が-C(R)=である組合せがより好ましい。
In formula (3b), the combination of X 31 , X 32 , and X 35 to X 39 is as a combination.
A combination in which X 31 , X 32 , and X 35 are -C (R 3 ) = and X 36 to X 39 are -N = or -C (R 3 ) = is preferable.
A combination in which X 31 , X 32 and X 35 to X 38 are -C (R 3 ) = and X 39 is -N =; or X 31 , X 32 and X 35 to X 39 are -C (R 3). The combination of) = is more preferable.
 式(3)で表される基は、下記式(3-1)~(3-4)のいずれかで表される基であることが好ましい:
Figure JPOXMLDOC01-appb-C000026
(式中、R311、R312、R321~R323、R331~R336、及びR341~R346は、それぞれ、水素原子、置換基を有していてもよいN,N-ジアリールアミノ基、置換基を有していてもよいシクロアルキル基、置換基を有していてもよいアリール基、又は置換基を有していてもよいヘテロアリール基であり、
波線は、Lとの結合部位を示す)。
The group represented by the formula (3) is preferably a group represented by any of the following formulas (3-1) to (3-4):
Figure JPOXMLDOC01-appb-C000026
(In the formula, R 311 , R 312 , R 321 to R 323 , R 331 to R 336 , and R 341 to R 346 , respectively, may have a hydrogen atom and a substituent N, N-diarylamino. A group, a cycloalkyl group which may have a substituent, an aryl group which may have a substituent, or a heteroaryl group which may have a substituent.
The wavy line indicates the binding site with L).
 R311、R312、R321~R323、R331~R336、及びR341~R346は、それぞれ、好ましくは水素原子、置換基を有していてもよいN,N-ジC6-12アリールアミノ基(例えばZが不存在である式(2)で表される基)、置換基を有していてもよいC5-12シクロアルキル基、置換基を有していてもよいC6-12アリール基、置換基を有していてもよい5員又は6員単環式ヘテロアリール基、置換基を有していてもよい縮合二乃至四環式ヘテロアリール基(例えばZが不存在以外である式(2)で表される基)である。前記置換基としては、例えば、アリール基(例えばC6-12アリール基)又はヘテロアリール基(例えば5員又は6員単環式ヘテロアリール基、縮合二乃至四環式ヘテロアリール基)であってもよく、式(2)で表される基であってもよい。 R 311, R 312, R 321 ~ R 323, R 331 ~ R 336, and R 341 ~ R 346 are each preferably a hydrogen atom, which may have a substituent N, N-di C 6- A 12arylamino group (for example, a group represented by the formula (2) in which Z is absent), a C 5-12 cycloalkyl group which may have a substituent, and a C which may have a substituent. A 6-12 aryl group, a 5- or 6-membered monocyclic heteroaryl group which may have a substituent, and a fused 2- to tetracyclic heteroaryl group which may have a substituent (for example, Z is not). It is a group represented by the formula (2) that is other than existence). Examples of the substituent include an aryl group (for example, C 6-12 aryl group) or a heteroaryl group (for example, a 5-membered or 6-membered monocyclic heteroaryl group, a condensed 2- to 4-cyclic heteroaryl group). It may be a group represented by the formula (2).

 Lが置換基を有していてもよいフェニレン基である場合、フェニレン基は、1,2-フェニレン基、1,3-フェニレン基、及び1,4-フェニレン基のいずれであってもよい。
 前記置換基は、
好ましくは置換基を有していてもよいN,N-ジアリールアミノ基、置換基を有していてもよいアリール基、又は置換基を有していてもよいヘテロアリール基であり、
より好ましくは置換基を有していてもよいN,N-ジC6-18アリールアミノ基、置換基を有していてもよいC6-18アリール基、置換基を有していてもよい5員又は6員単環式ヘテロアリール基、又は置換基を有していてもよい縮合二乃至四環式ヘテロアリール基であり、
さらに好ましくは式(2)で表される基又は式(3)で表される基である。
 前記置換基の数は、例えば、0、1、2、3、又は4個である。
L
When L is a phenylene group which may have a substituent, the phenylene group may be any of 1,2-phenylene group, 1,3-phenylene group, and 1,4-phenylene group.
The substituent is
Preferably, it is an N, N-diarylamino group which may have a substituent, an aryl group which may have a substituent, or a heteroaryl group which may have a substituent.
More preferably, it may have an N, N-di C 6-18 arylamino group which may have a substituent, a C 6-18 aryl group which may have a substituent, and a substituent. A fused 2- to tetracyclic heteroaryl group which may have a 5- or 6-membered monocyclic heteroaryl group or a substituent, and is a fused two- to tetracyclic heteroaryl group.
More preferably, it is a group represented by the formula (2) or a group represented by the formula (3).
The number of the substituents is, for example, 0, 1, 2, 3, or 4.
 一実施態様において、式(1)で表される化合物は、Lが単結合である化合物が好ましく、Arに、1個以上置換可能な最大数以下の式(2)で表される基が置換した化合物がより好ましく、下記式(4)で表される化合物であることがさらに好ましい:
Figure JPOXMLDOC01-appb-C000027
[式中、
41~X43は、それぞれ、-N=又は-C(R44)=であり、
41~R44は、それぞれ、水素原子、置換基を有していてもよいN,N-ジアリールアミノ基、置換基を有していてもよいシクロアルキル基、置換基を有していてもよいアリール基、又は置換基を有していてもよいヘテロアリール基(但し、R41~R43のうち、少なくとも1つは、式(2)で表される基)である]。
In one embodiment, the compound represented by the formula (1) is preferably a compound in which L is a single bond, and Ar is substituted with one or more groups represented by the formula (2) that can be replaced by one or more. It is more preferable that the compound is a compound represented by the following formula (4):
Figure JPOXMLDOC01-appb-C000027
[During the ceremony,
X 41 to X 43 are -N = or -C (R 44 ) =, respectively.
R 41 to R 44 may have a hydrogen atom, an N, N-diarylamino group which may have a substituent, a cycloalkyl group which may have a substituent, and a substituent, respectively. A good aryl group or a heteroaryl group which may have a substituent (provided that at least one of R 41 to R 43 is a group represented by the formula (2)).
 X41~X43の組合せとしては、
 X41~X43が-N=である組合せ;又は
 X41~X43のうち、いずれか2つが-N=であり、残りの1つが-C(R44)=である組合せ
が好ましい。
As a combination of X 41 to X 43,
A combination in which X 41 to X 43 are -N =; or a combination in which any two of X 41 to X 43 is -N = and the remaining one is -C (R 44 ) = is preferable.
 R41~R44は、それぞれ、好ましくは水素原子、置換基を有していてもよいN,N-ジC6-12アリールアミノ基(例えばZが不存在である式(2)で表される基)、置換基を有していてもよいC5-12シクロアルキル基、置換基を有していてもよいC6-12アリール基、置換基を有していてもよい5員又は6員単環式ヘテロアリール基、又は置換基を有していてもよい縮合二乃至四環式ヘテロアリール基(例えばZが不存在以外である式(2)で表される基)である。前記置換基としては、例えば、アリール基(例えばC6-12アリール基)又はヘテロアリール基(例えば5員又は6員単環式ヘテロアリール基、縮合二乃至四環式ヘテロアリール基)であってもよく、式(2)で表される基であってもよい。 R 41 to R 44 are represented by the formula (2) in which Z is absent, for example , N, N-di C 6-12 arylamino groups which may have a hydrogen atom and a substituent, respectively. Group), C 5-12 cycloalkyl group which may have a substituent, C 6-12 aryl group which may have a substituent, 5 members or 6 which may have a substituent. It is a member monocyclic heteroaryl group or a fused bi to tetracyclic heteroaryl group which may have a substituent (for example, a group represented by the formula (2) in which Z is other than absent). Examples of the substituent include an aryl group (for example, C 6-12 aryl group) or a heteroaryl group (for example, a 5-membered or 6-membered monocyclic heteroaryl group, a condensed 2- to 4-cyclic heteroaryl group). It may be a group represented by the formula (2).
 式(4)で表される化合物は、下記式(4-1)又は(4-2)で表される化合物であることが好ましい:
Figure JPOXMLDOC01-appb-C000028
(式中、各々のCzは、互いに同一又は異なって、式(2)で表される基であり、X41~X43及びR41は前記と同じである)。
The compound represented by the formula (4) is preferably a compound represented by the following formula (4-1) or (4-2):
Figure JPOXMLDOC01-appb-C000028
(In the formula, each Cz is the same or different from each other and is a group represented by the formula (2), and X 41 to X 43 and R 41 are the same as described above).
 一実施態様において、式(1)で表される化合物は、Lが置換基を有していてもよいフェニレン基である化合物が好ましく、ベンゼン環に1個以上のAr及び1個以上の式(2)で表される基が置換した化合物(Ar及び式(2)で表される基の置換数の合計は2個以上6個以下である)がより好ましく、ベンゼン環に1個のAr及び1個以上5個以下の式(2)で表される基が置換した化合物がさらに好ましく、下記式(5)で表される化合物であることが特に好ましい:
Figure JPOXMLDOC01-appb-C000029
[式中、
51~X53は、それぞれ、-N=又は-C(R58)=であり、
51、R52、及びR58は、それぞれ、水素原子、置換基を有していてもよいN,N-ジアリールアミノ基、置換基を有していてもよいシクロアルキル基、置換基を有していてもよいアリール基、又は置換基を有していてもよいヘテロアリール基であり、
53~R57は、それぞれ、水素原子又は式(2)で表される基(但し、R53~R57のうち、少なくとも1つは、式(2)で表される基)である]。
In one embodiment, the compound represented by the formula (1) is preferably a compound in which L is a phenylene group which may have a substituent, and has one or more Ars on the benzene ring and one or more formulas (1 or more). A compound in which the group represented by 2) is substituted (the total number of Ars and the number of substitutions of the groups represented by the formula (2) is 2 or more and 6 or less) is more preferable, and one Ar and one Ar in the benzene ring and A compound in which one or more and five or less groups represented by the formula (2) are substituted is more preferable, and a compound represented by the following formula (5) is particularly preferable:
Figure JPOXMLDOC01-appb-C000029
[During the ceremony,
X 51 to X 53 are -N = or -C (R 58 ) =, respectively.
R 51 , R 52 , and R 58 each have a hydrogen atom, an N, N-diarylamino group which may have a substituent, a cycloalkyl group which may have a substituent, and a substituent, respectively. It is an aryl group which may have a substituent or a heteroaryl group which may have a substituent.
Each of R 53 to R 57 is a hydrogen atom or a group represented by the formula (2) (however , at least one of R 53 to R 57 is a group represented by the formula (2))]. ..
 X51~X53の組合せとしては、
 X51~X53が-N=である組合せ;又は
 X51が-C(R58)=であり、X52及びX53が-N=である組合せ
が好ましい。
As a combination of X 51 to X 53,
A combination in which X 51 to X 53 are -N =; or a combination in which X 51 is -C (R 58 ) = and X 52 and X 53 are -N = is preferable.
 R51、R52、及びR58は、それぞれ、好ましくは水素原子、置換基を有していてもよいN,N-ジC6-12アリールアミノ基(例えばZが不存在である式(2)で表される基)、置換基を有していてもよいC5-12シクロアルキル基、置換基を有していてもよいC6-12アリール基、置換基を有していてもよい5員又は6員単環式ヘテロアリール基、又は置換基を有していてもよい縮合二乃至四環式ヘテロアリール基(例えばZが不存在以外である式(2)で表される基)である。前記置換基としては、例えば、アリール基(例えばC6-12アリール基)又はヘテロアリール基(例えば5員又は6員単環式ヘテロアリール基、縮合二乃至四環式ヘテロアリール基)であってもよく、式(2)で表される基であってもよい。 R 51 , R 52 , and R 58 each preferably have an N, N-di C 6-12 arylamino group (eg, Z is absent), which may have a hydrogen atom and a substituent, respectively (eg, formula (2) in which Z is absent. ), C 5-12 cycloalkyl group which may have a substituent, C 6-12 aryl group which may have a substituent, and may have a substituent. A five- or six-membered monocyclic heteroaryl group or a fused two- to tetracyclic heteroaryl group which may have a substituent (for example, a group represented by the formula (2) in which Z is other than absent). Is. Examples of the substituent include an aryl group (for example, C 6-12 aryl group) or a heteroaryl group (for example, a 5-membered or 6-membered monocyclic heteroaryl group, a condensed 2- to 4-cyclic heteroaryl group). It may be a group represented by the formula (2).
 式(5)で表される化合物は、下記式(5-1)~(5-14)のいずれかで表される化合物であることが好ましい:
Figure JPOXMLDOC01-appb-C000030
(式中、Czは式(2)で表される基であり、複数のCzが存在する場合、複数のCzは互いに同一であっても異なっていてもよく、X51~X53、R51、及びR52は前記と同じである)。
The compound represented by the formula (5) is preferably a compound represented by any of the following formulas (5-1) to (5-14):
Figure JPOXMLDOC01-appb-C000030
(In the formula, Cz is a group represented by the formula (2), and when a plurality of Cz exists, the plurality of Cz may be the same or different from each other, and X 51 to X 53 , R 51. , And R 52 are the same as above).
 一実施態様において、式(1)で表される化合物は、下記式(6)で表される化合物であることが好ましい:
Figure JPOXMLDOC01-appb-C000031
[式中、
61~X67は、それぞれ、-N=又は-C(R66)=であり、
61~R65は、それぞれ、水素原子又は式(2)で表される基(但し、R61~R65のうち、少なくとも1つは、式(2)で表される基)であり、
66は、水素原子、置換基を有していてもよいN,N-ジアリールアミノ基、置換基を有していてもよいシクロアルキル基、置換基を有していてもよいアリール基、又は置換基を有していてもよいヘテロアリール基である]。
In one embodiment, the compound represented by the formula (1) is preferably a compound represented by the following formula (6):
Figure JPOXMLDOC01-appb-C000031
[During the ceremony,
X 61 to X 67 are -N = or -C (R 66 ) =, respectively.
R 61 to R 65 are hydrogen atoms or groups represented by the formula (2), respectively (however , at least one of R 61 to R 65 is a group represented by the formula (2)).
R 66 is a hydrogen atom, an N, N-diarylamino group which may have a substituent, a cycloalkyl group which may have a substituent, an aryl group which may have a substituent, or It is a heteroaryl group that may have a substituent].
 X61~X67の組合せとしては、
 X61~X65、及びX67が-C(R66)=であり、X66が-N=である組合せ;又は
 X61~X67が-C(R58)=である組合せ
が好ましい。
As a combination of X 61 to X 67,
A combination in which X 61 to X 65 and X 67 are -C (R 66 ) = and X 66 is -N =; or a combination in which X 61 to X 67 is -C (R 58 ) = is preferred.
 R66は、好ましくは水素原子、置換基を有していてもよいN,N-ジC6-12アリールアミノ基(例えばZが不存在である式(2)で表される基)、置換基を有していてもよいC5-12シクロアルキル基、置換基を有していてもよいC6-12アリール基、置換基を有していてもよい5員又は6員単環式ヘテロアリール基、又は置換基を有していてもよい縮合二乃至四環式ヘテロアリール基(例えばZが不存在以外である式(2)で表される基)である。前記置換基としては、例えば、アリール基(例えばC6-12アリール基)又はヘテロアリール基(例えば5員又は6員単環式ヘテロアリール基、縮合二乃至四環式ヘテロアリール基)であってもよく、式(2)で表される基であってもよい。 R 66 is preferably a hydrogen atom, an N, N-di C 6-12 arylamino group which may have a substituent (for example, a group represented by the formula (2) in which Z is absent), a substituent. A C 5-12 cycloalkyl group which may have a group, a C 6-12 aryl group which may have a substituent, and a 5-membered or 6-membered monocyclic hetero which may have a substituent. A fused bi- to tetracyclic heteroaryl group which may have an aryl group or a substituent (for example, a group represented by the formula (2) in which Z is other than absent). Examples of the substituent include an aryl group (for example, C 6-12 aryl group) or a heteroaryl group (for example, a 5-membered or 6-membered monocyclic heteroaryl group, a condensed 2- to 4-cyclic heteroaryl group). It may be a group represented by the formula (2).
 式(6)で表される化合物は、下記式(6-1)で表される化合物であることが好ましい:
Figure JPOXMLDOC01-appb-C000032
(式中、Czは式(2)で表される基であり、2個のCzは互いに同一であっても異なっていてもよく、X61~X67は前記と同じである)。
The compound represented by the formula (6) is preferably a compound represented by the following formula (6-1):
Figure JPOXMLDOC01-appb-C000032
(In the formula, Cz is a group represented by the formula (2), and the two Cz may be the same or different from each other, and X 61 to X 67 are the same as described above).
 一実施態様において、式(1)で表される化合物は、Lが置換基を有していてもよいフェニレン基である化合物が好ましく、ベンゼン環に2個のAr及び1個以上4個以下の式(2)で表される基が置換した化合物がより好ましく、下記式(7)で表される化合物であることがさらに好ましい:
Figure JPOXMLDOC01-appb-C000033
[式中、
71~X76は、それぞれ、-N=又は-C(R79)=であり、
71~R74及びR79は、それぞれ、水素原子、置換基を有していてもよいN,N-ジアリールアミノ基、置換基を有していてもよいシクロアルキル基、置換基を有していてもよいアリール基、又は置換基を有していてもよいヘテロアリール基であり、
75~R78は、水素原子又は式(2)で表される基(但し、R75~R78のうち、少なくとも1つは、式(2)で表される基)である]。
In one embodiment, the compound represented by the formula (1) is preferably a compound in which L is a phenylene group which may have a substituent, and has two Ars on the benzene ring and one or more and four or less. A compound in which the group represented by the formula (2) is substituted is more preferable, and a compound represented by the following formula (7) is further preferable:
Figure JPOXMLDOC01-appb-C000033
[During the ceremony,
X 71 to X 76 are -N = or -C (R 79 ) =, respectively.
R 71 to R 74 and R 79 each have a hydrogen atom, an N, N-diarylamino group which may have a substituent, a cycloalkyl group which may have a substituent, and a substituent, respectively. It is an aryl group that may be present, or a heteroaryl group that may have a substituent, and is
R 75 to R 78 are hydrogen atoms or groups represented by the formula (2) (however , at least one of R 75 to R 78 is a group represented by the formula (2))].
 X71~X76の組合せとしては、
 X71~X76が-N=である組合せ;又は
 X71、X73、X74、及びX76が-N=であり、X72及びX75が-C(R79)=である組合せ
が好ましい。
As a combination of X 71 to X 76,
Combinations where X 71 to X 76 are -N =; or combinations where X 71 , X 73 , X 74 , and X 76 are -N = and X 72 and X 75 are -C (R 79 ) = preferable.
 R71~R74及びR79は、それぞれ、好ましくは水素原子、置換基を有していてもよいN,N-ジC6-12アリールアミノ基(例えばZが不存在である式(2)で表される基)、置換基を有していてもよいC5-12シクロアルキル基、置換基を有していてもよいC6-12アリール基、置換基を有していてもよい5員又は6員単環式ヘテロアリール基、又は置換基を有していてもよい縮合二乃至四環式ヘテロアリール基(例えばZが不存在以外である式(2)で表される基)である。前記置換基としては、例えば、アリール基(例えばC6-12アリール基)又はヘテロアリール基(例えば5員又は6員単環式ヘテロアリール基、縮合二乃至四環式ヘテロアリール基)であってもよく、式(2)で表される基であってもよい。 R 71 to R 74 and R 79 each preferably have a hydrogen atom and a substituent, respectively, N, N-di C 6-12 arylamino groups (for example, formula (2) in which Z is absent). Group represented by), C 5-12 cycloalkyl group which may have a substituent, C 6-12 aryl group which may have a substituent, and may have a substituent 5 A fused two- to tetracyclic heteroaryl group which may have a member or 6-membered monocyclic heteroaryl group or a substituent (for example, a group represented by the formula (2) in which Z is other than absent). be. Examples of the substituent include an aryl group (for example, C 6-12 aryl group) or a heteroaryl group (for example, a 5-membered or 6-membered monocyclic heteroaryl group, a condensed 2- to 4-cyclic heteroaryl group). It may be a group represented by the formula (2).
 式(7)で表される化合物は、下記式(7-1)~(7-3)のいずれかで表される化合物であることが好ましい:
Figure JPOXMLDOC01-appb-C000034
(式中、Czは式(2)で表される基であり、複数のCzが存在する場合、複数のCzは互いに同一であっても異なっていてもよく、X71~X76及びR71~R74は前記と同じである)。
The compound represented by the formula (7) is preferably a compound represented by any of the following formulas (7-1) to (7-3):
Figure JPOXMLDOC01-appb-C000034
(In the formula, Cz is a group represented by the formula (2), and when a plurality of Cz exists, the plurality of Cz may be the same or different from each other, and X 71 to X 76 and R 71. ~ R 74 is the same as above).
 一実施態様において、式(1)で表される化合物は、下記式(8)で表される化合物であることが好ましい:
Figure JPOXMLDOC01-appb-C000035
[式中、
81~X86は、それぞれ、-N=又は-C(R89)=であり、
81~R84及びR89は、それぞれ、水素原子、置換基を有していてもよいN,N-ジアリールアミノ基、置換基を有していてもよいシクロアルキル基、置換基を有していてもよいアリール基、又は置換基を有していてもよいヘテロアリール基であり、
85~R88は、水素原子又は式(2)で表される基(但し、R85~R88のうち、少なくとも1つは、式(2)で表される基)である]。
In one embodiment, the compound represented by the formula (1) is preferably a compound represented by the following formula (8):
Figure JPOXMLDOC01-appb-C000035
[During the ceremony,
X 81 to X 86 are −N = or −C (R 89 ) =, respectively.
R 81 to R 84 and R 89 each have a hydrogen atom, an N, N-diarylamino group which may have a substituent, a cycloalkyl group which may have a substituent, and a substituent, respectively. It is an aryl group that may be present, or a heteroaryl group that may have a substituent, and is
R 85 to R 88 are hydrogen atoms or groups represented by the formula (2) (provided that at least one of R 85 to R 88 is a group represented by the formula (2))].
 X81~X86の組合せとしては、
 X81~X86が-N=である組合せ;又は
 X81、X83、X84、及びX86が-N=であり、X82及びX85が-C(R89)=である組合せ
が好ましい。
As a combination of X 81 to X 86,
A combination in which X 81 to X 86 are -N =; or a combination in which X 81 , X 83 , X 84 , and X 86 are -N = and X 82 and X 85 are -C (R 89 ) = preferable.
 R81~R84及びR89は、それぞれ、好ましくは水素原子、置換基を有していてもよいN,N-ジC6-12アリールアミノ基(例えばZが不存在である式(2)で表される基)、置換基を有していてもよいC5-12シクロアルキル基、置換基を有していてもよいC6-12アリール基、置換基を有していてもよい5員又は6員単環式ヘテロアリール基、又は置換基を有していてもよい縮合二乃至四環式ヘテロアリール基(例えばZが不存在以外である式(2)で表される基)である。前記置換基としては、例えば、アリール基(例えばC6-12アリール基)又はヘテロアリール基(例えば5員又は6員単環式ヘテロアリール基、縮合二乃至四環式ヘテロアリール基)であってもよく、式(2)で表される基であってもよい。 R 81 to R 84 and R 89 preferably have an N, N-diC 6-12 arylamino group which may have a hydrogen atom and a substituent, respectively (for example, formula (2) in which Z is absent). Group represented by), C 5-12 cycloalkyl group which may have a substituent, C 6-12 aryl group which may have a substituent, and may have a substituent 5 A fused two- to tetracyclic heteroaryl group which may have a member or 6-membered monocyclic heteroaryl group or a substituent (for example, a group represented by the formula (2) in which Z is other than absent). be. Examples of the substituent include an aryl group (for example, C 6-12 aryl group) or a heteroaryl group (for example, a 5-membered or 6-membered monocyclic heteroaryl group, a condensed 2- to 4-cyclic heteroaryl group). It may be a group represented by the formula (2).
 式(8)で表される化合物は、下記式(8-1)~(8-6)のいずれかで表される化合物であることが好ましい:
Figure JPOXMLDOC01-appb-C000036
(式中、Czは式(2)で表される基であり、複数のCzが存在する場合、複数のCzは互いに同一であっても異なっていてもよく、X81~X86及びR81~R84は前記と同じである)。
The compound represented by the formula (8) is preferably a compound represented by any of the following formulas (8-1) to (8-6):
Figure JPOXMLDOC01-appb-C000036
(In the formula, Cz is a group represented by the formula (2), and when a plurality of Cz exists, the plurality of Cz may be the same or different from each other, and X 81 to X 86 and R 81. ~ R 84 is the same as above).
 本発明の化合物の発光ピークの半値幅は、好ましくは90nm以下、より好ましくは85nm以下、さらに好ましくは80nm以下であってもよく、10nm以上であってもよい。半値幅は、本発明の化合物を溶解した溶液(濃度:1×10-5M)に室温下340nmの励起光を照射した場合の発光スペクトル測定により決定することができる。なお、発光スペクトルにおいて、ピークトップ強度の半分の値のスペクトル幅を半値幅(FWHM, Full Width Half Maximum)と定義する。 The half width of the emission peak of the compound of the present invention may be preferably 90 nm or less, more preferably 85 nm or less, further preferably 80 nm or less, or 10 nm or more. The full width at half maximum can be determined by measuring the emission spectrum when a solution (concentration: 1 × 10-5 M) in which the compound of the present invention is dissolved is irradiated with excitation light at 340 nm at room temperature. In the emission spectrum, the spectrum width of half the peak top intensity is defined as the half width (FWHM, Full Width Half Maximum).
 本発明の化合物の発光効率(PLQY)は、好ましくは50%以上、より好ましくは55%以上、さらに好ましくは60%以上である。発光効率(PLQY)は、本発明の化合物を溶解した溶液(濃度:1×10-5M)に室温下340nmの励起光を照射した場合の値であり、絶対PL量子収率測定装置(例えば、浜松ホトニクス社製 Quantaurus-QY C11347-01)を用いて測定することができる。 The luminous efficiency (PLQY) of the compound of the present invention is preferably 50% or more, more preferably 55% or more, still more preferably 60% or more. Luminous efficiency (PLQY) is a value when a solution (concentration: 1 × 10-5 M) in which the compound of the present invention is dissolved is irradiated with excitation light at 340 nm at room temperature, and is an absolute PL quantum yield measuring device (for example). , Hamamatsu Photonics Quantaurus-QY C11347-01) can be used for measurement.
 本発明の化合物のHOMO準位は、好ましくは-5.0eV以下又は-5.5eV以下であってもよく、-7.0eV以上、-6.5eV以上、又は-6.4eV以上であってもよい。このようなHOMO準位により、ホスト材料などの周辺材料との適合性に優れる。HOMO準位は、大気中光電子分光装置(例えば、理研計器株式会社製AC―3)を用いて測定することができる。 The HOMO level of the compound of the present invention may preferably be -5.0 eV or less or -5.5 eV or less, and is -7.0 eV or more, -6.5 eV or more, or -6.4 eV or more. May be good. Due to such a HOMO level, compatibility with peripheral materials such as host materials is excellent. The HOMO level can be measured using an atmospheric photoelectron spectrometer (for example, AC-3 manufactured by RIKEN Keiki Co., Ltd.).
 本発明の化合物の配向度パラメータSは、発光効率の点から、好ましくは0.002以上、0.003以上、0.004以上、又は0.005以上であってもよく、0.05以下であってもよい。配向度パラメータSは、発光材料の単膜(膜厚 約 30nm)をベアシリコン基板上に作製し、分光エリプソメータ(J.A. Woollam Japan製品)を使用して45~75度(5度刻み)の範囲でスペクトル測定を行い、得られたスペクトルのフィッティング解析により算出することができる。 From the viewpoint of luminous efficiency, the orientation parameter S of the compound of the present invention may be preferably 0.002 or more, 0.003 or more, 0.004 or more, or 0.005 or more, and is 0.05 or less. There may be. The orientation parameter S is in the range of 45 to 75 degrees (in 5 degree increments) using a spectroscopic ellipsometer (JA Woollam Japan product) by forming a single film (film thickness of about 30 nm) of the light emitting material on a bare silicon substrate. It can be calculated by performing spectrum measurement and fitting analysis of the obtained spectrum.
 本発明の化合物の酸化還元特性ΔEは、耐久性の点から、好ましくは0.1eV以下、0.08eV以下、0.06eV以下、又は0.05eV以下であってもよく、0.01eV以上であってもよい。ΔEは、以下の測定条件でサイクリックボルタンメトリー測定を行うことにより算出することができる。
<測定条件>
作用極:グラッシーカーボン
対極:白金ワイヤ
参照極:Ag/AgNOアセトニトリル溶液
溶媒:THF
電解質:BuNPF
走引速度:50meV/s
発光材料濃度:1mM
電解質濃度:100mM
From the viewpoint of durability, the redox characteristic ΔE of the compound of the present invention may be preferably 0.1 eV or less, 0.08 eV or less, 0.06 eV or less, or 0.05 eV or less, and is 0.01 eV or more. There may be. ΔE can be calculated by performing cyclic voltammetry measurement under the following measurement conditions.
<Measurement conditions>
Working electrode: Glassy carbon Counter electrode: Platinum wire Reference electrode: Ag / AgNO 3 Acetonitrile solution Solvent: THF
Electrolyte: Bu 4 NPF 6
Running speed: 50 meV / s
Luminescent material concentration: 1 mM
Electrolyte concentration: 100 mM
式(1)で表される化合物の製造方法
 式(1)で表される化合物は、特に限定されるものではないが、例えば、下記式(11):
Figure JPOXMLDOC01-appb-C000037
(式中、Z及びR21~R28は前記と同じである)
で表される化合物を、下記式(12):
Ar-L-(Q) (12)
(式中、
はハロゲン原子であり、
Ar及びLは前記と同じであり、
Lが単結合である場合、nはArの価数に応じて選択される1以上の整数であり、
Lが置換基を有していてもよいフェニレン基である場合、nはLの価数に応じて選択される1以上の整数である)
で表される化合物と反応させる工程を含む方法により製造することができる。
Method for producing a compound represented by the formula (1) The compound represented by the formula (1) is not particularly limited, but for example, the following formula (11):
Figure JPOXMLDOC01-appb-C000037
(In the formula, Z and R 21 to R 28 are the same as above)
The compound represented by the following formula (12):
Ar-L- (Q 1 ) n (12)
(During the ceremony,
Q 1 is a halogen atom
Ar and L are the same as above,
When L is a single bond, n is an integer greater than or equal to 1 selected according to the valence of Ar.
When L is a phenylene group which may have a substituent, n is an integer of 1 or more selected according to the valence of L).
It can be produced by a method including a step of reacting with a compound represented by.
式(11)で表される化合物
 式(11)で表される化合物は、公知の反応の組合せにより製造することができる。例えば、式(11)で表される化合物は、下記式(13):
Figure JPOXMLDOC01-appb-C000038
(式中、Q及びQは、それぞれ、ハロゲン原子であり、R21、R22、R24、R25、R27、及びR28は前記と同じである)
で表される化合物を、下記式(14):
Figure JPOXMLDOC01-appb-C000039
(式中、R23は前記と同じである)
で表される化合物、及び下記式(15):
Figure JPOXMLDOC01-appb-C000040
(式中、R26は前記と同じである)
で表される化合物と反応させる工程を含む方法により製造することができる。
The compound represented by the formula (11) The compound represented by the formula (11) can be produced by a combination of known reactions. For example, the compound represented by the formula (11) is represented by the following formula (13):
Figure JPOXMLDOC01-appb-C000038
(In the formula, Q 2 and Q 3 are halogen atoms, respectively, and R 21 , R 22 , R 24 , R 25 , R 27 , and R 28 are the same as above).
The compound represented by the following formula (14):
Figure JPOXMLDOC01-appb-C000039
(In the formula, R 23 is the same as above)
The compound represented by, and the following formula (15):
Figure JPOXMLDOC01-appb-C000040
(In the formula, R 26 is the same as above)
It can be produced by a method including a step of reacting with a compound represented by.
 式(13)において、Q及びQは、互いに同一であっても異なっていてもよく、それぞれ、フッ素原子、塩素原子、又は臭素原子であることが好ましい。 In formula (13), Q 2 and Q 3 may be the same or different from each other, and are preferably fluorine atoms, chlorine atoms, or bromine atoms, respectively.
 式(14)及び(15)において、-B(OH)は、下記式:
Figure JPOXMLDOC01-appb-C000041
で表される基であってもよい。
In the formulas (14) and (15), −B (OH) 2 is expressed by the following formula:
Figure JPOXMLDOC01-appb-C000041
It may be a group represented by.
 式(14)及び(15)で表される化合物の使用量の合計は、式(13)で表される化合物1モルに対して、2モル以上、2.5モル以上、又は3モル以上であることが好ましく、6モル以下、5モル以下、又は4モル以下であることが好ましい。 The total amount of the compounds represented by the formulas (14) and (15) used is 2 mol or more, 2.5 mol or more, or 3 mol or more with respect to 1 mol of the compound represented by the formula (13). It is preferably 6 mol or less, 5 mol or less, or 4 mol or less.
 当該反応は、触媒の存在下で行うことが好ましい。触媒としては、例えば、遷移金属触媒が挙げられ、その具体例としては、パラジウム触媒、銅触媒、ニッケル触媒、コバルト触媒などが挙げられる。これらの触媒は、1種を単独で又は2種以上を組み合わせて使用することができる。なお、これらの触媒を使用する場合、国際公開第2011/08902号、国際公開第2015/137472号などを参照できる。 The reaction is preferably carried out in the presence of a catalyst. Examples of the catalyst include a transition metal catalyst, and specific examples thereof include a palladium catalyst, a copper catalyst, a nickel catalyst, and a cobalt catalyst. These catalysts can be used alone or in combination of two or more. When these catalysts are used, International Publication No. 2011/08902, International Publication No. 2015/137472, and the like can be referred to.
 当該反応は、塩基の存在下で行うことが好ましい。塩基としては、例えば、n-ブチルリチウム、NaH、t-ブトキシナトリウム、KOH、KCO、KPO、t-ブトキシカリウム、酢酸カリウム、CsCOなどが挙げられる。これらの塩基は、1種を単独で又は2種以上を組み合わせて使用することができる。なお、これらの塩基を使用する場合、国際公開第2008/117826号、Chemistry of Materials, 2010, 22(7), 2403~2410、韓国特許出願公開公報第2018-063708号などを参照できる。 The reaction is preferably carried out in the presence of a base. Examples of the base include n-butyllithium, NaH, t-butoxysodium, KOH, K 2 CO 3 , K 3 PO 4 , t-butoxy potassium, potassium acetate, Cs 2 CO 3. and the like. These bases can be used alone or in combination of two or more. When these bases are used, International Publication No. 2008/1178226, Chemistry of Materials, 2010, 22 (7), 2403-2410, Korean Patent Application Publication No. 2018-063708, etc. can be referred to.
 当該反応は、溶媒の存在下で行うことが好ましい。溶媒としては、反応成分を溶解可能である限り、特に制限されず、例えば、エーテル(例:ジエチルエーテル、ジプロピルエーテル、ジブチルエーテル、1,4-ジオキサン、テトラヒドロフラン)、芳香族炭化水素(例:トルエン、キシレン)、アミン(例:トリエチルアミンなどの鎖状アミン、N-メチルピロリドンなどの環状アミン)、アミド(例:ジメチルホルムアミド)、スルホキシド(例:ジメチルスルホキシド)などが挙げられる。溶媒は1種を単独で又は2種以上を混合して使用することができる。 The reaction is preferably carried out in the presence of a solvent. The solvent is not particularly limited as long as the reaction component can be dissolved, and is, for example, ether (eg, diethyl ether, dipropyl ether, dibutyl ether, 1,4-dioxane, tetrahydrofuran), aromatic hydrocarbon (eg, tetrahydrofuran). Examples include toluene, xylene), amines (eg, chain amines such as triethylamine, cyclic amines such as N-methylpyrrolidone), amides (eg, dimethylformamide), sulfoxides (eg, dimethylsulfoxide) and the like. As the solvent, one type can be used alone or two or more types can be mixed and used.
 当該反応の反応温度及び反応時間は、反応が進行する限り、特に制限されない。反応温度は、例えば0℃以上、15℃以上、又は25℃以上であってもよく、200℃以下、150℃以下、又は100℃以下であってもよい。反応時間は、例えば1時間以上、2時間以上、又は5時間以上であってもよく、50時間以下、30時間以下、又は10時間以下であってもよい。 The reaction temperature and reaction time of the reaction are not particularly limited as long as the reaction proceeds. The reaction temperature may be, for example, 0 ° C. or higher, 15 ° C. or higher, or 25 ° C. or higher, or 200 ° C. or lower, 150 ° C. or lower, or 100 ° C. or lower. The reaction time may be, for example, 1 hour or more, 2 hours or more, or 5 hours or more, and may be 50 hours or less, 30 hours or less, or 10 hours or less.
式(12)で表される化合物
 Qは、フッ素原子、塩素原子、又は臭素原子であることが好ましい。
Equation (12) Compound Q 1 represented by the fluorine atom is preferably a chlorine atom, or bromine atom.
 式(12)で表される化合物は、公知の反応の組合せにより製造することができる。例えば、式(12)で表される化合物のうち、Lが単結合である化合物は、市販品をそのまま使用することができ、Lが置換基を有していてもよいフェニレン基である化合物は、下記式(16):
Ar-Q (16)
(式中、Qはハロゲン原子である)
で表される化合物を、下記式(17):
(Q)-L-B(OH) (17)
(式中、L及びQは前記と同じである)
で表される化合物と反応させる工程を含む方法により製造することができる。
The compound represented by the formula (12) can be produced by a combination of known reactions. For example, among the compounds represented by the formula (12), the compound in which L is a single bond can be a commercially available product as it is, and the compound in which L is a phenylene group which may have a substituent may be used. , The following formula (16):
Ar-Q 4 (16)
(Wherein, Q 4 is a halogen atom)
The compound represented by the following formula (17):
(Q 1 ) n- LB (OH) 2 (17)
(In the formula, L and Q 1 are the same as above)
It can be produced by a method including a step of reacting with a compound represented by.
 式(17)において、-B(OH)は、下記式:
Figure JPOXMLDOC01-appb-C000042
で表される基であってもよい。
In the formula (17), −B (OH) 2 is expressed by the following formula:
Figure JPOXMLDOC01-appb-C000042
It may be a group represented by.
 当該反応は、式(13)~(15)で表される化合物の反応と同様の反応条件を採用することができる。 For the reaction, the same reaction conditions as the reaction of the compounds represented by the formulas (13) to (15) can be adopted.
式(11)で表される化合物と式(12)で表される化合物の反応
 当該反応は、式(13)~(15)で表される化合物の反応と同様の反応条件を採用することができる。
 式(11)及び(12)で表される化合物の反応は、式(13)~(15)で表される化合物を反応させた後、引き続き(式(11)で表される化合物を精製することなく)、式(12)で表される化合物と反応させる反応(ワンポット反応)であってもよく、式(16)及び(17)で表される化合物を反応させた後、引き続き(式(12)で表される化合物を精製することなく)、式(13)~(15)で表される化合物と反応させる反応(ワンポット反応)であってもよい。
Reaction of the compound represented by the formula (11) and the compound represented by the formula (12) The reaction may adopt the same reaction conditions as the reaction of the compounds represented by the formulas (13) to (15). can.
In the reaction of the compounds represented by the formulas (11) and (12), the compounds represented by the formulas (13) to (15) are reacted, and then the compound represented by the formula (11) is continuously purified. It may be a reaction (one-pot reaction) in which the compound represented by the formula (12) is reacted (without), and after the compounds represented by the formulas (16) and (17) are reacted, the reaction (without the formula (12)) is continued. It may be a reaction (one-pot reaction) in which the compound represented by the formulas (13) to (15) is reacted without purifying the compound represented by 12).
<遅延蛍光材料>
 一実施態様において、本発明の遅延蛍光材料は、本発明の化合物を含むことが好ましい。遅延蛍光材料は、例えば、後述の有機発光素子の発光材料として好適に使用することができる。
<Delayed fluorescent material>
In one embodiment, the delayed fluorescent material of the present invention preferably comprises the compound of the present invention. The delayed fluorescent material can be suitably used, for example, as a light emitting material for an organic light emitting device described later.
<有機発光素子>
 一実施形態において、本発明の有機発光素子は、本発明の化合物を含むことが好ましい。
<Organic light emitting element>
In one embodiment, the organic light emitting device of the present invention preferably contains the compound of the present invention.
 有機発光素子としては、例えば、有機フォトルミネッセンス素子(有機PL素子)、有機エレクトロルミネッセンス素子(有機EL素子)などが挙げられる。有機発光素子は、有機EL素子であることが好ましい。 Examples of the organic light emitting element include an organic photoluminescence element (organic PL element) and an organic electroluminescence element (organic EL element). The organic light emitting element is preferably an organic EL element.
 有機EL素子は、陽極、陰極、及び陽極と陰極との間に形成された有機層とを有することが好ましい。 The organic EL element preferably has an anode, a cathode, and an organic layer formed between the anode and the cathode.
 有機層は、少なくとも発光層を含むことが好ましく、発光層のみからなるものであってもよいし、発光層に加えて、1層以上の他の有機層を含んでいてもよい。他の有機層としては、例えば、注入層(例:正孔注入層、電子注入層)、阻止層(例:電子阻止層、正孔阻止層、励起子阻止層)、輸送層(例:正孔輸送層、電子輸送層)などが挙げられる。正孔輸送層は、正孔注入機能を有した正孔注入輸送層でもよく、電子輸送層は電子注入機能を有した電子注入輸送層でもよい。 The organic layer preferably contains at least a light emitting layer, and may be composed of only a light emitting layer, or may include one or more other organic layers in addition to the light emitting layer. Other organic layers include, for example, injection layers (eg, hole injection layer, electron injection layer), blocking layers (eg, electron blocking layer, hole blocking layer, exciton blocking layer), transport layers (eg, positive). Hole transport layer, electron transport layer) and the like. The hole transport layer may be a hole injection transport layer having a hole injection function, and the electron transport layer may be an electron injection transport layer having an electron injection function.
 有機EL素子は、発光層で発生した光を基板側から取り出すボトムエミッション型であってもよいし、発光層で発生した光を基板の反対側から取り出すトップエミッション型であってもよい。いずれの型であっても、基板側に形成する電極は陽極であってもよいし、陰極であってもよい。光を取り出す側の電極は透明であることが好ましく、その反対側の電極は透明であっても透明でなくてもよい。 The organic EL element may be a bottom emission type that extracts the light generated in the light emitting layer from the substrate side, or may be a top emission type that extracts the light generated in the light emitting layer from the opposite side of the substrate. In any type, the electrode formed on the substrate side may be an anode or a cathode. The electrode on the side that extracts light is preferably transparent, and the electrode on the opposite side may or may not be transparent.
 有機EL素子は、基板に支持されていることが好ましい。基板については、特に制限はなく、従来から有機EL素子に慣用されているものであればよく、例えば、ガラス、透明プラスチック、石英、シリコンなどからなるものを用いることができる。 The organic EL element is preferably supported by a substrate. The substrate is not particularly limited as long as it is conventionally used for organic EL elements, and for example, a substrate made of glass, transparent plastic, quartz, silicon, or the like can be used.
 有機EL素子における陽極としては、仕事関数の大きい(例えば4eV以上)金属、合金、電気伝導性化合物、及びこれらの混合物を電極材料とするものが好ましく用いられる。このような電極材料の具体例としては、Auなどの金属、CuI、インジウムチンオキシド(ITO)、SnO、ZnOなどの透明導電性材料が挙げられる。また、IDIXO(In-ZnO)などの非晶質で透明導電膜を作製可能な材料を用いてもよい。陽極は、電極材料を蒸着、スパッタリングなどの方法により薄膜を形成し、フォトリソグラフィー法で所望の形状のパターンを形成してもよく、電極材料の蒸着、スパッタリング時に所望の形状のマスクを介してパターンを形成してもよい。或いは、有機導電性化合物のように塗布可能な材料を用いる場合には、印刷方式、コーティング方式など湿式成膜法を用いることもできる。陽極から発光を取り出す場合には、透過率を10%よりも大きくすることが望ましく、また陽極としてのシート抵抗は数百Ω/□以下が好ましい。陽極の膜厚は材料にもよるが、通常、10~1000nm、好ましくは10~200nmの範囲で選ばれる。 As the anode in the organic EL element, a metal having a large work function (for example, 4 eV or more), an alloy, an electrically conductive compound, and a mixture thereof as an electrode material are preferably used. Specific examples of such electrode materials include metals such as Au and transparent conductive materials such as CuI, indium tin oxide (ITO), SnO 2, and ZnO. Further, a material capable of producing an amorphous transparent conductive film such as IDIXO (In 2 O 3-ZnO) may be used. For the anode, a thin film may be formed by a method such as vapor deposition or sputtering of the electrode material to form a pattern having a desired shape by a photolithography method. May be formed. Alternatively, when a coatable material such as an organic conductive compound is used, a wet film forming method such as a printing method or a coating method can also be used. When extracting light from the anode, it is desirable to increase the transmittance to more than 10%, and the sheet resistance as the anode is preferably several hundred Ω / □ or less. The film thickness of the anode depends on the material, but is usually selected in the range of 10 to 1000 nm, preferably 10 to 200 nm.
 陰極としては、仕事関数の小さい(例えば4eV以下)金属(電子注入性金属)、合金、電気伝導性化合物、及びこれらの混合物を電極材料とするものが好ましく用いられる。このような電極材料の具体例としては、ナトリウム、ナトリウム-カリウム合金、マグネシウム、リチウム、マグネシウム/銅混合物、マグネシウム/銀混合物、マグネシウム/アルミニウム混合物、マグネシウム/インジウム混合物、アルミニウム/酸化アルミニウム(Al)混合物、リチウム/アルミニウム混合物、アルミニウムなどが好適である。陰極は、電極材料を蒸着、スパッタリングなどの方法により薄膜を形成することにより作製することができる。また、陰極としてのシート抵抗は数百Ω/□以下が好ましい。陰極の膜厚は通常10nm~5μm、好ましくは50~200nmの範囲で選ばれる。なお、有機EL素子の陽極又は陰極のいずれか一方が、透明又は半透明であれば発光輝度が向上するため好ましい。また、陽極の説明で挙げた透明導電性材料を陰極に用いることで透明又は半透明の陰極を作製することができ、陽極と陰極の両方が透過性を有する素子を作製することができる。 As the cathode, a metal having a small work function (for example, 4 eV or less) (electron-injectable metal), an alloy, an electrically conductive compound, or a mixture thereof as an electrode material is preferably used. Specific examples of such electrode materials include sodium, sodium-potassium alloy, magnesium, lithium, magnesium / copper mixture, magnesium / silver mixture, magnesium / aluminum mixture, magnesium / indium mixture, aluminum / aluminum oxide (Al 2 O). 3 ) A mixture, a lithium / aluminum mixture, aluminum and the like are suitable. The cathode can be produced by forming a thin film of an electrode material by a method such as thin film deposition or sputtering. Further, the sheet resistance as a cathode is preferably several hundred Ω / □ or less. The film thickness of the cathode is usually selected in the range of 10 nm to 5 μm, preferably 50 to 200 nm. It is preferable that either the anode or the cathode of the organic EL element is transparent or translucent because the emission brightness is improved. Further, by using the transparent conductive material mentioned in the description of the anode for the cathode, a transparent or translucent cathode can be produced, and an element in which both the anode and the cathode have transparency can be produced.
 発光層は、陽極及び陰極のそれぞれから注入された正孔及び電子が再結合することにより励起子が生成した後、発光(例:蛍光発光、遅延蛍光発光、及びその両方)する層であることが好ましい。発光層は、発光材料を単独で含む層であってもよいが、発光材料及びホスト材料を含む層であることが好ましい。発光材料として、本発明の化合物(1種又は2種以上)を用いることができる。ホスト材料としては、特に制限されないが、励起一重項エネルギー及び励起三重項エネルギーの少なくとも一方が、本発明の化合物よりも高い値を有する有機化合物を用いることが好ましい。また、ホスト材料は、正孔輸送能、電子輸送能を有し、かつ発光の長波長化を防ぎ、なおかつ高いガラス転移温度を有する有機化合物であることが好ましい。 The light emitting layer is a layer that emits light (eg, fluorescent light emission, delayed fluorescent light emission, or both) after excitons are generated by recombination of holes and electrons injected from each of the anode and cathode. Is preferable. The light emitting layer may be a layer containing a light emitting material alone, but is preferably a layer containing a light emitting material and a host material. As the light emitting material, the compound of the present invention (one type or two or more types) can be used. The host material is not particularly limited, but it is preferable to use an organic compound in which at least one of the excitation singlet energy and the excitation triplet energy has a value higher than that of the compound of the present invention. Further, the host material is preferably an organic compound having a hole transporting ability and an electron transporting ability, preventing a long wavelength of light emission, and having a high glass transition temperature.
 さらに、ホスト材料及び発光材料を含む発光層に、TADF性を示す化合物を第三成分(アシストドーパント化合物)として発光層に含めると、高発光効率発現に有効である(H.Nakanоtani,et al.,Nature Communicaion,2014,5,4016-4022)。アシストドーパント化合物上に25%の一重項励起子と75%の三重項励起子を電界励起により発生させることによって、三重項励起子は逆項間交差(RISC)を伴って一重項励起子を生成することができる。一重項励起子のエネルギーは、発光材料へエネルギー移動し、発光材料が発光することが可能となる。従って、理論上100%の励起子エネルギーを利用して、発光材料を発光させることが可能となり、高発光効率が発現する。 Further, when a compound exhibiting TADF property is included in the light emitting layer as a third component (assist dopant compound) in the light emitting layer containing the host material and the light emitting material, it is effective in developing high luminous efficiency (H. Nakanоtani, et al. , Nature Compound, 2014, 5, 4016-4022). By generating 25% singlet excitons and 75% triplet excitons on the assist dopant compound by electric field excitation, the triplet excitons generate singlet excitons with inverse intersystem crossing (RISC). can do. The energy of the singlet excitons is transferred to the light emitting material, and the light emitting material can emit light. Therefore, theoretically 100% of the exciton energy can be used to make the light emitting material emit light, and high luminous efficiency is exhibited.
 発光層中の本発明の化合物の含有量は0.1質量%以上であることが好ましく、1質量%以上であることがより好ましく、また、50質量%以下であることが好ましく、20質量%以下であることがより好ましく、10質量%以下であることがさらに好ましい。 The content of the compound of the present invention in the light emitting layer is preferably 0.1% by mass or more, more preferably 1% by mass or more, and preferably 50% by mass or less, preferably 20% by mass. It is more preferably 10% by mass or less, and further preferably 10% by mass or less.
 注入層は、駆動電圧低下又は発光輝度向上のため、電極と有機層との間に設けられる層であることが好ましい。注入層は、正孔注入層及び電子注入層を包含する。注入層は、陽極と発光層又は正孔輸送層との間、及び、陰極と発光層又は電子輸送層との間に設けてもよい。 The injection layer is preferably a layer provided between the electrode and the organic layer in order to reduce the driving voltage or improve the emission brightness. The injection layer includes a hole injection layer and an electron injection layer. The injection layer may be provided between the anode and the light emitting layer or the hole transport layer, and between the cathode and the light emitting layer or the electron transport layer.
 阻止層は、発光層中に存在する電荷(電子もしくは正孔)及び/又は励起子の発光層外への拡散を阻止できる層であることが好ましい。電子阻止層は、発光層と正孔輸送層との間に配置することができ、電子が正孔輸送層の方に向かって発光層を通過することを阻止できる。同様に、正孔阻止層は、発光層と電子輸送層との間に配置することができ、正孔が電子輸送層の方に向かって発光層を通過することを阻止できる。電子阻止層及び正孔阻止層は、それぞれ励起子阻止層としての機能も兼ね備えることができる。本明細書でいう電子阻止層又は励起子阻止層は、一つの層で電子阻止層及び励起子阻止層の機能を有する層を含む意味で使用される。 The blocking layer is preferably a layer capable of blocking the diffusion of charges (electrons or holes) and / or excitons existing in the light emitting layer to the outside of the light emitting layer. The electron blocking layer can be arranged between the light emitting layer and the hole transporting layer, and can prevent electrons from passing through the light emitting layer toward the hole transporting layer. Similarly, the hole blocking layer can be placed between the light emitting layer and the electron transporting layer to prevent holes from passing through the light emitting layer towards the electron transporting layer. The electron blocking layer and the hole blocking layer can also function as exciton blocking layers, respectively. The electron blocking layer or exciton blocking layer referred to in the present specification is used in the sense that one layer includes a layer having the functions of an electron blocking layer and an exciton blocking layer.
 正孔阻止層とは、広い意味では電子輸送層の機能を有する。正孔阻止層は電子を輸送しつつ、正孔が電子輸送層へ到達することを阻止する役割があり、これにより発光層中での電子と正孔の再結合確率を向上させることができる。正孔阻止層の材料としては、後述する電子輸送層の材料を必要に応じて用いることができる。 The hole blocking layer has the function of an electron transport layer in a broad sense. The hole blocking layer has a role of blocking the holes from reaching the electron transporting layer while transporting electrons, which can improve the recombination probability of electrons and holes in the light emitting layer. As the material of the hole blocking layer, a material of the electron transport layer described later can be used as needed.
 電子阻止層とは、広い意味では正孔を輸送する機能を有する。電子阻止層は正孔を輸送しつつ、電子が正孔輸送層へ到達することを阻止する役割があり、これにより発光層中での電子と正孔が再結合する確率を向上させることができる。 The electron blocking layer has a function of transporting holes in a broad sense. The electron blocking layer has a role of blocking electrons from reaching the hole transporting layer while transporting holes, which can improve the probability of recombination of electrons and holes in the light emitting layer. ..
 励起子阻止層とは、発光層内で正孔と電子が再結合することにより生じた励起子が電荷輸送層に拡散することを阻止するための層であることが好ましい。励起子阻止層の挿入により励起子を効率的に発光層内に閉じ込めることが可能となり、素子の発光効率を向上させることができる。励起子阻止層は発光層に隣接して陽極側、陰極側のいずれにも挿入することができ、両方同時に挿入することも可能である。すなわち、励起子阻止層を陽極側に有する場合、正孔輸送層と発光層との間に、発光層に隣接して該層を挿入することができ、陰極側に挿入する場合、発光層と陰極との間に、発光層に隣接して該層を挿入することができる。また、陽極と、発光層の陽極側に隣接する励起子阻止層との間には、正孔注入層、電子阻止層などを有することができる。陰極と、発光層の陰極側に隣接する励起子阻止層との間には、電子注入層、電子輸送層、正孔阻止層などを有することができる。阻止層を配置する場合、阻止層として用いる材料の励起一重項エネルギー及び励起三重項エネルギーの少なくともいずれか一方は、発光材料の励起一重項エネルギー及び励起三重項エネルギーよりも高いことが好ましい。 The exciton blocking layer is preferably a layer for blocking excitons generated by recombination of holes and electrons in the light emitting layer from diffusing into the charge transport layer. By inserting the exciton blocking layer, excitons can be efficiently confined in the light emitting layer, and the luminous efficiency of the element can be improved. The exciton blocking layer can be inserted into either the anode side or the cathode side adjacent to the light emitting layer, and both can be inserted at the same time. That is, when the exciton blocking layer is provided on the anode side, the layer can be inserted between the hole transport layer and the light emitting layer adjacent to the light emitting layer, and when inserted on the cathode side, the light emitting layer and the light emitting layer can be inserted. The layer can be inserted adjacent to the light emitting layer between the cathode and the light emitting layer. Further, a hole injection layer, an electron blocking layer and the like can be provided between the anode and the exciton blocking layer adjacent to the anode side of the light emitting layer. An electron injection layer, an electron transport layer, a hole blocking layer, and the like can be provided between the cathode and the exciton blocking layer adjacent to the cathode side of the light emitting layer. When the blocking layer is arranged, it is preferable that at least one of the excitation singlet energy and the excitation triplet energy of the material used as the blocking layer is higher than the excitation singlet energy and the excitation triplet energy of the light emitting material.
 正孔輸送層は正孔を輸送する機能を有する正孔輸送材料からなることが好ましく、正孔輸送層は単層又は複数層設けることができる。正孔輸送材料としては、正孔の注入又は輸送、電子の障壁性のいずれかを有するものが好ましく、有機物、無機物のいずれであってもよい。使用できる正孔輸送材料としては、例えば、トリアゾール誘導体、オキサジアゾール誘導体、イミダゾール誘導体、カルバゾール誘導体、インドロカルバゾール誘導体、ポリアリールアルカン誘導体、ピラゾリン誘導体及びピラゾロン誘導体、フェニレンジアミン誘導体、アリールアミン誘導体、アミノ置換カルコン誘導体、オキサゾール誘導体、スチリルアントラセン誘導体、フルオレノン誘導体、ヒドラゾン誘導体、スチルベン誘導体、シラザン誘導体、アニリン系共重合体、また導電性高分子オリゴマー、特にチオフェンオリゴマーなどが挙げられる。正孔輸送材料としては、ポルフィリン化合物、芳香族第3級アミン化合物、及びスチリルアミン化合物を用いることが好ましく、芳香族第3級アミン化合物を用いることがより好ましい。また、酸化モリブデンなどの無機半導体を正孔輸送材料として用いることもできる。 The hole transport layer is preferably made of a hole transport material having a function of transporting holes, and the hole transport layer can be provided as a single layer or a plurality of layers. As the hole transporting material, a material having any of hole injection or transport and electron barrier property is preferable, and either an organic substance or an inorganic substance may be used. Examples of the hole transporting material that can be used include triazole derivative, oxadiazole derivative, imidazole derivative, carbazole derivative, indolocarbazole derivative, polyarylalkane derivative, pyrazoline derivative and pyrazolone derivative, phenylenediamine derivative, arylamine derivative, and amino. Examples thereof include substituted chalcone derivatives, oxazole derivatives, styrylanthracene derivatives, fluorenone derivatives, hydrazone derivatives, stilben derivatives, silazane derivatives, aniline-based copolymers, and conductive polymer oligomers, particularly thiophene oligomers. As the hole transport material, it is preferable to use a porphyrin compound, an aromatic tertiary amine compound, and a styrylamine compound, and it is more preferable to use an aromatic tertiary amine compound. Inorganic semiconductors such as molybdenum oxide can also be used as the hole transport material.
 電子輸送層とは電子を輸送する機能を有する材料からなることが好ましく、電子輸送層は単層又は複数層設けることができる。電子輸送材料(正孔阻止材料を兼ねる場合もある)は、陰極より注入された電子を発光層に伝達する機能を有することが好ましい。使用できる電子輸送層としては、例えば、ニトロ置換フルオレン誘導体、ジフェニルキノン誘導体、チオピランジオキシド誘導体、カルボジイミド、フレオレニリデンメタン誘導体、アントラキノジメタン及びアントロン誘導体、オキサジアゾール誘導体などが挙げられる。さらに、上記オキサジアゾール誘導体において、オキサジアゾール環の酸素原子を硫黄原子に置換したチアジアゾール誘導体、電子求引基として知られているキノキサリン環を有するキノキサリン誘導体も、電子輸送材料として用いることができる。さらにこれらの材料を高分子鎖に導入した、又はこれらの材料を高分子の主鎖とした高分子材料を用いることもできる。また、酸化亜鉛などの無機半導体を電子輸送材料として用いることもできる。 The electron transport layer is preferably made of a material having a function of transporting electrons, and the electron transport layer can be provided with a single layer or a plurality of layers. The electron transporting material (which may also serve as a hole blocking material) preferably has a function of transferring electrons injected from the cathode to the light emitting layer. Examples of the electron transporting layer that can be used include nitro-substituted fluorene derivatives, diphenylquinone derivatives, thiopyrandioxide derivatives, carbodiimides, freolenidenemethane derivatives, anthracinodimethane and anthron derivatives, and oxadiazole derivatives. Further, among the above oxadiazole derivatives, a thiadiazole derivative in which the oxygen atom of the oxadiazole ring is replaced with a sulfur atom, and a quinoxalin derivative having a quinoxalin ring known as an electron attractant can also be used as an electron transport material. .. Further, a polymer material in which these materials are introduced into a polymer chain or these materials are used as a polymer main chain can also be used. Further, an inorganic semiconductor such as zinc oxide can also be used as an electron transport material.
 有機EL素子を作製する際には、本発明の化合物を発光層に用いるだけでなく、発光層以外の層にも用いてもよい。その際、発光層に用いる本発明の化合物と、発光層以外の層に用いる本発明の化合物は、同一であっても異なっていてもよい。例えば、上記の注入層、阻止層(例:正孔阻止層、電子阻止層、励起子阻止層)、正孔輸送層、電子輸送層などにも本発明の化合物を用いてもよい。 When producing an organic EL device, the compound of the present invention may be used not only for the light emitting layer but also for a layer other than the light emitting layer. At that time, the compound of the present invention used for the light emitting layer and the compound of the present invention used for the layer other than the light emitting layer may be the same or different. For example, the compound of the present invention may be used for the above-mentioned injection layer, blocking layer (eg, hole blocking layer, electron blocking layer, exciton blocking layer), hole transport layer, electron transport layer and the like.
 これらの層の製膜方法は、特に限定されず、ドライプロセス、ウェットプロセスのどちらで作製してもよい。 The film forming method for these layers is not particularly limited, and may be formed by either a dry process or a wet process.
 以下に、有機エレクトロルミネッセンス素子に用いることができる好ましい材料を具体的に例示する。ただし、本発明において用いることができる材料は、以下の例示化合物によって限定的に解釈されることはない。また、特定の機能を有する材料として例示した化合物であっても、その他の機能を有する材料として転用することも可能である。なお、以下の例示化合物の構造式におけるR、R’、R~R10は、各々独立に水素原子又は置換基を表す。Xは環骨格を形成する炭素原子または複素原子を表し、nは3~5の整数を表し、Yは置換基を表し、mは0以上の整数を表す。  Hereinafter, preferable materials that can be used for the organic electroluminescence device will be specifically exemplified. However, the materials that can be used in the present invention are not limitedly interpreted by the following exemplary compounds. Further, even a compound exemplified as a material having a specific function can be diverted as a material having another function. In addition, R, R', and R 1 to R 10 in the structural formulas of the following exemplified compounds each independently represent a hydrogen atom or a substituent. X represents a carbon atom or a complex atom forming a ring skeleton, n represents an integer of 3 to 5, Y represents a substituent, and m represents an integer of 0 or more.
 発光層のホスト材料としても用いることができる好ましい化合物を挙げる。使用する発光材料のHOMO/LUMO準位に適合させるために、下記の例示化合物の基本骨格に適宜置換基を導入することによりホスト材料のHOMO/LUMO準位を調整することができる。例えば、下記の例示化合物の基本骨格にシアノ基やパーフルオロアルキル基を導入することによりHOMO/LUMO準位を深くした化合物とし、これをホスト材料や周辺化合物に用いることができる。ホスト材料としては、バイポーラー性(正孔と電子を両方よく流す)であっても、ユニポーラー性であってもよく、発光材料よりも励起三重項エネルギー準位ET1が高いものであることが好ましい。より好ましいホスト材料はバイポーラー性を有し、発光材料よりも励起三重項エネルギー準位ET1が高いものである。
Figure JPOXMLDOC01-appb-C000043
Figure JPOXMLDOC01-appb-I000044
Figure JPOXMLDOC01-appb-I000045
Preferred compounds that can also be used as host material for the light emitting layer are listed. In order to match the HOMO / LUMO level of the luminescent material to be used, the HOMO / LUMO level of the host material can be adjusted by appropriately introducing a substituent into the basic skeleton of the following exemplified compound. For example, by introducing a cyano group or a perfluoroalkyl group into the basic skeleton of the following exemplified compound, a compound having a deepened HOMO / LUMO level can be obtained, which can be used as a host material or a peripheral compound. As the host material, it is also a bipolar character (flow good both holes and electrons) may be a unipolar resistance, but high excited triplet energy level E T1 than the light emitting material Is preferable. More preferred host material has a bipolar property, those high excited triplet energy level E T1 than the light emitting material.
Figure JPOXMLDOC01-appb-C000043
Figure JPOXMLDOC01-appb-I000044
Figure JPOXMLDOC01-appb-I000045
 次に、正孔注入材料として用いることができる好ましい化合物例を挙げる。
Figure JPOXMLDOC01-appb-C000046
Next, examples of preferable compounds that can be used as the hole injection material will be given.
Figure JPOXMLDOC01-appb-C000046
 次に、電子注入材料として用いることができる好ましい化合物例を挙げる。
Figure JPOXMLDOC01-appb-C000047
Next, examples of preferable compounds that can be used as an electron injection material will be given.
Figure JPOXMLDOC01-appb-C000047
 次に、正孔阻止材料として用いることができる好ましい化合物例を挙げる。
Figure JPOXMLDOC01-appb-C000048
Next, examples of preferable compounds that can be used as a hole blocking material are given.
Figure JPOXMLDOC01-appb-C000048
 次に、電子阻止材料として用いることができる好ましい化合物例を挙げる。
Figure JPOXMLDOC01-appb-C000049
Next, examples of preferable compounds that can be used as an electron blocking material are given.
Figure JPOXMLDOC01-appb-C000049
 次に、正孔輸送材料として用いることができる好ましい化合物例を挙げる。
Figure JPOXMLDOC01-appb-C000050
Figure JPOXMLDOC01-appb-I000051
Figure JPOXMLDOC01-appb-I000052
Next, examples of preferable compounds that can be used as a hole transport material will be given.
Figure JPOXMLDOC01-appb-C000050
Figure JPOXMLDOC01-appb-I000051
Figure JPOXMLDOC01-appb-I000052
 次に、電子輸送材料として用いることができる好ましい化合物例を挙げる。
Figure JPOXMLDOC01-appb-C000053
Figure JPOXMLDOC01-appb-I000054
Next, examples of preferable compounds that can be used as an electron transport material will be given.
Figure JPOXMLDOC01-appb-C000053
Figure JPOXMLDOC01-appb-I000054
 さらに添加可能な材料として好ましい化合物例を挙げる。例えば、安定化材料として添加することができる。
Figure JPOXMLDOC01-appb-C000055
Examples of preferable compounds as materials that can be further added are given. For example, it can be added as a stabilizing material.
Figure JPOXMLDOC01-appb-C000055
 本発明の有機EL素子は、単一の素子、アレイ状に配置された構造からなる素子、陽極と陰極がX-Yマトリックス状に配置された構造のいずれにおいても適用することができる。本発明の有機EL素子などの有機発光素子は、さらに様々な用途へ応用することが可能である。例えば、本発明の有機EL素子を用いて、有機エレクトロルミネッセンス表示装置を製造することが可能であり、詳細については、時任静士、安達千波矢、村田英幸共著「有機ELディスプレイ」(オーム社)を参照することができる。また、特に本発明の有機EL素子は、需要が大きい有機エレクトロルミネッセンス照明やバックライトに応用することもできる。さらに、本発明の有機発光素子は、有機発光ダイオードに応用することが可能である。 The organic EL element of the present invention can be applied to any of a single element, an element having a structure arranged in an array, and a structure in which an anode and a cathode are arranged in an XY matrix. The organic light emitting device such as the organic EL device of the present invention can be further applied to various applications. For example, it is possible to manufacture an organic electroluminescence display device using the organic EL element of the present invention. For details, see "Organic EL Display" by Shizushi Tokito, Chihaya Adachi, and Hideyuki Murata (Ohmsha). Can be referred to. In particular, the organic EL device of the present invention can also be applied to organic electroluminescence lighting and backlight, which are in great demand. Further, the organic light emitting device of the present invention can be applied to an organic light emitting diode.
 以下、本発明を実施例により詳細に説明するが、本発明はこれらに限定されるものではない。 Hereinafter, the present invention will be described in detail with reference to Examples, but the present invention is not limited thereto.
(中間体D1の合成)
Figure JPOXMLDOC01-appb-C000056
(Synthesis of intermediate D1)
Figure JPOXMLDOC01-appb-C000056
 窒素雰囲気下、200mLナスフラスコに、2,7-ビス(トリフルオロメチル)-9H-カルバゾール(4.55g)、トリフェニルホスフィンスルフィド(220mg)を入れ、DMF(100mL)に溶解させた。室温下撹拌しながら、N-ブロモスクシンイミド(10.8g)を2回に分割して添加した。室温下で23時間撹拌後、反応溶液に飽和亜硫酸水素ナトリウム水溶液(40mL)、1N水酸化ナトリウム水溶液(50mL)を加えた。析出物をろ取し、昇華精製することで、3,6-ジブロモ-2,7-ビス(トリフルオロメチル)-9H-カルバゾール(5.8g、収率84%)を得た。当該化合物のH NMRスペクトル及び19F NMRスペクトルをそれぞれ図1及び図2に示す。 In a nitrogen atmosphere, 2,7-bis (trifluoromethyl) -9H-carbazole (4.55 g) and triphenylphosphine sulfide (220 mg) were placed in a 200 mL eggplant flask and dissolved in DMF (100 mL). N-Bromosuccinimide (10.8 g) was added in two portions with stirring at room temperature. After stirring at room temperature for 23 hours, a saturated aqueous sodium hydrogen sulfite solution (40 mL) and a 1N aqueous sodium hydroxide solution (50 mL) were added to the reaction solution. The precipitate was collected by filtration and sublimated and purified to obtain 3,6-dibromo-2,7-bis (trifluoromethyl) -9H-carbazole (5.8 g, yield 84%). The 1 H NMR spectrum and the 19 F NMR spectrum of the compound are shown in FIGS. 1 and 2, respectively.
Figure JPOXMLDOC01-appb-C000057
Figure JPOXMLDOC01-appb-C000057
 窒素雰囲気下、50mLナスフラスコに、3,6-ジブロモ-2,7-ビス(トリフルオロメチル)-9H-カルバゾール(1.38g)、フェニルボロン酸(1.46g)、リン酸カリウム(5.12g)、トリ-tert-ブチルホスホニウムテトラフルオロボラート(87mg)、トリス(ジベンジリデンアセトン)二パラジウム・クロロホルム錯体(155mg)を入れ、キシレン(25mL)に溶解させた。反応溶媒を脱気後、110℃で17時間撹拌した。反応液を放冷し水を加えて分液した。水層を酢酸エチルで抽出し、有機層を合わせて減圧濃縮した、得られた粗生成物をシリカゲルカラム(ヘキサン:クロロホルム=1:1)に供することで中間体D1(1.05g、収率77%)を得た。中間体D1のH NMRスペクトル及び19F NMRスペクトルをそれぞれ図3及び図4に示す。 3. In a nitrogen atmosphere, in a 50 mL eggplant flask, 3,6-dibromo-2,7-bis (trifluoromethyl) -9H-carbazole (1.38 g), phenylboronic acid (1.46 g), potassium phosphate (5. 12 g), tri-tert-butylphosphonium tetrafluoroborate (87 mg) and tris (dibenzylideneacetone) dipalladium-chloroform complex (155 mg) were added and dissolved in xylene (25 mL). After degassing the reaction solvent, the mixture was stirred at 110 ° C. for 17 hours. The reaction solution was allowed to cool, water was added, and the solution was separated. The aqueous layer was extracted with ethyl acetate, the organic layers were combined and concentrated under reduced pressure, and the obtained crude product was subjected to a silica gel column (hexane: chloroform = 1: 1) to obtain intermediate D1 (1.05 g, yield). 77%) was obtained. The 1 H NMR spectrum and the 19 F NMR spectrum of the intermediate D1 are shown in FIGS. 3 and 4, respectively.
(中間体D2の合成)
Figure JPOXMLDOC01-appb-C000058
(Synthesis of intermediate D2)
Figure JPOXMLDOC01-appb-C000058
 窒素雰囲気下、30mLナスフラスコに、3,6-ジブロモ-2,7-ビス(トリフルオロメチル)-9H-カルバゾール(461mg)、メチルボロン酸(239mg)、リン酸カリウム(10.6g)、ジクロロ(1,1'-ビス(ジフェニルホスフィノ)フェロセン)パラジウム(73mg)を入れ、1,4-ジオキサン(10mL)、水(3mL)を加えて溶解させた。反応溶媒を脱気後、加熱還流しながら13時間撹拌した。反応液を放冷し酢酸エチル、飽和塩化ナトリウム水溶液を加えて分液した。水層を酢酸エチルで抽出し有機層を合わせて減圧濃縮した、得られた粗生成物をシリカゲルろ過カラム(酢酸エチル)に供した後、ヘキサンで洗浄することで中間体D2(125mg、収率38%)を得た。中間体D2のH NMRスペクトル及び19F NMRスペクトルをそれぞれ図5及び図6に示す。 In a 30 mL eggplant flask under a nitrogen atmosphere, 3,6-dibromo-2,7-bis (trifluoromethyl) -9H-carbazole (461 mg), methylboronic acid (239 mg), potassium phosphate (10.6 g), dichloro ( 1,1'-Bis (diphenylphosphino) ferrocene) palladium (73 mg) was added, and 1,4-dioxane (10 mL) and water (3 mL) were added and dissolved. After degassing the reaction solvent, the mixture was stirred with heating under reflux for 13 hours. The reaction mixture was allowed to cool, ethyl acetate and saturated aqueous sodium chloride solution were added, and the layers were separated. The aqueous layer was extracted with ethyl acetate, the organic layers were combined and concentrated under reduced pressure. The obtained crude product was subjected to a silica gel filtration column (ethyl acetate) and then washed with hexane to obtain intermediate D2 (125 mg, yield). 38%) was obtained. The 1 H NMR spectrum and the 19 F NMR spectrum of the intermediate D2 are shown in FIGS. 5 and 6, respectively.
(中間体D3の合成)
Figure JPOXMLDOC01-appb-C000059
(Synthesis of intermediate D3)
Figure JPOXMLDOC01-appb-C000059
 窒素雰囲気下、50mLナスフラスコに、3,6-ジブロモ-2,7-ビス(トリフルオロメチル)-9H-カルバゾール(1.73g)、ジベンゾフラン-4-ボロン酸(1.79g)、炭酸カリウム(1.99g)、テトラキストリフェニルホスフィンパラジウム(266mg)を入れ、トルエン(26.5mL)、水(10mL)を加えて溶解させた。反応溶媒を脱気後、加熱還流しながら16時間撹拌した。反応液を放冷し酢酸エチル、水を加えて分液した。水層を酢酸エチルで抽出し有機層を合わせて減圧濃縮した、得られた粗生成物をシリカゲルカラム(ヘキサン/酢酸エチル=4/1)に供し、中間体D3(1.84g、収率77%)を得た。中間体D3のH NMRスペクトル及び19F NMRスペクトルをそれぞれ図7及び図8に示す。 3,6-Dibromo-2,7-bis (trifluoromethyl) -9H-carbazole (1.73 g), dibenzofuran-4-boronic acid (1.79 g), potassium carbonate (1.79 g) in a 50 mL eggplant flask under a nitrogen atmosphere. 1.99 g) and tetrakistriphenylphosphine palladium (266 mg) were added, and toluene (26.5 mL) and water (10 mL) were added to dissolve the mixture. After degassing the reaction solvent, the mixture was stirred with heating under reflux for 16 hours. The reaction mixture was allowed to cool, ethyl acetate and water were added, and the layers were separated. The aqueous layer was extracted with ethyl acetate, the organic layers were combined and concentrated under reduced pressure, and the obtained crude product was subjected to a silica gel column (hexane / ethyl acetate = 4/1) and used as an intermediate D3 (1.84 g, yield 77). %) Was obtained. The 1 H NMR spectrum and the 19 F NMR spectrum of the intermediate D3 are shown in FIGS. 7 and 8, respectively.
(中間体D4の合成)
Figure JPOXMLDOC01-appb-C000060
(Synthesis of intermediate D4)
Figure JPOXMLDOC01-appb-C000060
 窒素雰囲気下、50mLナスフラスコに、3,6-ジブロモ-2,7-ビス(トリフルオロメチル)-9H-カルバゾール(461mg)、9-フェニルカルバゾール-3-ボロン酸(860mg)、リン酸カリウム(1.06g)、ジクロロ(1,1'-ビス(ジフェニルホスフィノ)フェロセン)パラジウム(70mg)を入れ、1,4-ジオキサン(9mL)、水(3mL)を加えて溶解させた。反応溶媒を脱気後、加熱還流しながら17時間撹拌した。反応液を放冷し酢酸エチル、水を加えて分液した。水層を酢酸エチルで抽出し有機層を合わせて減圧濃縮した、得られた粗生成物をシリカゲルカラム(ヘキサン:クロロホルム=1:1)に供し、中間体D4(650mg、収率75%)を得た。質量分析(ASAP, positive) により目的物のm/zを観測した。 In a 50 mL eggplant flask under a nitrogen atmosphere, 3,6-dibromo-2,7-bis (trifluoromethyl) -9H-carbazole (461 mg), 9-phenylcarbazole-3-boronic acid (860 mg), potassium phosphate (860 mg) 1.06 g), dichloro (1,1'-bis (diphenylphosphino) ferrocene) palladium (70 mg) was added, and 1,4-dioxane (9 mL) and water (3 mL) were added and dissolved. After degassing the reaction solvent, the mixture was stirred with heating under reflux for 17 hours. The reaction mixture was allowed to cool, ethyl acetate and water were added, and the layers were separated. The aqueous layer was extracted with ethyl acetate, the organic layers were combined and concentrated under reduced pressure, and the obtained crude product was subjected to a silica gel column (hexane: chloroform = 1: 1) to obtain intermediate D4 (650 mg, yield 75%). Obtained. The m / z of the target object was observed by mass spectrometry (ASAP, positive).
(中間体D5の合成)
Figure JPOXMLDOC01-appb-C000061
(Synthesis of intermediate D5)
Figure JPOXMLDOC01-appb-C000061
 窒素雰囲気下、10mLシュレンク管に、4-メチル-3-トリフルオロメチルアニリン(96mg)、4-ブロモ-2-トリフルオロメチルトルエン(120mg)、tert-ブトキシナトリム(96mg)、トリス(ジベンジリデンアセトン)二パラジウム・クロロホルム錯体(51mg)、Xphos(48mg)を入れ、1,4-ジオキサン(2mL)を加えて懸濁させた。反応溶媒を脱気後、80℃下15時間撹拌した。反応液を放冷し酢酸エチル、飽和塩化ナトリウム水溶液を加えて分液した。水層を酢酸エチルで抽出し有機層を合わせて減圧濃縮した、得られた粗生成物をシリカゲルカラム(ヘキサン:クロロホルム=1:1)に供することで中間体D5(218mg、収率65%)を得た。中間体D5のH NMRスペクトル及び19F NMRスペクトルをそれぞれ図9及び図10に示す。 4-Methyl-3-trifluoromethylaniline (96 mg), 4-bromo-2-trifluoromethyltoluene (120 mg), tert-butoxynatrim (96 mg), tris (dibenzilidenacetone) in a 10 mL Schlenck tube under a nitrogen atmosphere. ) Dipalladium / chloroform complex (51 mg) and Xphos (48 mg) were added, and 1,4-dioxane (2 mL) was added and suspended. After degassing the reaction solvent, the mixture was stirred at 80 ° C. for 15 hours. The reaction mixture was allowed to cool, ethyl acetate and saturated aqueous sodium chloride solution were added, and the layers were separated. The aqueous layer was extracted with ethyl acetate, the organic layers were combined and concentrated under reduced pressure, and the obtained crude product was subjected to a silica gel column (hexane: chloroform = 1: 1) to obtain intermediate D5 (218 mg, yield 65%). Got The 1 H NMR spectrum and the 19 F NMR spectrum of the intermediate D5 are shown in FIGS. 9 and 10, respectively.
(中間体A1の合成)
Figure JPOXMLDOC01-appb-C000062
(Synthesis of intermediate A1)
Figure JPOXMLDOC01-appb-C000062
 窒素雰囲気下、50mLナスフラスコに、2-クロロ-4,6-ジフェニル-1,3,5-トリアジン(803mg)、3,4,5-トリフルオロフェニルボロン酸(528mg)、炭酸カリウム(1.24g)、テトラキストリフェニルフォスフィンパラジウム(174mg)を入れ、THF(22mL)、水(7mL)を加えて溶解させた。反応液を脱気し、24時間加熱還流した。反応液を放冷し、酢酸エチル(15mL)、水(15mL)を加えた。不溶物をろ取し、酢酸エチル、アセトンで洗浄することで、中間体A1(902mg、収率83%)を得た。 In a nitrogen atmosphere, in a 50 mL eggplant flask, 2-chloro-4,6-diphenyl-1,3,5-triazine (803 mg), 3,4,5-trifluorophenylboronic acid (528 mg), potassium carbonate (1. 24 g) and tetrakistriphenylphosphine palladium (174 mg) were added, and THF (22 mL) and water (7 mL) were added to dissolve the mixture. The reaction mixture was degassed and heated to reflux for 24 hours. The reaction mixture was allowed to cool, and ethyl acetate (15 mL) and water (15 mL) were added. The insoluble material was collected by filtration and washed with ethyl acetate and acetone to obtain Intermediate A1 (902 mg, yield 83%).
(中間体A2の合成)
Figure JPOXMLDOC01-appb-C000063
(Synthesis of intermediate A2)
Figure JPOXMLDOC01-appb-C000063
 窒素雰囲気下、50mLナスフラスコに、1,4-ジブロモ-2,5-ジフルオロベンゼン(1.00g)、ビスピナコラートジボロン(2.02g)、酢酸カリウム(1.81g)、ジクロロ(1,1'-ビス(ジフェニルホスフィノ)フェロセン)パラジウム(150mg)を入れ、1,4-ジオキサン(25mL)に懸濁させた。反応溶媒を脱気後、100℃下20時間撹拌した。反応液を濃縮後、シリカゲルろ過カラム(酢酸エチル)に供した。ろ液を濃縮し、ヘキサンで洗浄することで2,2’-(2,5-ジフルオロ-1,4-フェニレン)ビス(4,4,5,5-テトラメチル-1,3,2-ジオキサボロラン)(806mg、収率60%)を得た。
 窒素雰囲気下、50mLナスフラスコに、2,2’-(2,5-ジフルオロ-1,4-フェニレン)ビス(4,4,5,5-テトラメチル-1,3,2-ジオキサボロラン)(366mg)、2-クロロー4,6-ジフェニルー1,3,5-トリアジン(615mg)、炭酸カリウム(690mg)、テトラキストリフェニルフォスフィンパラジウム(57mg)を入れ、THF(20mL)、水(6mL)に溶解させた。反応溶媒を脱気後、加熱還流下14時間撹拌した。反応液を放冷し水を加えた。析出物をろ取し、酢酸エチルで洗浄することで中間体A2(495mg、収率86%)を得た。中間体A2のH NMRスペクトル及び19F NMRスペクトルを図11に示す。
In a nitrogen atmosphere, in a 50 mL eggplant flask, 1,4-dibromo-2,5-difluorobenzene (1.00 g), bispinacolato diboron (2.02 g), potassium acetate (1.81 g), dichloro (1,1) 1'-bis (diphenylphosphino) ferrocene) palladium (150 mg) was added and suspended in 1,4-dioxane (25 mL). After degassing the reaction solvent, the mixture was stirred at 100 ° C. for 20 hours. The reaction mixture was concentrated and then subjected to a silica gel filtration column (ethyl acetate). By concentrating the filtrate and washing with hexane, 2,2'-(2,5-difluoro-1,4-phenylene) bis (4,4,5,5-tetramethyl-1,3,2-dioxaborolane) ) (806 mg, yield 60%) was obtained.
2,2'-(2,5-difluoro-1,4-phenylene) bis (4,4,5,5-tetramethyl-1,3,2-dioxaborolane) (366 mg) in a 50 mL eggplant flask under a nitrogen atmosphere. ), 2-Chloro-4,6-diphenyl-1,3,5-triazine (615 mg), potassium carbonate (690 mg), tetrakistriphenylphosphine palladium (57 mg), and dissolved in THF (20 mL) and water (6 mL). I let you. After degassing the reaction solvent, the mixture was stirred under heating under reflux for 14 hours. The reaction solution was allowed to cool and water was added. The precipitate was collected by filtration and washed with ethyl acetate to obtain Intermediate A2 (495 mg, yield 86%). The 1 H NMR spectrum and the 19 F NMR spectrum of the intermediate A2 are shown in FIG.
(中間体A3の合成)
Figure JPOXMLDOC01-appb-C000064
(Synthesis of intermediate A3)
Figure JPOXMLDOC01-appb-C000064
 窒素雰囲気下、50mLナスフラスコに、1,5-ジブロモ-2,4-ジフルオロベンゼン(1.00g)、ビスピナコラートジボロン(2.02g)、酢酸カリウム(1.81g)、ジクロロ(1,1'-ビス(ジフェニルホスフィノ)フェロセン)パラジウム(150mg)を入れ、1,4-ジオキサン(25mL)に懸濁させた。反応溶媒を脱気後、100℃下23時間撹拌した。反応液を濃縮後、シリカゲルろ過カラム(酢酸エチル)に供した。ろ液を濃縮することで2,2’-(4,6-ジフルオロ-1,3-フェニレン)ビス(4,4,5,5-テトラメチル-1,3,2-ジオキサボロラン)の粗品(1.93g、粗収率143%)を得た。精製は次の反応後に行った。
 窒素雰囲気下、50mLナスフラスコに、2,2’-(4,6-ジフルオロ-1,3-フェニレン)ビス(4,4,5,5-テトラメチル-1,3,2-ジオキサボロラン)の粗品(523mg)、2-クロロ-4,6-ジフェニル-1,3,5-トリアジン(615mg)、炭酸カリウム(690mg)、テトラキストリフェニルフォスフィンパラジウム(57mg)を入れ、THF(20mL)、水(6mL)に溶解させた。反応溶媒を脱気後、加熱還流下14時間撹拌した。反応液を放冷し水を加えた。析出物をろ取し、酢酸エチル、クロロホルムで洗浄することで中間体A3(297mg、2段階収率52%)を得た。中間体A3のH NMRスペクトル及び19F NMRスペクトルをそれぞれ図12及び図13に示す。
In a nitrogen atmosphere, in a 50 mL eggplant flask, 1,5-dibromo-2,4-difluorobenzene (1.00 g), bispinacolato diboron (2.02 g), potassium acetate (1.81 g), dichloro (1,1) 1'-bis (diphenylphosphino) ferrocene) palladium (150 mg) was added and suspended in 1,4-dioxane (25 mL). After degassing the reaction solvent, the mixture was stirred at 100 ° C. for 23 hours. The reaction mixture was concentrated and then subjected to a silica gel filtration column (ethyl acetate). By concentrating the filtrate, a crude product (1) of 2,2'-(4,6-difluoro-1,3-phenylene) bis (4,4,5,5-tetramethyl-1,3,2-dioxaborolane) .93 g, crude yield 143%) was obtained. Purification was performed after the next reaction.
A crude product of 2,2'-(4,6-difluoro-1,3-phenylene) bis (4,4,5,5-tetramethyl-1,3,2-dioxaborolane) in a 50 mL eggplant flask under a nitrogen atmosphere. (523 mg), 2-chloro-4,6-diphenyl-1,3,5-triazine (615 mg), potassium carbonate (690 mg), tetrakistriphenylphosphine palladium (57 mg), THF (20 mL), water ( It was dissolved in 6 mL). After degassing the reaction solvent, the mixture was stirred under heating under reflux for 14 hours. The reaction solution was allowed to cool and water was added. The precipitate was collected by filtration and washed with ethyl acetate and chloroform to obtain Intermediate A3 (297 mg, 2-step yield 52%). The 1 H NMR spectrum and the 19 F NMR spectrum of Intermediate A3 are shown in FIGS. 12 and 13, respectively.
(中間体A4の合成)
Figure JPOXMLDOC01-appb-C000065
(Synthesis of intermediate A4)
Figure JPOXMLDOC01-appb-C000065
 窒素雰囲気下、50mLナスフラスコに、2-ブロモ-4,6-ジフェニル-1,3,5-トリアジン(623mg)、2,4,6-トリフルオロフェニルボロン酸(387mg)、炭酸カリウム(982mg)、トリス(ジベンジリデンアセトン)ジパラジウム(0) クロロホルム付加体(109mg)、トリフェニルホスフィン(63mg)を入れ、THF(15mL)、水(5mL)を加えて溶解させた。反応溶媒を脱気後、加熱還流しながら20時間撹拌した。反応液を放冷し、シリカゲルろ過カラム(酢酸エチル)に供した。ろ液に析出した固体をろ取し、中間体A4(308mg、収率42%)を得た。中間体A4のH NMRスペクトル及び19F NMRスペクトルをそれぞれ図14及び図15に示す。 2-Bromo-4,6-diphenyl-1,3,5-triazine (623 mg), 2,4,6-trifluorophenylboronic acid (387 mg), potassium carbonate (982 mg) in a 50 mL eggplant flask under a nitrogen atmosphere. , Tris (dibenzylideneacetone) dipalladium (0) chloroform adduct (109 mg) and triphenylphosphine (63 mg) were added, and THF (15 mL) and water (5 mL) were added and dissolved. After degassing the reaction solvent, the mixture was stirred with heating under reflux for 20 hours. The reaction mixture was allowed to cool and subjected to a silica gel filtration column (ethyl acetate). The solid precipitated in the filtrate was collected by filtration to obtain Intermediate A4 (308 mg, yield 42%). The 1 H NMR spectrum and the 19 F NMR spectrum of the intermediate A4 are shown in FIGS. 14 and 15, respectively.
(中間体A5の合成)
Figure JPOXMLDOC01-appb-C000066
(Synthesis of intermediate A5)
Figure JPOXMLDOC01-appb-C000066
 窒素雰囲気下、20mLナスフラスコに、2-ブロモ-4,6-ジフェニルピリミジン(611mg)、2,4,6-トリフルオロフェニルボロン酸(482mg)、炭酸カリウム(1.33g)、トリス(ジベンジリデンアセトン)ジパラジウム(0) クロロホルム付加体(124mg)、トリ-tert-ブチルホスホニウムテトラフルオロボラート(156mg)を入れ、DMF(10mL)を加えて溶解させた。反応溶媒を脱気後、加熱還流しながら20時間撹拌した。反応液を放冷し、トルエン、水を加えて分液した。水層をトルエンで抽出し有機層を合わせて減圧濃縮した、得られた粗生成物をシリカゲルカラム(ヘキサン/酢酸エチル=95/5)に供しすることで中間体A5(522mg、収率73%)を得た。中間体A5のH NMRスペクトル及び19F NMRスペクトルをそれぞれ図16及び図17に示す。 2-Bromo-4,6-diphenylpyrimidine (611 mg), 2,4,6-trifluorophenylboronic acid (482 mg), potassium carbonate (1.33 g), tris (dibenzylidene) in a 20 mL eggplant flask under a nitrogen atmosphere. Acelatin) dipalladium (0) chloroform adduct (124 mg) and tri-tert-butylphosphonium tetrafluoroborate (156 mg) were added, and DMF (10 mL) was added to dissolve the mixture. After degassing the reaction solvent, the mixture was stirred with heating under reflux for 20 hours. The reaction mixture was allowed to cool, and toluene and water were added to separate the solutions. The aqueous layer was extracted with toluene, the organic layers were combined and concentrated under reduced pressure, and the obtained crude product was subjected to a silica gel column (hexane / ethyl acetate = 95/5) to provide intermediate A5 (522 mg, yield 73%). ) Was obtained. The 1 H NMR spectrum and the 19 F NMR spectrum of Intermediate A5 are shown in FIGS. 16 and 17, respectively.
(中間体A6の合成)
Figure JPOXMLDOC01-appb-C000067
(Synthesis of intermediate A6)
Figure JPOXMLDOC01-appb-C000067
 窒素雰囲気下、20mLナスフラスコに、6-ヨードキノリン(509mg)、3,5-ジフルオロフェニルボロン酸(471mg)、炭酸カリウム(1.08g)、テトラキストリフェニルホスフィンパラジウム(132mg)を入れ、トルエン(8mL)、水(3mL)を加えて溶解させた。反応溶媒を脱気後、加熱還流しながら21時間撹拌した。反応液を放冷し酢酸エチル、水を加えて分液した。水層を酢酸エチルで抽出し有機層を合わせて減圧濃縮した。得られた粗生成物をシリカゲルカラム(ヘキサン/酢酸エチル=3/2)に供し、中間体A6(463mg、収率87%)を得た。中間体A6のH NMRスペクトル及び19F NMRスペクトルをそれぞれ図18及び図19に示す。 In a nitrogen atmosphere, 6-iodoquinoline (509 mg), 3,5-difluorophenylboronic acid (471 mg), potassium carbonate (1.08 g), and tetrakistriphenylphosphine palladium (132 mg) were placed in a 20 mL eggplant flask, and toluene (toluene) was added. 8 mL) and water (3 mL) were added and dissolved. After degassing the reaction solvent, the mixture was stirred with heating under reflux for 21 hours. The reaction mixture was allowed to cool, ethyl acetate and water were added, and the layers were separated. The aqueous layer was extracted with ethyl acetate, and the organic layers were combined and concentrated under reduced pressure. The obtained crude product was subjected to a silica gel column (hexane / ethyl acetate = 3/2) to obtain Intermediate A6 (463 mg, yield 87%). The 1 H NMR spectrum and the 19 F NMR spectrum of Intermediate A6 are shown in FIGS. 18 and 19, respectively.
(中間体A7の合成)
Figure JPOXMLDOC01-appb-C000068
(Synthesis of Intermediate A7)
Figure JPOXMLDOC01-appb-C000068
 窒素雰囲気下、30mLナスフラスコに、6-ヨードキノリン(613mg)、3-ブロモ-5-フルオロフェニルボロン酸(796mg)、炭酸カリウム(1.28g)、テトラキストリフェニルホスフィンパラジウム(150mg)を入れ、トルエン(10mL)、水(4mL)を加えて溶解させた。反応溶媒を脱気後、加熱還流しながら17時間撹拌した。反応液を放冷し酢酸エチル、水を加えて分液した。水層を酢酸エチルで抽出し有機層を合わせて減圧濃縮した。得られた粗生成物をシリカゲルカラム(ヘキサン/酢酸エチル=3/2)に供し、中間体A7(461mg、収率63%)を得た。中間体A7のH NMRスペクトル及び19F NMRスペクトルをそれぞれ図20及び図21に示す。 In a nitrogen atmosphere, 6-iodoquinoline (613 mg), 3-bromo-5-fluorophenylboronic acid (796 mg), potassium carbonate (1.28 g), and tetrakistriphenylphosphine palladium (150 mg) were placed in a 30 mL eggplant flask. Toluene (10 mL) and water (4 mL) were added and dissolved. After degassing the reaction solvent, the mixture was stirred with heating under reflux for 17 hours. The reaction mixture was allowed to cool, ethyl acetate and water were added, and the layers were separated. The aqueous layer was extracted with ethyl acetate, and the organic layers were combined and concentrated under reduced pressure. The obtained crude product was subjected to a silica gel column (hexane / ethyl acetate = 3/2) to obtain Intermediate A7 (461 mg, yield 63%). The 1 H NMR spectrum and the 19 F NMR spectrum of Intermediate A7 are shown in FIGS. 20 and 21, respectively.
(中間体A8の合成)
Figure JPOXMLDOC01-appb-C000069
(Synthesis of Intermediate A8)
Figure JPOXMLDOC01-appb-C000069
 窒素雰囲気下、20mLシュレンク管に、2,2’-(2,5-ジフルオロ-1,4-フェニレン)ビス(4,4,5,5-テトラメチル-1,3,2-ジオキサボロラン)(183mg)、2-クロロ-4,6-ジフェニル-ピリミジン(307mg)、炭酸カリウム(207mg)、テトラキストリフェニルフォスフィンパラジウム(29mg)を入れ、THF(10mL)、水(3mL)に溶解させた。反応溶媒を脱気後、加熱還流下23時間撹拌した。反応液を放冷し水を加えた。析出物をろ取し、水、アセトンで洗浄することで中間体A8(216mg、収率75%)を得た。中間体A8のH NMRスペクトルを図22に示す。 2,2'-(2,5-difluoro-1,4-phenylene) bis (4,4,5,5-tetramethyl-1,3,2-dioxaborolane) (183 mg) in a 20 mL Schlenk tube under a nitrogen atmosphere ), 2-Chloro-4,6-diphenyl-pyrimidine (307 mg), potassium carbonate (207 mg) and tetrakistriphenylphosphine palladium (29 mg) were added and dissolved in THF (10 mL) and water (3 mL). After degassing the reaction solvent, the mixture was stirred under heating under reflux for 23 hours. The reaction solution was allowed to cool and water was added. The precipitate was collected by filtration and washed with water and acetone to obtain Intermediate A8 (216 mg, yield 75%). The 1 H NMR spectrum of Intermediate A8 is shown in FIG.
(中間体A9の合成)
Figure JPOXMLDOC01-appb-C000070
(Synthesis of Intermediate A9)
Figure JPOXMLDOC01-appb-C000070
 窒素雰囲気下、100mL四つ口フラスコに、1,4-ジブロモ-2-フルオロベンゼン(1.80g)、ビスピナコラートジボロン(3.88g)、酢酸カリウム(3.53g)、[1,1′-ビス(ジフェニルホスフィノ)フェロセン]ジクロロパラジウム(II)(291mg)を入れ、1,4-ジオキサン(36mL)を加えて溶解させた。反応溶媒を脱気後、加熱還流しながら17時間撹拌した。反応液を放冷し、シリカゲルろ過カラム(酢酸エチル)に供した後、ろ液を減圧濃縮した。得られた粗生成物にヘキサンを加え、析出物をろ取することで、2,2’-(2-フルオロ-1,4-フェニレン)ビス(4,4,5,5-テトラメチル-1,3,2-ジオキサボロラン)(1.79g、収率72%)を得た。
Figure JPOXMLDOC01-appb-C000071
Under a nitrogen atmosphere, in a 100 mL four-necked flask, 1,4-dibromo-2-fluorobenzene (1.80 g), bispinacholate diboron (3.88 g), potassium acetate (3.53 g), [1,1 ′ -Bis (diphenylphosphino) ferrocene] Dichloropalladium (II) (291 mg) was added, and 1,4-dioxane (36 mL) was added and dissolved. After degassing the reaction solvent, the mixture was stirred with heating under reflux for 17 hours. The reaction mixture was allowed to cool, subjected to a silica gel filtration column (ethyl acetate), and the filtrate was concentrated under reduced pressure. Hexane was added to the obtained crude product, and the precipitate was collected by filtration to obtain 2,2'-(2-fluoro-1,4-phenylene) bis (4,4,5,5-tetramethyl-1). , 3,2-Dioxaborolane) (1.79 g, yield 72%) was obtained.
Figure JPOXMLDOC01-appb-C000071
 窒素雰囲気下、10mLシュレンク管に、2,2’-(2-フルオロ-1,4-フェニレン)ビス(4,4,5,5-テトラメチル-1,3,2-ジオキサボロラン)(200mg)、2-ブロモ-4,6-ジフェニル-1,3,5-トリアジン(565mg)、炭酸カリウム(557mg)、テトラキストリフェニルホスフィンパラジウム(45mg)を入れ、THF(4mL)、水(1.3mL)を加えて溶解させた。反応溶媒を脱気後、加熱還流しながら17時間撹拌した。反応液の放冷後、水を加えたところ白色固体が析出した。析出物をろ取後、酢酸エチルで洗浄し、中間体A9(321mg、収率100%)を得た。中間体A9のH NMRスペクトル及び19F NMRスペクトルをそれぞれ図23及び図24に示す。 In a nitrogen atmosphere, in a 10 mL Schlenk tube, 2,2'-(2-fluoro-1,4-phenylene) bis (4,4,5,5-tetramethyl-1,3,2-dioxaborolane) (200 mg), Add 2-bromo-4,6-diphenyl-1,3,5-triazine (565 mg), potassium carbonate (557 mg), tetrakistriphenylphosphine palladium (45 mg), and add THF (4 mL) and water (1.3 mL). In addition, it was dissolved. After degassing the reaction solvent, the mixture was stirred with heating under reflux for 17 hours. After allowing the reaction solution to cool, water was added to precipitate a white solid. The precipitate was collected by filtration and washed with ethyl acetate to obtain Intermediate A9 (321 mg, yield 100%). The 1 H NMR spectrum and the 19 F NMR spectrum of Intermediate A9 are shown in FIGS. 23 and 24, respectively.
(実施例1の合成)
Figure JPOXMLDOC01-appb-C000072
 窒素雰囲気下、10mLシュレンク管に中間体D1(170mg)、中間体A1(38mg)、炭酸セシウム(182mg)を入れ、DMSO(2mL)に溶解させた。80℃下2時間反応後に放冷した。反応液に水(5mL)を加え、析出物をろ取した。ろ取物をシリカゲルカラム(ヘキサン:クロロホルム=1:1)に供することで実施例1(120mg、収率69%)を得た。実施例1のH NMRスペクトル及び19F NMRスペクトルをぞれぞれ図25及び図26に示す。
(Synthesis of Example 1)
Figure JPOXMLDOC01-appb-C000072
Intermediate D1 (170 mg), intermediate A1 (38 mg) and cesium carbonate (182 mg) were placed in a 10 mL Schlenk tube under a nitrogen atmosphere and dissolved in DMSO (2 mL). After reacting at 80 ° C. for 2 hours, the mixture was allowed to cool. Water (5 mL) was added to the reaction solution, and the precipitate was collected by filtration. Example 1 (120 mg, yield 69%) was obtained by subjecting the filtrate to a silica gel column (hexane: chloroform = 1: 1). The 1 H NMR spectrum and the 19 F NMR spectrum of Example 1 are shown in FIGS. 25 and 26, respectively.
(実施例2の合成)
Figure JPOXMLDOC01-appb-C000073
(Synthesis of Example 2)
Figure JPOXMLDOC01-appb-C000073
 窒素雰囲気下、10mLシュレンク管に中間体D1(285mg)、中間体A2(144mg)、炭酸セシウム(305mg)を入れ、NMP(15mL)に懸濁させた。130℃下21時間反応後に放冷した。反応液に水(5mL)を加え、析出物をろ取した。ろ取物を昇華精製することで実施例2(346mg、収率96%)を得た。実施例2のH NMRスペクトル及び19F NMRスペクトルをそれぞれ図27及び図28に示す。 Intermediate D1 (285 mg), intermediate A2 (144 mg) and cesium carbonate (305 mg) were placed in a 10 mL Schlenk tube under a nitrogen atmosphere and suspended in NMP (15 mL). After the reaction at 130 ° C. for 21 hours, the mixture was allowed to cool. Water (5 mL) was added to the reaction solution, and the precipitate was collected by filtration. Example 2 (346 mg, yield 96%) was obtained by sublimating and purifying the filtrate. The 1 H NMR spectrum and the 19 F NMR spectrum of Example 2 are shown in FIGS. 27 and 28, respectively.
(実施例3及び4の合成)
Figure JPOXMLDOC01-appb-C000074
 (実施例3:R=Ph、実施例4:R=Me)
(Synthesis of Examples 3 and 4)
Figure JPOXMLDOC01-appb-C000074
(Example 3: R = Ph, Example 4: R = Me)
 窒素雰囲気下、10mLシュレンク管に中間体D1(285mg)、中間体A3(144mg)、炭酸セシウム(305mg)を入れ、NMP(15mL)に懸濁させた。130℃下21時間反応後に放冷した。反応液に水(5mL)を加え、析出物をろ取した。ろ取物を昇華精製することで実施例3(355mg、収率98%)を得た。実施例3のH NMRスペクトル及び19F NMRスペクトルをそれぞれ図29及び図30に示す。
 窒素雰囲気下、10mLシュレンク管に中間体D2(125mg)、中間体A3(87mg)、炭酸セシウム(184mg)を入れ、NMP(5mL)に懸濁させた。130℃下2時間反応後に放冷した。反応液に水(5mL)を加え、析出物をろ取した。ろ取物を昇華精製することで実施例4(58mg、収率27%)を得た。実施例4のH NMRスペクトル及び19F NMRスペクトルをそれぞれ図31及び図32に示す。
Intermediate D1 (285 mg), intermediate A3 (144 mg) and cesium carbonate (305 mg) were placed in a 10 mL Schlenk tube under a nitrogen atmosphere and suspended in NMP (15 mL). After the reaction at 130 ° C. for 21 hours, the mixture was allowed to cool. Water (5 mL) was added to the reaction solution, and the precipitate was collected by filtration. Example 3 (355 mg, yield 98%) was obtained by sublimating and purifying the filtrate. The 1 H NMR spectrum and the 19 F NMR spectrum of Example 3 are shown in FIGS. 29 and 30, respectively.
Intermediate D2 (125 mg), intermediate A3 (87 mg) and cesium carbonate (184 mg) were placed in a 10 mL Schlenk tube under a nitrogen atmosphere and suspended in NMP (5 mL). After reacting at 130 ° C. for 2 hours, the mixture was allowed to cool. Water (5 mL) was added to the reaction solution, and the precipitate was collected by filtration. Example 4 (58 mg, yield 27%) was obtained by sublimating and purifying the filtrate. The 1 H NMR spectrum and the 19 F NMR spectrum of Example 4 are shown in FIGS. 31 and 32, respectively.
(実施例5の合成)
Figure JPOXMLDOC01-appb-C000075
(Synthesis of Example 5)
Figure JPOXMLDOC01-appb-C000075
 窒素雰囲気下、10mLシュレンク管に中間体D2(125mg)、中間体A8(86mg)、炭酸セシウム(184mg)を入れ、NMP(5mL)に溶解させた。150℃下22時間反応させた。反応液を放冷し水を加えたところ、肌色固体が析出した。析出物をろ取後、昇華精製することで実施例5(89mg、収率50%)を得た。質量分析(ASAP, positive)により同定した。 Under a nitrogen atmosphere, intermediate D2 (125 mg), intermediate A8 (86 mg), and cesium carbonate (184 mg) were placed in a 10 mL Schlenk tube and dissolved in NMP (5 mL). The reaction was carried out at 150 ° C. for 22 hours. When the reaction solution was allowed to cool and water was added, a flesh-colored solid was precipitated. The precipitate was collected by filtration and then sublimated and purified to give Example 5 (89 mg, yield 50%). It was identified by mass spectrometry (ASAP, positive).
(実施例6の合成)
Figure JPOXMLDOC01-appb-C000076
(Synthesis of Example 6)
Figure JPOXMLDOC01-appb-C000076
 窒素雰囲気下、10mLシュレンク管に中間体A9(287mg)、中間体D3(360mg)、炭酸セシウム(591mg)を入れ、NMP(5.8mL)に溶解させた。130℃下22時間反応させた。反応液を放冷し水を加えたところ、肌色固体が析出した。析出物をろ取後、昇華精製することで実施例6(417mg、収率70%)を得た。質量分析(ASAP, positive)により同定した。 Under a nitrogen atmosphere, intermediate A9 (287 mg), intermediate D3 (360 mg), and cesium carbonate (591 mg) were placed in a 10 mL Schlenk tube and dissolved in NMP (5.8 mL). The reaction was carried out at 130 ° C. for 22 hours. When the reaction solution was allowed to cool and water was added, a flesh-colored solid was precipitated. The precipitate was collected by filtration and then sublimated and purified to give Example 6 (417 mg, yield 70%). It was identified by mass spectrometry (ASAP, positive).
(比較例1)
 比較例1は、下記式:
Figure JPOXMLDOC01-appb-C000077
で表される化合物であり、Lumtec社製品(http://www.lumtec.com.tw/portal_c1_cnt_page.php?owner_num=c1_290785&button_num=c1&folder_id=36067&cnt_id=396136&search_field=&search_word=&search_field2=&search_word2=&search_field3=&search_word3=&bool1=&bool2=&search_type=1&up_page=3)
を使用した。
(Comparative Example 1)
Comparative Example 1 has the following formula:
Figure JPOXMLDOC01-appb-C000077
It is a compound represented by Lumtec (http://www.lumtec.com.tw/portal_c1_cnt_page.php?owner_num=c1_290785&button_num=c1&folder_id=36067&cnt_id=396136&search_field Will & Search_word = & search_field2 = & search_word2 = & search_field3 = & search_word & bool2 = & search_type = 1 & up_page = 3)
It was used.
(比較例2~4)
 比較例2~4は、それぞれ、下記式:
Figure JPOXMLDOC01-appb-C000078
で表される化合物であり、国際公開第2018047948号に記載の方法で合成した。
(Comparative Examples 2 to 4)
Comparative Examples 2 to 4 have the following formulas, respectively:
Figure JPOXMLDOC01-appb-C000078
It is a compound represented by, and was synthesized by the method described in International Publication No. 2018047948.
(比較例5の合成)
Figure JPOXMLDOC01-appb-C000079
(Synthesis of Comparative Example 5)
Figure JPOXMLDOC01-appb-C000079
 反応の1段階目として、窒素雰囲気下、30mLナスフラスコに、中間体A1(500mg)、2,7-ビストリフルオロメチルカルバゾール(444mg)、炭酸セシウム(961mg)を入れ、DMSO(20mL)に溶解させた。85℃で3時間撹拌した後、室温まで放冷した。反応溶液に水(12mL)、クロロホルム(10mL)を加え、10分間静置した。析出した灰色の結晶をろ取し、水(2mL)、クロロホルム(3mL)で洗浄することで、9-(4-(4,6-ジフェニル-1,3,5-トリアジン-2-イル)-2,6-ジフルオロフェニル)-2,7-ビス(トリフルオロメチル)-9H-カルバゾール(766mg、収率86%)を得た。 反応の2段階目として、窒素雰囲気下、30mLナスフラスコに、9-(4-(4,6-ジフェニル-1,3,5-トリアジン-2-イル)-2,6-ジフルオロフェニル)-2,7-ビス(トリフルオロメチル)-9H-カルバゾール(499mg)、カルバゾール(274mg)、炭酸セシウム(1.158g)を入れ、DMSO(20mL)に溶解させた。120℃で18時間撹拌した後、室温まで放冷した。次に、反応溶液に水(15mL)を加え、40分間静置した。析出した灰色の結晶をろ取し、冷クロロホルム(2mL)で洗浄することで比較例5(515mg、収率71%)を得た。比較例5のH NMRスペクトルを図33に示す。 As the first step of the reaction, intermediate A1 (500 mg), 2,7-bistrifluoromethylcarbazole (444 mg) and cesium carbonate (961 mg) were placed in a 30 mL eggplant flask under a nitrogen atmosphere and dissolved in DMSO (20 mL). rice field. After stirring at 85 ° C. for 3 hours, the mixture was allowed to cool to room temperature. Water (12 mL) and chloroform (10 mL) were added to the reaction solution, and the mixture was allowed to stand for 10 minutes. The precipitated gray crystals were collected by filtration and washed with water (2 mL) and chloroform (3 mL) to form 9- (4- (4,6-diphenyl-1,3,5-triazine-2-yl)-. 2,6-Difluorophenyl) -2,7-bis (trifluoromethyl) -9H-carbazole (766 mg, yield 86%) was obtained. As the second step of the reaction, 9-(4- (4,6-diphenyl-1,3,5-triazine-2-yl) -2,6-difluorophenyl) -2 was placed in a 30 mL eggplant flask under a nitrogen atmosphere. , 7-Bis (trifluoromethyl) -9H-carbazole (499 mg), carbazole (274 mg) and cesium carbonate (1.158 g) were added and dissolved in DMSO (20 mL). After stirring at 120 ° C. for 18 hours, the mixture was allowed to cool to room temperature. Next, water (15 mL) was added to the reaction solution, and the mixture was allowed to stand for 40 minutes. The precipitated gray crystals were collected by filtration and washed with cold chloroform (2 mL) to obtain Comparative Example 5 (515 mg, yield 71%). The 1 H NMR spectrum of Comparative Example 5 is shown in FIG. 33.
(比較例6の合成)
Figure JPOXMLDOC01-appb-C000080
(Synthesis of Comparative Example 6)
Figure JPOXMLDOC01-appb-C000080
 窒素雰囲気下、30mLナスフラスコに、9-(4-(4,6-ジフェニル-1,3,5-トリアジン-2-イル)-2,6-ジフルオロフェニル)-2,7-ビス(トリフルオロメチル)-9H-カルバゾール(65mg)、3,6-ジフェニルカルバゾール(80mg)、炭酸セシウム(82mg)を入れ、DMSO(3mL)に溶解させた。100℃で18時間撹拌した後、室温まで放冷した。次に、反応溶液に水(15mL)を加え、40分間静置した。析出した灰色の結晶をろ取し、IPA(2mL)で洗浄後、昇華することで比較例6(85mg、収率68%)を得た。比較例6のH NMRスペクトル及び19F NMRスペクトルをそれぞれ図34及び図35に示す。 In a nitrogen atmosphere, in a 30 mL eggplant flask, 9- (4- (4,6-diphenyl-1,3,5-triazine-2-yl) -2,6-difluorophenyl) -2,7-bis (trifluoro) Methyl) -9H-carbazole (65 mg), 3,6-diphenylcarbazole (80 mg) and cesium carbonate (82 mg) were added and dissolved in DMSO (3 mL). After stirring at 100 ° C. for 18 hours, the mixture was allowed to cool to room temperature. Next, water (15 mL) was added to the reaction solution, and the mixture was allowed to stand for 40 minutes. The precipitated gray crystals were collected by filtration, washed with IPA (2 mL), and then sublimated to obtain Comparative Example 6 (85 mg, yield 68%). The 1 H NMR spectrum and the 19 F NMR spectrum of Comparative Example 6 are shown in FIGS. 34 and 35, respectively.
(比較例7~9の合成)
 比較例7~9は、それぞれ、下記式:
Figure JPOXMLDOC01-appb-C000081
で表される化合物であり、Nature 2012, 492 (13), 234-238.に記載の方法で合成した。
(Synthesis of Comparative Examples 7 to 9)
Comparative Examples 7 to 9 have the following formulas, respectively:
Figure JPOXMLDOC01-appb-C000081
It is a compound represented by, and was synthesized by the method described in Nature 2012, 492 (13), 234-238.
(比較例10の合成)
 比較例10は、下記式:
Figure JPOXMLDOC01-appb-C000082
で表される化合物であり、中国特許出願公開公報107384364号に記載の方法で合成した。比較例10のH NMRスペクトル及び13C NMRスペクトルをそれぞれ図36及び図37に示す。
(Synthesis of Comparative Example 10)
Comparative Example 10 has the following formula:
Figure JPOXMLDOC01-appb-C000082
It is a compound represented by, and was synthesized by the method described in Chinese Patent Application Publication No. 107384364. The 1 H NMR spectrum and the 13 C NMR spectrum of Comparative Example 10 are shown in FIGS. 36 and 37, respectively.
(比較例11の合成)
 比較例11は、下記式:
Figure JPOXMLDOC01-appb-C000083
で表される化合物であり、国際公開第2019087936号に記載の方法で合成した。比較例11のH NMRスペクトル及び19F NMRスペクトルをそれぞれ図38及び図39に示す。
(Synthesis of Comparative Example 11)
Comparative Example 11 has the following formula:
Figure JPOXMLDOC01-appb-C000083
It is a compound represented by, and was synthesized by the method described in International Publication No. 2019087936. The 1 H NMR spectrum and the 19 F NMR spectrum of Comparative Example 11 are shown in FIGS. 38 and 39, respectively.
(比較例12の合成)
 比較例12は、下記式:
Figure JPOXMLDOC01-appb-C000084
で表される化合物であり、比較例11の合成において、原料の3,6-ビス(トリフルオロメチル)カルバゾールの代わりに2,7-ビス(トリフルオロメチル)カルバゾールを用いて合成した。質量分析(ASAP, positive)により目的物のm/zを確認した。
(Synthesis of Comparative Example 12)
Comparative Example 12 has the following formula:
Figure JPOXMLDOC01-appb-C000084
In the synthesis of Comparative Example 11, the compound represented by was synthesized using 2,7-bis (trifluoromethyl) carbazole instead of the raw material 3,6-bis (trifluoromethyl) carbazole. The m / z of the target object was confirmed by mass spectrometry (ASAP, positive).
(比較例13の合成)
Figure JPOXMLDOC01-appb-C000085
(Synthesis of Comparative Example 13)
Figure JPOXMLDOC01-appb-C000085
 窒素雰囲気下、10mLシュレンク管に中間体D1(170mg)、4,5-ジフルオロフタロニトリル(24mg)、炭酸セシウム(182mg)を入れ、DMSO(2mL)に溶解させた。80℃下2時間反応後に放冷した。反応液に水(5mL)を加え、析出物をろ取した。ろ取物をシリカゲルカラム(ヘキサン:クロロホルム=1:1)に供することで比較例13(20mg、収率13%)を得た。比較例13のH NMRスペクトル及び19F NMRスペクトルをそれぞれ図40及び図41に示す。 Intermediate D1 (170 mg), 4,5-difluorophthalonitrile (24 mg) and cesium carbonate (182 mg) were placed in a 10 mL Schlenk tube under a nitrogen atmosphere and dissolved in DMSO (2 mL). After reacting at 80 ° C. for 2 hours, the mixture was allowed to cool. Water (5 mL) was added to the reaction solution, and the precipitate was collected by filtration. Comparative Example 13 (20 mg, yield 13%) was obtained by subjecting the filtrate to a silica gel column (hexane: chloroform = 1: 1). The 1 H NMR spectrum and the 19 F NMR spectrum of Comparative Example 13 are shown in FIGS. 40 and 41, respectively.
(発光極大波長(λmax)、半値幅)
 比較例及び実施例のλmax、半値幅、及びCIEは、発光材料のトルエン溶液(発光材料濃度:1×10-5M)に室温下340nmの励起光を照射した場合の発光スペクトルを、HORIBA社製Fluoromax 4 を用いて測定し、当該発光スペクトルを基に次のように測定した。
 λmaxは、ピークトップの波長により測定した。
 半値幅は、ピークトップ強度の半分の値のスペクトル幅により測定した。
(Maximum emission wavelength (λmax), full width at half maximum)
Λmax, full width at half maximum, and CIE of Comparative Examples and Examples show the emission spectrum when a toluene solution of luminescent material (luminescent material concentration: 1 × 10-5 M) is irradiated with excitation light at 340 nm at room temperature. It was measured using Fluoromax 4 manufactured by Fluoromax 4 manufactured by Fluoromax 4 and measured as follows based on the emission spectrum.
λmax was measured by the wavelength of the peak top.
The full width at half maximum was measured by the spectral width of half the value of the peak top intensity.
(発光効率(PLQY))
 比較例及び実施例のPLQYは、発光材料のトルエン溶液(発光材料濃度:1×10-5M)に室温下340nmの励起光を照射した場合の値であり、絶対PL量子収率測定装置(浜松ホトニクス社製 Quantaurus-QY C11347-01)を用いて測定した。
(Luminous efficiency (PLQY))
The PLQY of Comparative Examples and Examples is a value when a toluene solution of a light emitting material (light emitting material concentration: 1 × 10-5 M) is irradiated with excitation light of 340 nm at room temperature, and is an absolute PL quantum yield measuring device (absolute PL quantum yield measuring device). It was measured using Quantaurus-QY C11347-01) manufactured by Hamamatsu Photonics.
(HOMO準位)
 比較例及び実施例のHOMO準位は、大気中光電子分光装置(理研計器株式会社製AC―3)を用いて測定した。測定サンプルは、発光材料をITO基板上に膜厚50nmとなるよう真空蒸着したものを用いた。測定は、紫外光強度10nW、測定範囲-4.00eVから-7.00eV(0.05eV刻み)で行い、紫外線照射時の光電子放出のエネルギーしきい値をHOMO準位とした。
(HOMO level)
The HOMO levels of Comparative Examples and Examples were measured using an atmospheric photoelectron spectrometer (AC-3 manufactured by RIKEN Keiki Co., Ltd.). As the measurement sample, a light emitting material vacuum-deposited on an ITO substrate so as to have a film thickness of 50 nm was used. The measurement was carried out with an ultraviolet light intensity of 10 nW and a measurement range of -4.00 eV to -7.00 eV (in increments of 0.05 eV), and the energy threshold value of photoelectron emission during ultraviolet irradiation was set as the HOMO level.
(配向度パラメータS)
 比較例及び実施例の配向度パラメータSは、発光材料の単膜 (膜厚 約 30nm) をベアシリコン基板上に作製し、分光エリプソメータ(J.A. Woollam Japan製品) を使用して45~75度(5度刻み)の範囲でスペクトル測定を行い、得られたスペクトルのフィッティング解析により算出した。
(Orientation parameter S)
The orientation parameter S of Comparative Examples and Examples is 45 to 75 degrees (5) using a spectroscopic ellipsometer (JA Woollam Japan product) after forming a single film (thickness of about 30 nm) of the light emitting material on a bare silicon substrate. The spectrum was measured in the range of (in increments), and the spectrum was calculated by fitting analysis of the obtained spectrum.
(酸化還元特性ΔE)
 比較例及び実施例の酸化還元特性は、以下の測定条件でサイクリックボルタンメトリー測定を行うことにより算出した。
<測定条件>
作用極:グラッシーカーボン
対極:白金ワイヤ
参照極:Ag/AgNOアセトニトリル溶液
溶媒:THF
電解質:BuNPF
走引速度:50meV/s
発光材料濃度:1mM
電解質濃度:100mM
(Redox characteristic ΔE)
The redox characteristics of Comparative Examples and Examples were calculated by performing cyclic voltammetry measurement under the following measurement conditions.
<Measurement conditions>
Working electrode: Glassy carbon Counter electrode: Platinum wire Reference electrode: Ag / AgNO 3 Acetonitrile solution Solvent: THF
Electrolyte: Bu 4 NPF 6
Running speed: 50 meV / s
Luminescent material concentration: 1 mM
Electrolyte concentration: 100 mM
 結果を表1に示す。
Figure JPOXMLDOC01-appb-T000086
The results are shown in Table 1.
Figure JPOXMLDOC01-appb-T000086

Claims (14)

  1.  下記式(1)で表される化合物:
    Cz-L-Ar (1)
    [式中、
    Czは、下記式(2):
    Figure JPOXMLDOC01-appb-C000001
    (式中、
    Zは、不存在、単結合、-C(R29a)(R29b)-、-O-、-S-、又は-N(R29c)-であり、
    22及びR27は、それぞれ、電子求引性基であり、
    23及びR26は、それぞれ、電子供与性基であり、
    21、R24、R25、R28、R29a、R29b、及びR29cは、それぞれ、水素原子、電子求引性基、又は電子供与性基であり、
    波線は、Lとの結合部位を示す)
    で表される基であり、
    Lは、単結合、又は置換基を有していてもよいフェニレン基であり、
    Arは、アリール基及びヘテロアリール基からなる群より選択される基であり、当該基は、置換基を有していてもよいN,N-ジアリールアミノ基、置換基を有していてもよいシクロアルキル基、置換基を有していてもよいアリール基、及び置換基を有していてもよいヘテロアリール基から選択される少なくとも一種の置換基を有していてもよい(但し、Arは、式(2)で表される基ではない)]。
    Compound represented by the following formula (1):
    Cz-L-Ar (1)
    [During the ceremony,
    Cz is calculated by the following equation (2):
    Figure JPOXMLDOC01-appb-C000001
    (During the ceremony,
    Z is absent, single bond, -C (R 29a ) (R 29b )-, -O-, -S-, or -N (R 29c )-.
    R 22 and R 27 are electron-attracting groups, respectively, and
    R 23 and R 26 are electron-donating groups, respectively.
    R 21 , R 24 , R 25 , R 28 , R 29a , R 29b , and R 29c are hydrogen atoms, electron attracting groups, or electron donating groups, respectively.
    The wavy line indicates the binding site with L)
    It is a group represented by
    L is a phenylene group which may have a single bond or a substituent, and is a phenylene group.
    Ar is a group selected from the group consisting of an aryl group and a heteroaryl group, and the group may have an N, N-diarylamino group or a substituent which may have a substituent. It may have at least one substituent selected from a cycloalkyl group, an aryl group which may have a substituent, and a heteroaryl group which may have a substituent (where Ar is. , Not a group represented by equation (2))].
  2.  Arが、フェニル基、縮合二乃至六環式アリール基、及び窒素含有ヘテロアリール基からなる群より選択される基であり、当該基は、置換基を有していてもよいN,N-ジアリールアミノ基、置換基を有していてもよいシクロアルキル基、置換基を有していてもよいアリール基、及び置換基を有していてもよいヘテロアリール基から選択される少なくとも一種の置換基を有していてもよい(但し、Arは、式(2)で表される基ではない)、請求項1に記載の化合物。 Ar is a group selected from the group consisting of a phenyl group, a fused bi to hexacyclic aryl group, and a nitrogen-containing heteroaryl group, and the group may have a substituent N, N-diaryl. At least one substituent selected from an amino group, a cycloalkyl group which may have a substituent, an aryl group which may have a substituent, and a heteroaryl group which may have a substituent. (However, Ar is not a group represented by the formula (2)), and the compound according to claim 1.
  3.  Arが、下記式(3):
    Figure JPOXMLDOC01-appb-C000002
    (式中、
    31~X35は、それぞれ、-N=又は-C(R)=であり、
    は、水素原子、置換基を有していてもよいN,N-ジアリールアミノ基、置換基を有していてもよいシクロアルキル基、置換基を有していてもよいアリール基、又は置換基を有していてもよいヘテロアリール基であり、
    互いにオルトの位置関係で存在し得る2つのRは、互いに結合して芳香環を形成していてもよく、当該芳香環は、置換基を有していてもよいN,N-ジアリールアミノ基、置換基を有していてもよいシクロアルキル基、置換基を有していてもよいアリール基、及び置換基を有していてもよいヘテロアリール基から選択される少なくとも一種の置換基を有していてもよく、
    波線は、Lとの結合部位を示す)
    で表される基である、請求項1又は2に記載の化合物。
    Ar is the following formula (3):
    Figure JPOXMLDOC01-appb-C000002
    (During the ceremony,
    X 31 to X 35 are -N = or -C (R 3 ) =, respectively.
    R 3 is a hydrogen atom, an N, N-diarylamino group which may have a substituent, a cycloalkyl group which may have a substituent, an aryl group which may have a substituent, or It is a heteroaryl group that may have a substituent and
    The two R 3 which may be present in a positional relationship ortho to each other, may form an aromatic ring bonded to each other, the aromatic ring may have a substituent N, N-diarylamino group Has at least one substituent selected from a cycloalkyl group which may have a substituent, an aryl group which may have a substituent, and a heteroaryl group which may have a substituent. You may be
    The wavy line indicates the binding site with L)
    The compound according to claim 1 or 2, which is a group represented by.
  4.  式(3)で表される基が、下記式(3-1)~(3-4):
    Figure JPOXMLDOC01-appb-C000003
    (式中、
    311、R312、R321~R323、R331~R336、及びR341~R346は、それぞれ、水素原子、置換基を有していてもよいN,N-ジアリールアミノ基、置換基を有していてもよいシクロアルキル基、置換基を有していてもよいアリール基、又は置換基を有していてもよいヘテロアリール基であり、
    波線は、Lとの結合部位を示す)
    のいずれかで表される基である、請求項3に記載の化合物。
    The groups represented by the formula (3) are the following formulas (3-1) to (3-4):
    Figure JPOXMLDOC01-appb-C000003
    (During the ceremony,
    R 311 and R 312 , R 321 to R 323 , R 331 to R 336 , and R 341 to R 346 , respectively, have a hydrogen atom and an N, N-diarylamino group and a substituent which may have a substituent. A cycloalkyl group which may have a substituent, an aryl group which may have a substituent, or a heteroaryl group which may have a substituent.
    The wavy line indicates the binding site with L)
    The compound according to claim 3, which is a group represented by any of the above.
  5.  Lが、式(2)で表される基及び式(3)で表される基からなる群より選択される少なくとも一種の置換基を有していてもよいフェニレン基である、請求項3又は4に記載の化合物。 Claim 3 or claim L is a phenylene group which may have at least one substituent selected from the group consisting of a group represented by the formula (2) and a group represented by the formula (3). The compound according to 4.
  6.  Zが単結合である、請求項1~5のいずれかに記載の化合物。 The compound according to any one of claims 1 to 5, wherein Z is a single bond.
  7.  R22及びR27が、それぞれ、パーフルオロアルキル基又はシアノ基である、請求項1~6のいずれかに記載の化合物。 The compound according to any one of claims 1 to 6, wherein R 22 and R 27 are perfluoroalkyl groups or cyano groups, respectively.
  8.  R23及びR26が、それぞれ、アルキル基、アルコキシ基、トリアルキルシリル基、置換基を有していてもよいN,N-ジアリールアミノ基、置換基を有していてもよいシクロアルキル基、置換基を有していてもよいアリール基、又は置換基を有していてもよいヘテロアリール基である、請求項1~7のいずれかに記載の化合物。 R 23 and R 26 each have an alkyl group, an alkoxy group, a trialkylsilyl group, an N, N-diarylamino group which may have a substituent, a cycloalkyl group which may have a substituent, and the like. The compound according to any one of claims 1 to 7, which is an aryl group which may have a substituent or a heteroaryl group which may have a substituent.
  9.  R21、R24、R25、及びR28が、水素原子である、又は
     R21及びR28が、それぞれ、電子供与性基であり、R24及びR25が、それぞれ、電子求引性基である、
    請求項1~8のいずれかに記載の化合物。
    R 21 , R 24 , R 25 , and R 28 are hydrogen atoms, or R 21 and R 28 are electron donating groups, respectively, and R 24 and R 25 are electron attracting groups, respectively. Is,
    The compound according to any one of claims 1 to 8.
  10.  下記式(4)で表される化合物:
    Figure JPOXMLDOC01-appb-C000004
    [式中、
    41~X43は、それぞれ、-N=又は-C(R44)=であり、
    41~R44は、それぞれ、水素原子、置換基を有していてもよいN,N-ジアリールアミノ基、置換基を有していてもよいシクロアルキル基、置換基を有していてもよいアリール基、又は置換基を有していてもよいヘテロアリール基(但し、R41~R43のうち、少なくとも1つは、式(2)で表される基)である];
     下記式(5)で表される化合物:
    Figure JPOXMLDOC01-appb-C000005
    [式中、
    51~X53は、それぞれ、-N=又は-C(R58)=であり、
    51、R52、及びR58は、それぞれ、水素原子、置換基を有していてもよいN,N-ジアリールアミノ基、置換基を有していてもよいシクロアルキル基、置換基を有していてもよいアリール基、又は置換基を有していてもよいヘテロアリール基であり、
    53~R57は、それぞれ、水素原子又は式(2)で表される基(但し、R53~R57のうち、少なくとも1つは、式(2)で表される基)である];
     下記式(6)で表される化合物:
    Figure JPOXMLDOC01-appb-C000006
    [式中、
    61~X67は、それぞれ、-N=又は-C(R66)=であり、
    61~R65は、それぞれ、水素原子又は式(2)で表される基(但し、R61~R65のうち、少なくとも1つは、式(2)で表される基)であり、
    66は、水素原子、置換基を有していてもよいN,N-ジアリールアミノ基、置換基を有していてもよいシクロアルキル基、置換基を有していてもよいアリール基、又は置換基を有していてもよいヘテロアリール基である];
     下記式(7)で表される化合物:
    Figure JPOXMLDOC01-appb-C000007
    [式中、
    71~X76は、それぞれ、-N=又は-C(R79)=であり、
    71~R74及びR79は、それぞれ、水素原子、置換基を有していてもよいN,N-ジアリールアミノ基、置換基を有していてもよいシクロアルキル基、置換基を有していてもよいアリール基、又は置換基を有していてもよいヘテロアリール基であり、
    75~R78は、水素原子又は式(2)で表される基(但し、R75~R78のうち、少なくとも1つは、式(2)で表される基)である];及び
     下記式(8)で表される化合物:
    Figure JPOXMLDOC01-appb-C000008
    [式中、
    81~X86は、それぞれ、-N=又は-C(R89)=であり、
    81~R84及びR89は、それぞれ、水素原子、置換基を有していてもよいN,N-ジアリールアミノ基、置換基を有していてもよいシクロアルキル基、置換基を有していてもよいアリール基、又は置換基を有していてもよいヘテロアリール基であり、
    85~R88は、水素原子又は式(2)で表される基(但し、R85~R88のうち、少なくとも1つは、式(2)で表される基)である]
    からなる群より選択される、請求項1に記載の化合物。
    Compound represented by the following formula (4):
    Figure JPOXMLDOC01-appb-C000004
    [During the ceremony,
    X 41 to X 43 are -N = or -C (R 44 ) =, respectively.
    R 41 to R 44 may have a hydrogen atom, an N, N-diarylamino group which may have a substituent, a cycloalkyl group which may have a substituent, and a substituent, respectively. A good aryl group or a heteroaryl group which may have a substituent (provided that at least one of R 41 to R 43 is a group represented by the formula (2))];
    Compound represented by the following formula (5):
    Figure JPOXMLDOC01-appb-C000005
    [During the ceremony,
    X 51 to X 53 are -N = or -C (R 58 ) =, respectively.
    R 51 , R 52 , and R 58 each have a hydrogen atom, an N, N-diarylamino group which may have a substituent, a cycloalkyl group which may have a substituent, and a substituent, respectively. It is an aryl group which may have a substituent or a heteroaryl group which may have a substituent.
    Each of R 53 to R 57 is a hydrogen atom or a group represented by the formula (2) (however , at least one of R 53 to R 57 is a group represented by the formula (2))]. ;
    Compound represented by the following formula (6):
    Figure JPOXMLDOC01-appb-C000006
    [During the ceremony,
    X 61 to X 67 are -N = or -C (R 66 ) =, respectively.
    R 61 to R 65 are hydrogen atoms or groups represented by the formula (2), respectively (however , at least one of R 61 to R 65 is a group represented by the formula (2)).
    R 66 is a hydrogen atom, an N, N-diarylamino group which may have a substituent, a cycloalkyl group which may have a substituent, an aryl group which may have a substituent, or It is a heteroaryl group that may have a substituent];
    Compound represented by the following formula (7):
    Figure JPOXMLDOC01-appb-C000007
    [During the ceremony,
    X 71 to X 76 are -N = or -C (R 79 ) =, respectively.
    R 71 to R 74 and R 79 each have a hydrogen atom, an N, N-diarylamino group which may have a substituent, a cycloalkyl group which may have a substituent, and a substituent, respectively. It is an aryl group that may be present, or a heteroaryl group that may have a substituent, and is
    R 75 to R 78 are hydrogen atoms or groups represented by the formula (2) (provided that at least one of R 75 to R 78 is a group represented by the formula (2))]; Compound represented by the following formula (8):
    Figure JPOXMLDOC01-appb-C000008
    [During the ceremony,
    X 81 to X 86 are −N = or −C (R 89 ) =, respectively.
    R 81 to R 84 and R 89 each have a hydrogen atom, an N, N-diarylamino group which may have a substituent, a cycloalkyl group which may have a substituent, and a substituent, respectively. It is an aryl group that may be present, or a heteroaryl group that may have a substituent, and is
    R 85 to R 88 are hydrogen atoms or groups represented by the formula (2) (however , at least one of R 85 to R 88 is a group represented by the formula (2))].
    The compound according to claim 1, which is selected from the group consisting of.
  11.  請求項1~10のいずれかに記載の化合物を含む遅延蛍光材料。 A delayed fluorescent material containing the compound according to any one of claims 1 to 10.
  12.  請求項1~10のいずれかに記載の化合物を含む有機発光素子。 An organic light emitting device containing the compound according to any one of claims 1 to 10.
  13.  有機EL素子である、請求項12に記載の有機発光素子。 The organic light emitting element according to claim 12, which is an organic EL element.
  14.  下記式(9):
    Figure JPOXMLDOC01-appb-C000009
    (式中、
    91及びR94は、それぞれ、パーフルオロアルキル基又はシアノ基であり、
    92及びR93は、それぞれ、アルキル基、アルコキシ基、トリアルキルシリル基、置換基を有していてもよいN,N-ジアリールアミノ基、置換基を有していてもよいシクロアルキル基、置換基を有していてもよいアリール基、又は置換基を有していてもよいヘテロアリール基であり、
    は、不存在、単結合、-C(R95)(R96)-、-O-、-S-、又は-N(R97)-であり、
    95~R97は、それぞれ、水素原子、電子求引性基、又は電子供与性基である)
    で表される化合物(但し、Zが不存在であり、R91及びR94がトリフルオロメチル基であり、R92及びR93がメトキシ基である化合物、並びに、Zが不存在であり、R91及びR94がシアノ基であり、R92及びR93がフェニル基である化合物を除く)。
    The following formula (9):
    Figure JPOXMLDOC01-appb-C000009
    (During the ceremony,
    R 91 and R 94 are perfluoroalkyl groups or cyano groups, respectively.
    R 92 and R 93 are an alkyl group, an alkoxy group, a trialkylsilyl group, an N, N-diarylamino group which may have a substituent, and a cycloalkyl group which may have a substituent, respectively. An aryl group which may have a substituent or a heteroaryl group which may have a substituent.
    Z 9 is absent, single bond, -C (R 95 ) (R 96 )-, -O-, -S-, or -N (R 97 )-, and
    R 95 to R 97 are a hydrogen atom, an electron attracting group, or an electron donating group, respectively)
    Compounds represented by (where Z 9 is absent, R 91 and R 94 are trifluoromethyl groups, R 92 and R 93 are methoxy groups, and Z 9 is absent. , R 91 and R 94 are cyano groups, and R 92 and R 93 are phenyl groups).
PCT/JP2021/016414 2020-04-28 2021-04-23 Nitrogen-containing heterocyclic compound and use thereof WO2021220952A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020-079716 2020-04-28
JP2020079716A JP2021172629A (en) 2020-04-28 2020-04-28 Nitrogen-containing heterocyclic compound and use thereof

Publications (1)

Publication Number Publication Date
WO2021220952A1 true WO2021220952A1 (en) 2021-11-04

Family

ID=78279498

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2021/016414 WO2021220952A1 (en) 2020-04-28 2021-04-23 Nitrogen-containing heterocyclic compound and use thereof

Country Status (2)

Country Link
JP (1) JP2021172629A (en)
WO (1) WO2021220952A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023149635A1 (en) * 2022-02-02 2023-08-10 Samsung Display Co., Ltd. Organic molecules for optoelectronic devices

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6219875A (en) * 1985-07-18 1987-01-28 Canon Inc Electrophotographic sensitive body
JPH10125468A (en) * 1996-08-30 1998-05-15 Mitsui Chem Inc Organic electroluminescent element
JPH10265773A (en) * 1997-03-24 1998-10-06 Toyo Ink Mfg Co Ltd Positive hole injection material for organic electroluminescence element and organic electroluminescence element using the same
JP2004253298A (en) * 2003-02-21 2004-09-09 Konica Minolta Holdings Inc White light-emitting organic electroluminescent element
JP2005116247A (en) * 2003-10-06 2005-04-28 Mitsui Chemicals Inc Organic electroluminescent element and amine compound
JP2008174661A (en) * 2007-01-19 2008-07-31 Tsujiden Co Ltd Carbazole-based random copolymer
KR20150115225A (en) * 2014-04-03 2015-10-14 (주)피엔에이치테크 An electroluminescent compound and an electroluminescent device comprising the same
WO2016058504A1 (en) * 2014-10-13 2016-04-21 江苏和成新材料有限公司 Aromatic amine derivative and organic electroluminescent device thereof
JP2017103440A (en) * 2015-12-04 2017-06-08 東洋紡株式会社 Organic light-emitting device, and luminescent material and compound that are used therefor
WO2018047948A1 (en) * 2016-09-09 2018-03-15 東洋紡株式会社 Organic light-emitting element, and light-emitting material and compound for use therein
JP6753545B1 (en) * 2020-03-23 2020-09-09 東洋紡株式会社 Nitrogen-containing heterocyclic compounds and their use
JP2021075491A (en) * 2019-11-11 2021-05-20 東洋紡株式会社 Nitrogen-containing heterocyclic compound having perfluoroalkyl group, and use therefor

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6219875A (en) * 1985-07-18 1987-01-28 Canon Inc Electrophotographic sensitive body
JPH10125468A (en) * 1996-08-30 1998-05-15 Mitsui Chem Inc Organic electroluminescent element
JPH10265773A (en) * 1997-03-24 1998-10-06 Toyo Ink Mfg Co Ltd Positive hole injection material for organic electroluminescence element and organic electroluminescence element using the same
JP2004253298A (en) * 2003-02-21 2004-09-09 Konica Minolta Holdings Inc White light-emitting organic electroluminescent element
JP2005116247A (en) * 2003-10-06 2005-04-28 Mitsui Chemicals Inc Organic electroluminescent element and amine compound
JP2008174661A (en) * 2007-01-19 2008-07-31 Tsujiden Co Ltd Carbazole-based random copolymer
KR20150115225A (en) * 2014-04-03 2015-10-14 (주)피엔에이치테크 An electroluminescent compound and an electroluminescent device comprising the same
WO2016058504A1 (en) * 2014-10-13 2016-04-21 江苏和成新材料有限公司 Aromatic amine derivative and organic electroluminescent device thereof
JP2017103440A (en) * 2015-12-04 2017-06-08 東洋紡株式会社 Organic light-emitting device, and luminescent material and compound that are used therefor
WO2018047948A1 (en) * 2016-09-09 2018-03-15 東洋紡株式会社 Organic light-emitting element, and light-emitting material and compound for use therein
JP2021075491A (en) * 2019-11-11 2021-05-20 東洋紡株式会社 Nitrogen-containing heterocyclic compound having perfluoroalkyl group, and use therefor
JP6753545B1 (en) * 2020-03-23 2020-09-09 東洋紡株式会社 Nitrogen-containing heterocyclic compounds and their use

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ASO FUMIHIRO, KAWASHIMA HIDEHISA, FUJIKI MICHIYA, KIJIMA MASASHI: "Synthesis of delayed-emissive poly(2,7-carbazole)s having an anchored triazine pendant at the N-position", POLYMER CHEMISTRY, vol. 10, no. 24, 18 June 2019 (2019-06-18), pages 3318 - 3324, XP055861540, ISSN: 1759-9954, DOI: 10.1039/C9PY00152B *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023149635A1 (en) * 2022-02-02 2023-08-10 Samsung Display Co., Ltd. Organic molecules for optoelectronic devices

Also Published As

Publication number Publication date
JP2021172629A (en) 2021-11-01

Similar Documents

Publication Publication Date Title
CN111357128B (en) Material for organic element, organic electroluminescent element, display device, and lighting device
JP5656534B2 (en) Indolo [3,2,1-jk] carbazole compound and organic light emitting device having the same
TWI468494B (en) Organic electroluminescent elements
JP5399418B2 (en) Organic electroluminescence device
WO2015002213A1 (en) Light-emitting material, long-persistent phosphor, organic light-emitting element and compound
WO2013039073A1 (en) Aromatic amine derivative and organic electroluminescence element using same
US20210143341A1 (en) Compound, material for organic electroluminescence element, organic electroluminescence element, and electronic device
KR101823400B1 (en) Organic electroluminescent element
WO2011081061A1 (en) Organic electroluminescent element
EP2796529B1 (en) Compound for an organic optoelectronic device, organic light-emitting element comprising same, and display device comprising the organic light-emitting element
JP2017226838A (en) Light-emitting material, organic light-emitting element and compound
WO2021095729A1 (en) Nitrogen-containing heterocyclic compound having perfluoroalkyl group, and use therefor
CN107325090B (en) Compound and organic electronic element comprising same
JP6753545B1 (en) Nitrogen-containing heterocyclic compounds and their use
KR20150030616A (en) Hetero-cyclic compound and organic electronic device comprising the same
KR20160095319A (en) Organic electronic element, and an electronic device comprising the same
KR20130100948A (en) New anthracene derivatives and organic electronic device using the same
US20170040546A1 (en) Novel compound and organic electronic device using the same
CN113968875A (en) Electroluminescent material and device
CN107406473B (en) Heteroleptic iridium complex, and light-emitting material and organic light-emitting element using same
WO2021220952A1 (en) Nitrogen-containing heterocyclic compound and use thereof
WO2021149510A1 (en) Pyrromethene boron complex, light-emitting element containing same, light-emitting element, display device, and illumination device
JP5672667B2 (en) Benzo [a] carbazole compound, light-emitting material containing the compound, and organic electroluminescent device using the same
KR20200001134A (en) Novel compound and organic electroluminescent divice including the same
KR102341068B1 (en) Compound, Organic EL Device and Display Device

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21796905

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 21796905

Country of ref document: EP

Kind code of ref document: A1